data_2f2j_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2f2j _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.462 ' SG ' ' HG2' ' A' ' 24' ' ' ARG . 14.5 m . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 121.338 0.59 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.62 -40.09 2.73 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.813 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.9 163.03 4.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.444 0.64 . . . . 0.0 112.289 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 20' ' ' ASN . 27.2 p -111.93 151.88 28.69 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.676 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.2 p -96.41 114.95 26.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.358 0.599 . . . . 0.0 110.499 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -87.35 55.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.984 0.897 . . . . 0.0 110.09 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.93 42.8 0.7 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.525 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.475 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.82 30.19 70.55 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.632 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 15.2 p -129.79 139.97 51.14 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 52.2 m -135.4 132.35 37.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.013 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -73.63 -35.49 65.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.32 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.619 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -61.56 121.79 66.47 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.35 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -56.18 125.52 19.35 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.002 2.468 . . . . 0.0 113.579 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.22 8.52 83.53 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 114.699 -1.137 . . . . 0.0 113.641 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.619 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 90.5 m -93.33 117.26 29.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.865 0.832 . . . . 0.0 111.209 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 p -81.68 138.69 35.23 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.945 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.475 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.3 t -64.79 135.8 56.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.885 0.374 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 20' ' ' ASN . 46.0 m -141.02 -170.98 3.16 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -46.74 83.18 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.485 ' O ' HG22 ' A' ' 4' ' ' THR . 15.5 t-20 58.76 18.94 6.41 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.073 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.406 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 32.3 mmtm -150.49 145.39 25.97 Favored 'General case' 0 C--O 1.223 -0.306 0 O-C-N 121.958 -0.464 . . . . 0.0 111.926 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 36.3 m -88.66 134.63 33.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.4 p -121.37 141.32 51.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.5 ' HG2' ' SG ' ' A' ' 15' ' ' CYS . 10.6 mmm180 -91.46 93.83 9.18 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 m120 58.38 36.46 25.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.053 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.26 -23.82 32.11 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.215 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.3 tp -81.04 114.39 48.38 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 117.41 0.605 . . . . 0.0 111.353 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.51 59.39 5.51 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.325 2.684 . . . . 0.0 112.283 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--N 1.317 -0.847 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.993 -179.133 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 37.3 m . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 121.117 0.484 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.57 38.82 79.01 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.121 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.732 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 5.0 pt-20 -137.84 160.22 39.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.699 0.285 . . . . 0.0 110.512 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 20' ' ' ASN . 15.1 p -113.9 150.81 33.13 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.155 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -94.92 132.05 40.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.107 0.48 . . . . 0.0 110.758 178.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.33 53.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.978 0.894 . . . . 0.0 109.767 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.25 -44.05 1.59 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.868 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.72 34.76 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.246 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 12.9 p -136.22 138.77 42.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 122.734 -0.274 . . . . 0.0 110.411 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.477 ' HB3' ' OE2' ' A' ' 3' ' ' GLU . 90.9 m -128.28 133.68 48.8 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -65.99 -50.8 63.01 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.5 m -69.05 114.85 26.22 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 121.153 0.502 . . . . 0.0 111.208 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.18 125.1 16.64 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.269 1.979 . . . . 0.0 110.965 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.69 -19.68 28.13 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.477 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.5 m -89.23 115.34 26.66 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.254 0.55 . . . . 0.0 110.517 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 p -83.63 134.04 34.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.933 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t -63.33 123.12 17.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.902 0.382 . . . . 0.0 110.252 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 20' ' ' ASN . 13.7 m -120.96 -168.8 1.72 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -47.59 83.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.489 ' O ' HG23 ' A' ' 4' ' ' THR . 28.9 t-20 61.04 15.14 5.92 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.314 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 7.1 mmtp -148.36 138.78 22.72 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 121.91 -0.494 . . . . 0.0 111.539 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.732 ' HB2' ' HG3' ' A' ' 3' ' ' GLU . 38.5 m -88.37 125.44 34.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.4 p -116.8 142.36 47.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.814 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.413 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 28.7 ttt85 -91.51 100.43 13.19 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.9 t30 59.36 40.87 20.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.717 0.77 . . . . 0.0 109.484 -177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.57 -12.39 65.38 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.613 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.542 HD22 HG13 ' A' ' 29' ' ' VAL . 16.2 tp -91.38 113.48 58.63 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 117.442 0.621 . . . . 0.0 110.778 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.97 56.94 3.76 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.429 2.752 . . . . 0.0 113.001 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.542 HG13 HD22 ' A' ' 27' ' ' LEU . 13.5 m . . . . . 0 C--N 1.315 -0.9 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.8 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 48.6 m . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.026 0.441 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.87 -36.56 2.32 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.689 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 23.1 mt-10 -57.88 173.88 0.29 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.92 -178.44 3.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.881 178.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -129.18 134.81 48.18 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.191 0.519 . . . . 0.0 111.25 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -79.85 53.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.996 0.903 . . . . 0.0 109.58 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.27 -44.28 1.54 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.735 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.3 35.78 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.2 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 10.7 p -136.03 139.83 43.4 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.646 -0.326 . . . . 0.0 110.748 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.4 m -131.15 136.83 48.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -70.72 -50.79 32.49 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.404 HG22 ' SG ' ' A' ' 15' ' ' CYS . 28.4 m -59.79 117.82 26.47 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 121.286 0.565 . . . . 0.0 111.818 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.97 131.85 48.05 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.023 2.482 . . . . 0.0 112.3 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.96 -16.5 60.75 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.38 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.674 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 85.6 m -89.24 117.21 28.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.383 0.611 . . . . 0.0 111.273 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.66 142.91 27.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.218 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.6 t -63.37 134.23 55.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.84 0.352 . . . . 0.0 110.722 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 20' ' ' ASN . 36.6 m -142.18 -171.3 3.35 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -46.57 83.71 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 4.2 m120 56.9 19.69 4.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.72 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 25.9 mmtm -150.94 145.59 25.7 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.674 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 44.7 m -89.16 133.09 34.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.5 p -125.45 143.49 50.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.983 0.42 . . . . 0.0 111.807 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 -88.7 93.35 9.54 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 56.46 36.92 28.32 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.889 0.743 . . . . 0.0 109.714 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.69 -26.94 14.39 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.313 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.565 HD22 HG11 ' A' ' 29' ' ' VAL . 26.7 tp -76.74 110.58 12.15 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 117.39 0.595 . . . . 0.0 111.505 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 5.6 Cg_exo -78.74 57.43 6.37 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.578 2.852 . . . . 0.0 112.681 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.565 HG11 HD22 ' A' ' 27' ' ' LEU . 8.3 p . . . . . 0 C--N 1.315 -0.933 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.889 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.29 0.567 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.82 -36.16 2.31 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.677 -0.692 . . . . 0.0 113.527 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -56.58 160.4 3.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.447 0.641 . . . . 0.0 112.239 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 20' ' ' ASN . 13.4 p -113.03 151.39 30.73 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.551 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.2 p -97.68 114.42 26.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.496 0.665 . . . . 0.0 110.825 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.3 55.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.109 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.66 43.23 0.9 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.418 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.551 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.57 30.4 68.8 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.66 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 17.0 p -129.04 138.79 52.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.799 0.333 . . . . 0.0 110.21 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.517 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 80.9 m -135.38 140.37 44.94 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.087 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -72.72 -56.52 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.9 m -58.98 117.64 22.93 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 121.206 0.527 . . . . 0.0 111.79 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.49 129.85 32.98 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.811 2.34 . . . . 0.0 111.458 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.63 -17.3 57.75 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.859 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 86.0 m -88.47 100.02 12.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.372 0.606 . . . . 0.0 110.86 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -74.71 138.11 42.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.666 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.551 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.6 t -63.02 127.45 31.29 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.895 0.379 . . . . 0.0 110.597 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 20' ' ' ASN . 14.4 m -127.15 -167.08 1.68 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -49.1 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 18' ' ' SER . 31.3 t30 58.56 21.28 8.46 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.004 0.921 . . . . 0.0 111.092 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 62.1 mmtt -150.42 143.08 24.57 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 29.4 m -88.98 130.69 35.42 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 53.4 p -119.64 137.55 53.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.804 0.335 . . . . 0.0 110.522 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -88.0 97.24 10.85 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 m120 59.1 38.49 23.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.839 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.12 -15.87 62.15 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.268 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.5 tp -86.73 111.52 40.5 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 117.322 0.561 . . . . 0.0 110.755 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.58 56.87 4.73 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.154 2.57 . . . . 0.0 113.469 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.314 -0.944 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.515 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 28.1 m . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.299 0.571 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.79 -34.84 2.52 Favored Glycine 0 C--O 1.238 0.391 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.836 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -59.82 172.46 0.73 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.448 0.642 . . . . 0.0 112.211 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -121.23 179.45 4.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.637 179.062 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -124.64 118.82 27.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.35 0.595 . . . . 0.0 111.208 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -89.48 54.53 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.883 0.849 . . . . 0.0 109.859 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.97 42.4 0.61 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.389 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.408 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.42 31.0 71.06 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.756 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 13.5 p -131.95 139.4 48.68 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 58.0 m -128.6 141.53 51.33 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.747 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -66.73 -56.71 9.31 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m -62.98 118.62 44.26 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 121.168 0.509 . . . . 0.0 111.599 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.61 129.77 32.4 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.644 2.229 . . . . 0.0 111.307 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.71 -18.9 54.34 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.621 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 73.6 m -89.15 105.45 17.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 110.843 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.54 140.62 38.51 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.424 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.408 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 7.0 t -63.52 132.1 50.23 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.159 0.287 . . . . 0.0 110.472 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 20' ' ' ASN . 10.1 t -138.35 -167.83 2.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -46.77 81.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.457 ' O ' HG22 ' A' ' 4' ' ' THR . 44.6 t30 58.13 18.07 5.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.695 0.798 . . . . 0.0 111.079 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt -150.71 144.31 25.08 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.917 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 36.2 m -88.53 130.61 35.19 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.3 p -115.21 133.57 55.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.828 0.347 . . . . 0.0 110.553 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.4 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 57.3 ttp180 -94.29 105.05 17.03 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 59.78 40.08 19.98 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.91 -10.96 63.64 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.704 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.414 HD21 HG12 ' A' ' 29' ' ' VAL . 16.4 tp -91.26 113.46 58.45 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 117.52 0.66 . . . . 0.0 110.827 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.93 56.21 4.7 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.203 2.602 . . . . 0.0 113.359 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.414 HG12 HD21 ' A' ' 27' ' ' LEU . 14.9 m . . . . . 0 C--N 1.313 -0.985 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.647 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 38.7 m . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 121.115 0.484 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.79 -38.38 2.34 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.857 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.71 155.85 12.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.25 0.547 . . . . 0.0 111.798 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.1 p -105.55 152.19 23.37 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.028 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.633 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.5 p -100.42 133.02 45.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.244 0.545 . . . . 0.0 110.883 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.66 54.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.952 0.882 . . . . 0.0 109.695 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.42 -41.6 2.11 Favored Glycine 0 C--N 1.315 -0.612 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.994 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.4 36.21 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.203 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.2 p -136.09 138.86 42.52 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 122.671 -0.311 . . . . 0.0 110.531 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.633 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 69.1 m -135.79 134.31 38.81 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.077 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -67.54 -54.78 17.11 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.411 HG21 ' NH2' ' A' ' 24' ' ' ARG . 31.9 m -62.19 116.16 20.54 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 121.255 0.55 . . . . 0.0 111.503 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.79 129.83 35.46 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.746 2.297 . . . . 0.0 111.775 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.74 -17.16 56.87 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.113 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 82.6 m -89.14 109.6 20.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.16 0.505 . . . . 0.0 110.83 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 p -80.36 139.46 36.55 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.631 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.0 t -63.71 135.94 57.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.451 . . . . 0.0 110.536 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.515 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 21.8 m -136.64 177.56 7.75 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -49.79 95.03 0.01 OUTLIER 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.1 m120 66.71 7.06 4.91 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.498 1.119 . . . . 0.0 113.674 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.515 ' HD2' ' HB2' ' A' ' 18' ' ' SER . 0.0 OUTLIER -154.79 151.52 28.75 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 118.685 0.675 . . . . 0.0 112.732 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.2 m -88.94 136.95 32.74 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.1 p -125.94 141.75 51.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.017 0.437 . . . . 0.0 111.5 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.411 ' NH2' HG21 ' A' ' 12' ' ' THR . 52.8 ttm-85 -93.85 97.31 10.31 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 58.89 42.45 19.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.34 -20.95 40.56 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.53 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.1 tp -79.11 113.37 35.45 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 117.614 0.707 . . . . 0.0 111.276 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 6.1 Cg_exo -77.75 57.68 6.13 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.237 2.624 . . . . 0.0 112.329 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--N 1.314 -0.964 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.981 -179.168 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 60.1 m . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.988 0.423 . . . . 0.0 111.282 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.02 -33.85 2.17 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.124 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.406 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 9.6 mt-10 -54.59 155.01 4.35 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.943 0.497 . . . . 0.0 111.691 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 20' ' ' ASN . 15.9 p -111.35 149.41 31.19 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.827 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.2 p -97.97 116.25 29.82 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.421 0.629 . . . . 0.0 110.823 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 t -86.42 55.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.093 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.95 43.14 0.88 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.508 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.495 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.73 30.71 68.12 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.539 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 16.1 p -129.23 138.48 51.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.542 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 90.1 m -135.67 140.34 44.4 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.124 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -66.26 -62.43 1.48 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.7 m -66.03 122.01 78.98 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 121.366 0.603 . . . . 0.0 112.506 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.7 130.74 36.5 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.688 2.258 . . . . 0.0 110.767 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.33 -20.61 39.6 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.068 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.572 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 79.9 m -88.64 83.51 6.75 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.056 0.455 . . . . 0.0 110.287 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.09 135.4 54.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.692 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.495 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 8.8 t -59.84 136.55 58.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 0.0 110.708 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 20' ' ' ASN . 14.6 t -140.72 -163.96 1.64 Allowed 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -46.73 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.828 0.705 . . . . 0.0 112.04 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 18' ' ' SER . 19.2 p30 49.59 23.26 0.9 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.978 1.311 . . . . 0.0 111.939 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 12.9 mmtp -150.16 145.11 26.1 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.427 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.572 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 32.8 m -88.41 130.4 35.18 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 45.2 p -114.47 134.42 55.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.007 0.432 . . . . 0.0 110.959 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.584 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.0 ttm180 -89.71 101.12 13.81 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 59.89 35.12 21.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.589 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.72 -14.62 64.54 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.397 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.0 tp -89.22 116.37 66.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.478 0.639 . . . . 0.0 111.148 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.466 ' HA ' HG23 ' A' ' 23' ' ' THR . 63.0 Cg_endo -75.08 56.4 4.29 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.028 2.485 . . . . 0.0 112.435 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.314 -0.955 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.962 -179.254 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 21.4 m . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.069 0.462 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.05 -38.87 2.01 Favored Glycine 0 C--O 1.238 0.367 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.873 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.472 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 18.8 mm-40 -54.43 161.74 1.32 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.215 0.606 . . . . 0.0 112.222 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -110.59 155.03 22.92 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.895 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -99.01 134.63 41.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 178.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.5 t -79.11 55.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.894 0.854 . . . . 0.0 109.478 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.48 -43.93 1.58 Allowed Glycine 0 C--N 1.314 -0.683 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.876 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.03 32.79 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.203 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.7 p -136.6 138.8 41.6 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 50.3 m -125.12 128.47 48.48 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.205 0.526 . . . . 0.0 110.804 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -70.41 -30.09 66.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.088 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.496 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 1.3 m -73.62 119.46 76.12 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 120.764 0.316 . . . . 0.0 110.623 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.3 Cg_endo -56.64 131.72 47.35 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.693 2.262 . . . . 0.0 112.524 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.52 -7.22 69.61 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.371 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.2 m -94.15 123.0 37.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.268 0.556 . . . . 0.0 111.432 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.43 145.49 24.42 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.059 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.8 t -65.41 135.07 54.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.941 0.4 . . . . 0.0 111.117 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 37.2 m -141.31 -174.5 4.04 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -47.5 86.0 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.542 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 59.0 t30 56.62 21.02 5.4 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.665 0.786 . . . . 0.0 111.322 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 7.9 mmtm -150.8 141.54 22.75 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 69.2 m -89.59 129.99 35.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.7 p -115.01 137.18 52.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.068 0.461 . . . . 0.0 111.489 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HG2' ' OD1' ' A' ' 25' ' ' ASN . 41.6 ttm180 -96.15 113.42 25.02 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.405 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 5.5 p-10 47.59 37.2 6.25 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.088 0.868 . . . . 0.0 111.218 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.16 -16.1 60.54 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.816 -0.629 . . . . 0.0 114.012 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.1 tp -90.86 116.49 66.53 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 117.592 0.696 . . . . 0.0 111.498 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.85 58.67 6.13 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.079 2.519 . . . . 0.0 112.372 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.315 -0.914 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.097 -179.004 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 121.137 0.494 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.73 -37.92 2.11 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.595 -0.73 . . . . 0.0 113.378 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -55.86 154.7 6.89 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.347 0.594 . . . . 0.0 111.681 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.49 HG21 ' O ' ' A' ' 20' ' ' ASN . 2.9 p -104.8 153.75 20.91 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.302 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.61 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.8 p -102.07 133.1 47.44 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.14 0.495 . . . . 0.0 110.705 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 t -78.55 54.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.979 0.895 . . . . 0.0 109.615 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.85 -42.71 1.83 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.98 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.72 36.45 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.321 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 9.9 p -136.17 139.73 43.07 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 122.623 -0.339 . . . . 0.0 110.244 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.61 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 99.7 m -135.33 137.65 42.62 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.67 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -67.56 -57.28 6.75 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.1 m -62.38 119.89 53.97 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 121.237 0.541 . . . . 0.0 111.898 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -59.82 129.64 31.51 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.671 2.247 . . . . 0.0 111.082 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.04 49.08 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.569 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 23' ' ' THR . 68.3 m -88.71 105.58 17.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.068 0.461 . . . . 0.0 110.363 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -81.93 145.08 30.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 t -64.09 137.13 57.83 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 20' ' ' ASN . 17.4 t -140.85 -166.76 2.22 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -45.8 80.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.49 ' O ' HG21 ' A' ' 4' ' ' THR . 28.8 t-20 60.41 13.98 4.45 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.385 0.674 . . . . 0.0 111.175 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.457 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 10.1 mmtp -149.45 147.3 28.08 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 121.962 -0.461 . . . . 0.0 111.969 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 50.6 m -88.51 134.4 33.87 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 65.8 p -122.48 136.77 54.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.795 0.331 . . . . 0.0 110.802 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -89.04 99.42 12.41 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 58.44 38.28 25.65 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.879 0.737 . . . . 0.0 109.911 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.61 -13.99 66.16 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.192 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.589 ' HG ' HG11 ' A' ' 29' ' ' VAL . 17.5 tp -87.99 112.58 50.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 117.533 0.666 . . . . 0.0 110.986 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 3.0 Cg_exo -75.93 57.36 5.1 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.587 2.858 . . . . 0.0 113.053 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.589 HG11 ' HG ' ' A' ' 27' ' ' LEU . 16.1 m . . . . . 0 C--N 1.315 -0.921 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.772 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.482 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 32.6 m . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 121.103 0.477 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.52 -41.17 2.48 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.888 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -56.28 160.1 3.19 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.637 0.732 . . . . 0.0 112.399 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.569 HG21 ' O ' ' A' ' 20' ' ' ASN . 20.9 p -116.82 152.77 33.73 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.205 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -95.31 132.49 40.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.09 0.471 . . . . 0.0 110.732 178.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 t -79.46 54.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.95 0.881 . . . . 0.0 109.625 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.84 -43.87 1.63 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.103 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.41 33.91 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.411 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.7 p -136.3 138.06 41.33 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.629 -0.336 . . . . 0.0 110.374 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 62.6 m -130.24 128.79 42.34 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.198 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -71.03 -34.15 71.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.465 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.509 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 2.5 m -73.14 117.22 58.24 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 120.96 0.409 . . . . 0.0 110.979 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.14 131.62 46.31 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.794 2.329 . . . . 0.0 112.298 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.32 -11.58 69.3 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.929 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 64.2 m -89.57 106.93 18.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.438 0.619 . . . . 0.0 111.455 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.95 137.89 40.62 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.4 t -67.49 124.49 23.36 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.334 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.532 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 62.8 m -125.89 -166.73 1.6 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.656 ' H ' ' HD3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -45.49 82.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -179.129 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.569 ' O ' HG21 ' A' ' 4' ' ' THR . 14.6 t-20 57.22 20.65 5.88 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.177 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.408 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 33.1 mmtm -150.68 144.28 25.09 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 122.008 -0.432 . . . . 0.0 111.643 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 38.4 m -87.8 127.35 35.33 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.467 HG23 ' HA ' ' A' ' 28' ' ' PRO . 61.9 p -128.38 140.93 51.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.393 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.482 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 91.6 mtt180 -92.88 103.69 16.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 59.39 35.69 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.669 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.71 -14.84 64.4 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.534 -0.757 . . . . 0.0 113.31 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.1 tp -82.06 114.99 54.85 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 117.311 0.556 . . . . 0.0 111.079 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.467 ' HA ' HG23 ' A' ' 23' ' ' THR . 72.5 Cg_endo -79.75 60.74 7.95 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.038 2.492 . . . . 0.0 112.411 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.61 -179.34 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 25.5 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.282 0.563 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.66 -38.74 3.17 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.435 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -56.35 161.9 2.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.552 0.691 . . . . 0.0 112.04 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 20' ' ' ASN . 16.5 p -114.23 151.07 33.37 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.606 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -95.08 117.99 31.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.353 0.597 . . . . 0.0 110.612 178.471 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -88.32 54.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.959 0.885 . . . . 0.0 110.099 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.68 42.7 0.61 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.388 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.55 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 68.83 32.13 73.57 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.726 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.2 p -135.09 140.18 45.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.742 0.306 . . . . 0.0 110.263 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 72.5 m -132.53 133.64 44.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.366 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -69.29 -42.56 75.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.754 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.5 m -68.87 118.26 59.3 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 121.033 0.444 . . . . 0.0 111.572 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.41 131.44 42.83 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.803 2.335 . . . . 0.0 111.873 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.98 -19.17 55.41 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.932 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.548 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.4 m -89.62 104.79 17.32 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.217 0.532 . . . . 0.0 111.066 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 p -81.24 143.56 32.2 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.634 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.55 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 13.5 t -62.59 135.02 57.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.813 0.339 . . . . 0.0 110.677 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 20' ' ' ASN . 40.1 m -141.82 -171.55 3.37 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -46.83 89.36 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.608 0.567 . . . . 0.0 111.931 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.54 ' O ' HG22 ' A' ' 4' ' ' THR . 17.8 p30 48.5 24.22 0.72 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.816 1.246 . . . . 0.0 112.268 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.6 mmtm -150.58 144.13 25.09 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 122.342 0.257 . . . . 0.0 111.449 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.548 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 60.2 m -89.35 128.02 35.86 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 41.0 p -110.57 133.01 53.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.244 0.545 . . . . 0.0 111.428 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.538 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 50.7 ttp180 -90.28 102.66 15.38 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 59.26 37.49 23.65 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.812 0.695 . . . . 0.0 109.703 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.47 -14.24 65.73 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.674 -0.693 . . . . 0.0 113.568 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.3 tp -91.4 114.08 60.59 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 117.601 0.7 . . . . 0.0 111.128 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.26 56.2 3.74 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.18 2.587 . . . . 0.0 112.656 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.314 -0.973 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.353 -179.035 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 46.0 m . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.037 0.446 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.0 -36.58 2.34 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.738 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.44 158.22 4.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.294 0.568 . . . . 0.0 112.148 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 20' ' ' ASN . 1.6 p -107.63 156.18 19.33 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.855 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.572 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 4.5 p -108.82 132.4 54.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.367 0.603 . . . . 0.0 111.106 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.65 54.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.671 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.15 -41.4 2.14 Favored Glycine 0 C--N 1.315 -0.633 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.219 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.75 36.34 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.223 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 9.2 p -136.41 139.64 42.6 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 66.9 m -134.35 137.61 44.28 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.126 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -65.81 -57.77 7.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.8 m -64.59 115.6 21.6 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.282 0.563 . . . . 0.0 111.641 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.75 128.07 26.76 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.66 2.24 . . . . 0.0 111.074 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.38 -22.96 25.83 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.301 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 68.2 m -89.58 118.46 29.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.937 0.399 . . . . 0.0 110.254 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -89.68 147.84 23.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.2 t -66.47 134.57 52.73 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.682 0.277 . . . . 0.0 110.437 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.443 ' HB3' ' HD2' ' A' ' 21' ' ' LYS . 10.0 t -137.77 -177.51 4.84 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -48.87 91.91 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.557 ' O ' HG23 ' A' ' 4' ' ' THR . 39.9 t30 62.14 11.07 4.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.459 1.104 . . . . 0.0 113.008 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -155.19 151.37 28.09 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.558 -0.714 . . . . 0.0 112.419 179.23 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 47.1 m -88.89 133.19 34.37 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.9 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.4 p -117.75 138.48 52.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.053 0.454 . . . . 0.0 110.754 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.4 ttt85 -91.65 98.87 11.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.3 t30 58.57 37.48 25.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.663 0.744 . . . . 0.0 109.137 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.04 -20.66 49.93 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.521 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.444 HD21 HG23 ' A' ' 29' ' ' VAL . 16.2 tp -81.95 114.09 47.96 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 117.46 0.63 . . . . 0.0 111.028 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.16 56.45 5.45 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.918 2.412 . . . . 0.0 113.45 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.444 HG23 HD21 ' A' ' 27' ' ' LEU . 15.5 m . . . . . 0 C--N 1.313 -1.009 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.751 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.547 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 1.6 m . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.596 0.236 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.74 -37.24 0.73 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.456 -0.402 . . . . 0.0 113.824 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.438 ' H ' ' C ' ' A' ' 1' ' ' CYS . 47.2 mm-40 -57.25 164.01 1.95 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.298 0.57 . . . . 0.0 112.449 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 20' ' ' ASN . 1.2 p -104.95 153.95 20.74 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.698 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -96.45 137.13 35.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.72 178.485 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.9 t -78.83 55.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.93 0.872 . . . . 0.0 109.413 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.68 -42.77 1.81 Allowed Glycine 0 C--N 1.314 -0.641 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.722 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.61 34.22 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.01 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 9.1 p -136.75 140.12 42.35 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.3 m -127.17 133.98 50.23 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.908 0.385 . . . . 0.0 110.553 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -60.42 -45.42 93.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.118 -177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.547 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 8.7 m -77.52 112.45 24.15 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-O 120.951 0.405 . . . . 0.0 111.438 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.9 Cg_endo -57.56 127.5 25.61 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.526 2.151 . . . . 0.0 111.379 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.68 -24.65 14.74 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.429 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 74.3 m -92.42 118.52 31.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.356 0.598 . . . . 0.0 111.498 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 p -84.08 143.24 29.85 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.434 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.9 t -63.17 133.43 54.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.717 0.294 . . . . 0.0 110.812 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 27.8 m -138.69 -176.1 4.36 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -48.31 88.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.541 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 8.0 m120 54.17 23.12 3.98 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.783 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 10.4 mmtm -150.98 138.4 19.49 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 1' ' ' CYS . 69.1 m -89.8 121.35 31.86 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.0 p -109.61 137.47 47.39 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.111 0.481 . . . . 0.0 111.295 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -88.79 92.79 9.35 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 57.57 44.04 21.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.26 -177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.18 -21.79 43.33 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.441 -0.799 . . . . 0.0 113.603 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.736 ' HG ' HG13 ' A' ' 29' ' ' VAL . 18.4 tp -83.19 110.94 26.9 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 117.558 0.679 . . . . 0.0 111.151 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.32 63.27 4.39 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 123.341 2.694 . . . . 0.0 113.076 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.736 HG13 ' HG ' ' A' ' 27' ' ' LEU . 8.3 m . . . . . 0 C--N 1.319 -0.732 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.449 -0.521 0 CA-C-O 120.996 0.427 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.54 -38.76 2.64 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.929 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.93 156.85 10.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.377 0.608 . . . . 0.0 112.031 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 20' ' ' ASN . 20.4 p -113.19 151.22 31.23 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.742 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.593 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.2 p -98.11 131.35 44.57 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.172 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 t -78.38 55.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.627 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.92 -42.03 2.02 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.869 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.421 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . -179.79 36.08 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.058 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 10.6 p -136.32 139.04 42.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.88 0.371 . . . . 0.0 110.997 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 89.6 m -135.38 140.73 45.22 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.33 -52.07 8.59 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.454 HG22 ' SG ' ' A' ' 15' ' ' CYS . 54.1 m -61.84 118.08 34.99 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-O 121.48 0.657 . . . . 0.0 111.834 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.89 130.84 41.98 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.11 2.54 . . . . 0.0 112.015 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.49 -20.09 49.87 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.03 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.454 ' SG ' HG22 ' A' ' 12' ' ' THR . 62.5 m -89.47 110.97 21.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.195 0.521 . . . . 0.0 110.802 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 t -85.85 145.72 27.06 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 8.5 t -64.32 131.74 48.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.006 0.432 . . . . 0.0 109.97 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.0 m -132.65 179.43 6.15 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 17.7 mtpp -47.9 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.509 ' O ' HG23 ' A' ' 4' ' ' THR . 7.1 m120 63.83 7.82 3.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.676 178.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.402 ' O ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -154.84 152.44 29.81 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.551 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 33.5 m -88.87 136.74 32.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.095 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.5 p -128.36 145.03 51.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.07 0.462 . . . . 0.0 110.629 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 ttm-85 -89.12 90.95 8.6 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 57.25 43.08 24.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.386 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.421 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 99.68 -24.16 33.3 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.421 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.407 ' HG ' HG11 ' A' ' 29' ' ' VAL . 16.2 tp -78.41 111.26 17.59 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 117.401 0.6 . . . . 0.0 110.968 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 71.8 Cg_endo -79.0 57.79 6.63 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.986 2.457 . . . . 0.0 113.344 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.407 HG11 ' HG ' ' A' ' 27' ' ' LEU . 19.1 m . . . . . 0 C--N 1.315 -0.901 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.407 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 39.3 m . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 120.91 0.386 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.33 -33.7 2.48 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.268 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.9 172.51 0.4 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.915 0.864 . . . . 0.0 112.561 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 20' ' ' ASN . 2.0 p -126.65 156.07 41.59 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.284 -1.326 . . . . 0.0 111.74 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -102.88 115.01 29.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.192 0.52 . . . . 0.0 110.578 178.527 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 t -89.97 54.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.855 0.835 . . . . 0.0 110.049 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.97 42.84 0.5 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.365 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.36 29.6 73.17 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.734 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.9 p -135.17 140.28 45.23 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m -127.05 129.7 48.53 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.769 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -69.51 -34.05 73.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.983 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.45 HG21 ' SG ' ' A' ' 15' ' ' CYS . 4.4 m -70.34 117.68 57.06 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-O 120.903 0.382 . . . . 0.0 111.116 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 13.2 Cg_endo -57.34 130.52 39.69 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.971 2.447 . . . . 0.0 112.697 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.3 -15.01 60.9 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.684 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.45 ' SG ' HG21 ' A' ' 12' ' ' THR . 42.2 m -92.73 123.4 35.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.158 0.504 . . . . 0.0 111.397 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.6 t -95.13 154.44 17.18 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 t -67.89 139.5 56.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.067 0.46 . . . . 0.0 110.716 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 20' ' ' ASN . 41.7 m -144.25 -172.52 3.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -48.16 86.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.456 ' O ' HG22 ' A' ' 4' ' ' THR . 8.7 m120 54.36 22.11 3.58 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.729 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 26.6 mmtp -151.41 149.98 29.92 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 120.466 0.174 . . . . 0.0 111.318 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 1' ' ' CYS . 60.8 m -93.56 130.06 39.57 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.0 p -118.46 138.61 52.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.892 0.377 . . . . 0.0 110.535 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.3 ttp180 -103.87 112.43 25.39 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.11 32.08 19.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.584 0.707 . . . . 0.0 109.115 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.05 -10.4 73.05 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.292 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.2 tp -90.53 116.57 66.7 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 117.147 0.473 . . . . 0.0 111.12 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.15 56.93 5.64 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.205 2.603 . . . . 0.0 112.286 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.314 -0.957 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.859 -179.148 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 121.344 0.593 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.47 -41.11 2.78 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.488 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -60.14 161.78 6.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.4 0.619 . . . . 0.0 112.041 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.499 HG21 ' O ' ' A' ' 20' ' ' ASN . 22.4 p -111.69 151.79 28.48 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.031 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -93.26 115.49 28.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.228 0.537 . . . . 0.0 110.66 178.363 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -87.28 54.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.9 0.857 . . . . 0.0 110.05 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.5 42.64 0.68 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.467 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.428 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.86 29.95 70.63 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.464 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 14.9 p -130.34 140.73 50.61 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 50.6 m -135.17 131.55 36.9 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.787 0.327 . . . . 0.0 111.166 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -74.54 -32.34 62.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.771 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.664 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -63.06 121.83 71.45 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-O 120.89 0.376 . . . . 0.0 110.516 -179.475 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.5 122.74 12.29 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.711 2.274 . . . . 0.0 113.53 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.46 12.1 84.15 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.019 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.664 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 96.0 m -100.3 115.26 29.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.546 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 p -84.09 139.33 32.54 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.521 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.428 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 9.0 t -62.76 135.87 57.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.733 0.301 . . . . 0.0 110.763 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 20' ' ' ASN . 15.7 t -140.49 -168.74 2.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -46.4 80.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.499 ' O ' HG21 ' A' ' 4' ' ' THR . 4.7 m120 57.56 22.07 7.78 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.338 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 32.2 mmtm -150.95 145.55 25.66 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.499 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 40.6 m -88.47 138.81 31.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.7 p -128.92 140.29 51.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -177.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.611 ' HB3' ' NH1' ' A' ' 24' ' ' ARG . 3.6 mtp-105 -89.09 95.36 10.28 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 m120 57.85 33.53 23.32 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.724 0.64 . . . . 0.0 109.868 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.83 -24.47 23.43 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.187 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.737 ' HG ' HG12 ' A' ' 29' ' ' VAL . 18.7 tp -78.89 111.98 23.92 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 117.317 0.558 . . . . 0.0 111.219 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.0 57.82 6.28 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.111 2.541 . . . . 0.0 113.843 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.737 HG12 ' HG ' ' A' ' 27' ' ' LEU . 15.8 m . . . . . 0 C--N 1.314 -0.97 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.691 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 120.989 0.423 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.01 -37.89 2.37 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.537 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.475 ' HG3' ' HG1' ' A' ' 12' ' ' THR . 20.7 mm-40 -58.96 165.13 2.55 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.535 0.683 . . . . 0.0 112.45 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 20' ' ' ASN . 7.3 p -115.68 153.41 31.38 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.067 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.581 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.5 p -101.92 133.56 46.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.184 0.516 . . . . 0.0 110.842 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.53 54.02 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.914 0.864 . . . . 0.0 109.681 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.63 -43.23 1.73 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.03 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.74 35.61 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.355 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.559 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 10.2 p -136.2 139.78 43.05 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 56.8 m -133.6 129.77 37.42 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.109 0.481 . . . . 0.0 111.229 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -75.69 -26.83 57.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.767 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.56 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.8 OUTLIER -72.14 121.49 84.8 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-O 120.93 0.395 . . . . 0.0 110.569 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.4 Cg_endo -56.99 129.41 34.35 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.598 2.199 . . . . 0.0 112.768 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.24 10.07 85.51 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.555 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.56 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 86.1 m -103.82 117.53 34.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.672 0.736 . . . . 0.0 111.596 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.84 140.44 30.42 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.926 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.7 t -64.25 135.96 56.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.74 0.305 . . . . 0.0 110.421 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 20' ' ' ASN . 13.4 t -137.58 -167.11 2.06 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -47.48 86.31 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.585 ' O ' HG22 ' A' ' 4' ' ' THR . 6.6 m120 56.78 15.78 2.38 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.125 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 62.2 mmtt -150.27 150.26 31.27 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 46.1 m -88.45 131.48 34.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.827 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.7 p -122.92 137.55 54.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.415 ' HG2' ' OD1' ' A' ' 25' ' ' ASN . 43.3 ttm180 -93.88 113.48 25.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.415 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 5.6 p-10 47.39 36.97 5.42 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.163 0.914 . . . . 0.0 111.274 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.23 -13.65 64.42 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.744 -0.662 . . . . 0.0 114.072 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 tp -91.42 118.12 68.23 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 117.506 0.653 . . . . 0.0 111.529 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.63 58.34 6.35 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.073 2.515 . . . . 0.0 112.24 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--N 1.316 -0.856 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.865 -179.048 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 23.1 m . . . . . 0 C--O 1.223 -0.327 0 CA-C-O 121.317 0.58 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.05 -39.36 3.03 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.406 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -57.28 165.67 1.37 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.239 0.543 . . . . 0.0 112.071 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.81 178.4 4.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.97 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -120.08 119.91 34.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.322 0.582 . . . . 0.0 110.774 179.089 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 t -87.35 54.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.935 0.874 . . . . 0.0 109.979 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.14 42.59 0.64 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.347 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.568 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.0 32.46 73.26 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.781 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 14.1 p -135.03 139.51 44.86 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 110.439 179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 69.2 m -128.07 132.86 49.01 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.056 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -71.81 -45.16 62.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.953 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 m -59.89 116.61 17.77 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.561 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -57.43 128.5 29.69 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.064 2.509 . . . . 0.0 112.643 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.61 -20.04 52.18 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.945 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 57.3 m -89.66 118.5 29.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.325 0.583 . . . . 0.0 111.112 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.88 145.24 25.54 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.568 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 15.2 t -62.26 133.3 54.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.949 0.404 . . . . 0.0 111.012 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 20' ' ' ASN . 35.1 m -141.58 -170.73 3.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -47.39 83.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 18' ' ' SER . 18.1 t30 55.83 22.9 5.96 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.999 0.92 . . . . 0.0 111.026 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 28.7 mmtp -151.48 144.04 24.26 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.678 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 66.7 m -89.43 127.62 35.85 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 43.9 p -108.51 133.79 52.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.972 0.415 . . . . 0.0 111.015 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.572 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 44.6 ttt-85 -97.21 110.94 23.38 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.15 30.78 20.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.79 0.681 . . . . 0.0 109.543 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.37 -14.01 65.78 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.42 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 tp -91.8 116.55 66.66 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.546 0.673 . . . . 0.0 111.296 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -75.11 56.52 4.34 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.071 2.514 . . . . 0.0 112.627 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.445 -178.832 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 1.7 m . . . . . 0 C--O 1.225 -0.187 0 CA-C-O 120.898 0.38 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.53 -27.75 1.28 Allowed Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.256 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 1' ' ' CYS . 6.5 mt-10 -58.64 172.02 0.56 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.67 0.788 . . . . 0.0 112.011 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.34 -179.91 3.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.09 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -128.74 134.59 48.49 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.218 0.532 . . . . 0.0 111.538 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 t -80.82 53.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.911 0.862 . . . . 0.0 109.372 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.02 -43.97 1.6 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.011 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.83 35.65 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.282 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 8.9 p -136.13 140.88 44.01 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.794 -0.239 . . . . 0.0 110.507 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 66.1 m -129.83 143.38 50.78 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.973 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -61.32 -56.85 15.74 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.552 HG21 ' NH2' ' A' ' 24' ' ' ARG . 76.3 m -70.74 116.09 42.38 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 121.374 0.606 . . . . 0.0 111.945 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.76 129.92 34.47 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.631 2.221 . . . . 0.0 110.766 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.87 -28.0 10.4 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.063 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.629 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 34.6 m -88.81 112.22 22.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.583 0.706 . . . . 0.0 110.9 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.43 142.52 34.24 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.979 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.5 t -62.18 124.24 20.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.804 0.335 . . . . 0.0 110.474 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 13.0 m -126.76 -175.78 3.51 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -48.49 85.51 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 18' ' ' SER . 79.5 m-20 60.69 14.89 5.35 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.037 0.935 . . . . 0.0 111.974 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 18' ' ' SER . 50.7 mmtt -147.82 141.27 25.35 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.629 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 50.0 m -89.41 127.47 35.83 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.1 p -119.84 136.69 54.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.855 0.359 . . . . 0.0 110.954 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.552 ' NH2' HG21 ' A' ' 12' ' ' THR . 13.9 ptp180 -99.68 109.99 22.42 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.36 34.09 22.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.141 -177.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.28 -14.94 64.1 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.596 -0.729 . . . . 0.0 113.577 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 28.5 tp -82.88 112.12 35.31 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 117.288 0.544 . . . . 0.0 111.343 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 6.2 Cg_exo -78.65 59.4 7.21 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.578 2.852 . . . . 0.0 112.204 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.315 -0.901 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.589 -178.896 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.628 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 25.9 m . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 121.2 0.524 . . . . 0.0 111.418 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.6 -40.14 2.85 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.539 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -58.0 162.18 3.52 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.89 0.852 . . . . 0.0 112.489 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 20' ' ' ASN . 28.5 p -119.84 150.61 40.17 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.444 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.7 p -92.79 114.93 27.62 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.454 0.645 . . . . 0.0 110.91 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -86.94 54.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.058 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.02 42.91 0.69 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.409 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.571 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.92 31.26 69.83 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.664 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 12.7 p -132.96 139.23 47.2 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.909 0.385 . . . . 0.0 110.588 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 67.3 m -135.65 136.92 41.35 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.804 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -75.03 -48.91 21.7 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.468 HG22 ' SG ' ' A' ' 15' ' ' CYS . 16.2 m -60.0 118.34 31.75 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.768 -178.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.94 131.29 42.77 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.948 2.432 . . . . 0.0 112.258 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.13 -16.05 61.82 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.233 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.9 m -88.7 108.39 19.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.238 0.542 . . . . 0.0 110.944 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -83.99 146.11 28.16 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.571 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 9.8 t -65.89 121.79 15.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.833 0.349 . . . . 0.0 110.188 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 20' ' ' ASN . 6.8 m -122.53 -170.61 2.11 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -49.47 85.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.561 ' O ' HG23 ' A' ' 4' ' ' THR . 7.0 m120 56.11 23.01 6.46 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.525 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.43 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 26.1 mmtp -151.07 143.95 24.52 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.4 m -89.76 132.87 34.99 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 79.8 p -128.75 141.71 51.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.847 0.356 . . . . 0.0 111.297 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.628 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 71.4 mtp180 -88.68 96.94 10.86 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 m120 58.63 34.35 23.77 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.81 0.694 . . . . 0.0 110.01 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.402 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 103.88 -20.15 42.0 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.059 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.623 ' HG ' HG11 ' A' ' 29' ' ' VAL . 17.5 tp -81.83 111.06 23.32 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 117.358 0.579 . . . . 0.0 110.947 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 72.8 Cg_endo -78.46 57.37 6.25 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.187 2.591 . . . . 0.0 113.454 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.623 HG11 ' HG ' ' A' ' 27' ' ' LEU . 15.8 m . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.313 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.462 ' SG ' ' HG2' ' A' ' 24' ' ' ARG . 14.5 m . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 121.338 0.59 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.62 -40.09 2.73 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.813 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.9 163.03 4.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.444 0.64 . . . . 0.0 112.289 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.485 HG22 ' O ' ' A' ' 20' ' ' ASN . 27.2 p -111.93 151.88 28.69 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.676 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.613 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.2 p -96.41 114.95 26.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.358 0.599 . . . . 0.0 110.499 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -87.35 55.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.984 0.897 . . . . 0.0 110.09 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.93 42.8 0.7 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.525 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.475 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.82 30.19 70.55 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.632 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.613 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 15.2 p -129.79 139.97 51.14 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.466 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 52.2 m -135.4 132.35 37.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.013 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -73.63 -35.49 65.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.32 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.619 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -61.56 121.79 66.47 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.35 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -56.18 125.52 19.35 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.002 2.468 . . . . 0.0 113.579 -178.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.22 8.52 83.53 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 114.699 -1.137 . . . . 0.0 113.641 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.619 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 90.5 m -93.33 117.26 29.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.865 0.832 . . . . 0.0 111.209 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 p -81.68 138.69 35.23 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.945 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.475 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.3 t -64.79 135.8 56.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.885 0.374 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 20' ' ' ASN . 46.0 m -141.02 -170.98 3.16 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -46.74 83.18 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.485 ' O ' HG22 ' A' ' 4' ' ' THR . 15.5 t-20 58.76 18.94 6.41 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.073 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.406 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 32.3 mmtm -150.49 145.39 25.97 Favored 'General case' 0 C--O 1.223 -0.306 0 O-C-N 121.958 -0.464 . . . . 0.0 111.926 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.547 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 36.3 m -88.66 134.63 33.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.4 p -121.37 141.32 51.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.5 ' HG2' ' SG ' ' A' ' 15' ' ' CYS . 10.6 mmm180 -91.46 93.83 9.18 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 m120 58.38 36.46 25.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.053 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.26 -23.82 32.11 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.215 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.3 tp -81.04 114.39 48.38 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 117.41 0.605 . . . . 0.0 111.353 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.51 59.39 5.51 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.325 2.684 . . . . 0.0 112.283 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--N 1.317 -0.847 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.993 -179.133 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.413 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 37.3 m . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 121.117 0.484 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.57 38.82 79.01 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.121 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.732 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 5.0 pt-20 -137.84 160.22 39.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.699 0.285 . . . . 0.0 110.512 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.489 HG23 ' O ' ' A' ' 20' ' ' ASN . 15.1 p -113.9 150.81 33.13 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.155 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.592 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -94.92 132.05 40.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.107 0.48 . . . . 0.0 110.758 178.56 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.33 53.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.978 0.894 . . . . 0.0 109.767 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.25 -44.05 1.59 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.868 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.72 34.76 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.246 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.592 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 12.9 p -136.22 138.77 42.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 122.734 -0.274 . . . . 0.0 110.411 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.477 ' HB3' ' OE2' ' A' ' 3' ' ' GLU . 90.9 m -128.28 133.68 48.8 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -65.99 -50.8 63.01 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.5 m -69.05 114.85 26.22 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 121.153 0.502 . . . . 0.0 111.208 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.18 125.1 16.64 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.269 1.979 . . . . 0.0 110.965 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.69 -19.68 28.13 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.477 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.5 m -89.23 115.34 26.66 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.254 0.55 . . . . 0.0 110.517 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 p -83.63 134.04 34.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.933 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t -63.33 123.12 17.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.902 0.382 . . . . 0.0 110.252 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 20' ' ' ASN . 13.7 m -120.96 -168.8 1.72 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -47.59 83.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.489 ' O ' HG23 ' A' ' 4' ' ' THR . 28.9 t-20 61.04 15.14 5.92 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.314 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.434 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 7.1 mmtp -148.36 138.78 22.72 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 121.91 -0.494 . . . . 0.0 111.539 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.732 ' HB2' ' HG3' ' A' ' 3' ' ' GLU . 38.5 m -88.37 125.44 34.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.4 p -116.8 142.36 47.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.814 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.413 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 28.7 ttt85 -91.51 100.43 13.19 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.9 t30 59.36 40.87 20.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.717 0.77 . . . . 0.0 109.484 -177.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.57 -12.39 65.38 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.613 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.542 HD22 HG13 ' A' ' 29' ' ' VAL . 16.2 tp -91.38 113.48 58.63 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 117.442 0.621 . . . . 0.0 110.778 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.97 56.94 3.76 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.429 2.752 . . . . 0.0 113.001 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.542 HG13 HD22 ' A' ' 27' ' ' LEU . 13.5 m . . . . . 0 C--N 1.315 -0.9 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.8 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 48.6 m . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.026 0.441 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.87 -36.56 2.32 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.689 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 23.1 mt-10 -57.88 173.88 0.29 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -122.92 -178.44 3.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.881 178.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -129.18 134.81 48.18 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.191 0.519 . . . . 0.0 111.25 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -79.85 53.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.996 0.903 . . . . 0.0 109.58 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.27 -44.28 1.54 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.735 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.3 35.78 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.2 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 10.7 p -136.03 139.83 43.4 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.646 -0.326 . . . . 0.0 110.748 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.4 m -131.15 136.83 48.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -70.72 -50.79 32.49 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.404 HG22 ' SG ' ' A' ' 15' ' ' CYS . 28.4 m -59.79 117.82 26.47 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 121.286 0.565 . . . . 0.0 111.818 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -56.97 131.85 48.05 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.023 2.482 . . . . 0.0 112.3 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.96 -16.5 60.75 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.38 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.674 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 85.6 m -89.24 117.21 28.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.383 0.611 . . . . 0.0 111.273 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.66 142.91 27.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.218 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.6 t -63.37 134.23 55.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.84 0.352 . . . . 0.0 110.722 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 20' ' ' ASN . 36.6 m -142.18 -171.3 3.35 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -46.57 83.71 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.467 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 4.2 m120 56.9 19.69 4.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.72 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 25.9 mmtm -150.94 145.59 25.7 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.674 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 44.7 m -89.16 133.09 34.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.5 p -125.45 143.49 50.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.983 0.42 . . . . 0.0 111.807 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.5 mtt85 -88.7 93.35 9.54 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 56.46 36.92 28.32 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.889 0.743 . . . . 0.0 109.714 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.69 -26.94 14.39 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.313 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.565 HD22 HG11 ' A' ' 29' ' ' VAL . 26.7 tp -76.74 110.58 12.15 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 117.39 0.595 . . . . 0.0 111.505 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 5.6 Cg_exo -78.74 57.43 6.37 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.578 2.852 . . . . 0.0 112.681 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.565 HG11 HD22 ' A' ' 27' ' ' LEU . 8.3 p . . . . . 0 C--N 1.315 -0.933 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.889 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.29 0.567 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.82 -36.16 2.31 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.677 -0.692 . . . . 0.0 113.527 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -56.58 160.4 3.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.447 0.641 . . . . 0.0 112.239 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.407 HG22 ' O ' ' A' ' 20' ' ' ASN . 13.4 p -113.03 151.39 30.73 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.551 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.588 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.2 p -97.68 114.42 26.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.496 0.665 . . . . 0.0 110.825 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.3 55.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.109 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.66 43.23 0.9 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.418 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.551 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.57 30.4 68.8 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.66 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.588 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 17.0 p -129.04 138.79 52.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.799 0.333 . . . . 0.0 110.21 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.517 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 80.9 m -135.38 140.37 44.94 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.087 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -72.72 -56.52 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.9 m -58.98 117.64 22.93 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 121.206 0.527 . . . . 0.0 111.79 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -59.49 129.85 32.98 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.811 2.34 . . . . 0.0 111.458 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.63 -17.3 57.75 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.859 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 86.0 m -88.47 100.02 12.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.372 0.606 . . . . 0.0 110.86 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -74.71 138.11 42.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.666 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.551 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.6 t -63.02 127.45 31.29 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.895 0.379 . . . . 0.0 110.597 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 20' ' ' ASN . 14.4 m -127.15 -167.08 1.68 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -49.1 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.457 ' N ' ' O ' ' A' ' 18' ' ' SER . 31.3 t30 58.56 21.28 8.46 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.004 0.921 . . . . 0.0 111.092 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 62.1 mmtt -150.42 143.08 24.57 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 29.4 m -88.98 130.69 35.42 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 53.4 p -119.64 137.55 53.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.804 0.335 . . . . 0.0 110.522 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -88.0 97.24 10.85 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 m120 59.1 38.49 23.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.839 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.12 -15.87 62.15 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.268 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.5 tp -86.73 111.52 40.5 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 117.322 0.561 . . . . 0.0 110.755 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.58 56.87 4.73 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.154 2.57 . . . . 0.0 113.469 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.314 -0.944 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.515 179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 28.1 m . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.299 0.571 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.79 -34.84 2.52 Favored Glycine 0 C--O 1.238 0.391 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.836 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -59.82 172.46 0.73 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.448 0.642 . . . . 0.0 112.211 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -121.23 179.45 4.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.637 179.062 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.564 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -124.64 118.82 27.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.35 0.595 . . . . 0.0 111.208 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -89.48 54.53 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.883 0.849 . . . . 0.0 109.859 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.97 42.4 0.61 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.389 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.408 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.42 31.0 71.06 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.756 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.564 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 13.5 p -131.95 139.4 48.68 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 58.0 m -128.6 141.53 51.33 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.747 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -66.73 -56.71 9.31 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m -62.98 118.62 44.26 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 121.168 0.509 . . . . 0.0 111.599 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.61 129.77 32.4 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.644 2.229 . . . . 0.0 111.307 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.71 -18.9 54.34 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.621 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 73.6 m -89.15 105.45 17.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 110.843 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.54 140.62 38.51 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.424 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.408 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 7.0 t -63.52 132.1 50.23 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.159 0.287 . . . . 0.0 110.472 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 20' ' ' ASN . 10.1 t -138.35 -167.83 2.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -46.77 81.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.457 ' O ' HG22 ' A' ' 4' ' ' THR . 44.6 t30 58.13 18.07 5.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.695 0.798 . . . . 0.0 111.079 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt -150.71 144.31 25.08 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.917 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.559 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 36.2 m -88.53 130.61 35.19 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 64.3 p -115.21 133.57 55.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.828 0.347 . . . . 0.0 110.553 -179.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.4 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 57.3 ttp180 -94.29 105.05 17.03 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 59.78 40.08 19.98 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.91 -10.96 63.64 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.704 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.414 HD21 HG12 ' A' ' 29' ' ' VAL . 16.4 tp -91.26 113.46 58.45 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 117.52 0.66 . . . . 0.0 110.827 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.93 56.21 4.7 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.203 2.602 . . . . 0.0 113.359 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.414 HG12 HD21 ' A' ' 27' ' ' LEU . 14.9 m . . . . . 0 C--N 1.313 -0.985 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.647 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 38.7 m . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 121.115 0.484 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.79 -38.38 2.34 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.857 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.71 155.85 12.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.25 0.547 . . . . 0.0 111.798 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 25.1 p -105.55 152.19 23.37 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.028 179.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.633 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.5 p -100.42 133.02 45.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.244 0.545 . . . . 0.0 110.883 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.66 54.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.952 0.882 . . . . 0.0 109.695 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.42 -41.6 2.11 Favored Glycine 0 C--N 1.315 -0.612 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.994 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.4 36.21 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.203 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.2 p -136.09 138.86 42.52 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 122.671 -0.311 . . . . 0.0 110.531 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.633 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 69.1 m -135.79 134.31 38.81 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.077 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -67.54 -54.78 17.11 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.411 HG21 ' NH2' ' A' ' 24' ' ' ARG . 31.9 m -62.19 116.16 20.54 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 121.255 0.55 . . . . 0.0 111.503 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.79 129.83 35.46 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.746 2.297 . . . . 0.0 111.775 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.74 -17.16 56.87 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.113 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 82.6 m -89.14 109.6 20.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.16 0.505 . . . . 0.0 110.83 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 p -80.36 139.46 36.55 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.631 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.0 t -63.71 135.94 57.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.451 . . . . 0.0 110.536 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.515 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 21.8 m -136.64 177.56 7.75 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -49.79 95.03 0.01 OUTLIER 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.1 m120 66.71 7.06 4.91 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.498 1.119 . . . . 0.0 113.674 178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.515 ' HD2' ' HB2' ' A' ' 18' ' ' SER . 0.0 OUTLIER -154.79 151.52 28.75 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 118.685 0.675 . . . . 0.0 112.732 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.2 m -88.94 136.95 32.74 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 56.1 p -125.94 141.75 51.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.017 0.437 . . . . 0.0 111.5 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.411 ' NH2' HG21 ' A' ' 12' ' ' THR . 52.8 ttm-85 -93.85 97.31 10.31 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 58.89 42.45 19.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.34 -20.95 40.56 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.53 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.1 tp -79.11 113.37 35.45 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 117.614 0.707 . . . . 0.0 111.276 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 6.1 Cg_exo -77.75 57.68 6.13 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.237 2.624 . . . . 0.0 112.329 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--N 1.314 -0.964 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.981 -179.168 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.584 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 60.1 m . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.988 0.423 . . . . 0.0 111.282 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.02 -33.85 2.17 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.124 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.406 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 9.6 mt-10 -54.59 155.01 4.35 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.943 0.497 . . . . 0.0 111.691 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.415 HG22 ' O ' ' A' ' 20' ' ' ASN . 15.9 p -111.35 149.41 31.19 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.827 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.585 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.2 p -97.97 116.25 29.82 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.421 0.629 . . . . 0.0 110.823 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 t -86.42 55.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.093 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.95 43.14 0.88 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.508 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.495 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.73 30.71 68.12 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.539 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.585 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 16.1 p -129.23 138.48 51.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.542 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 90.1 m -135.67 140.34 44.4 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.124 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -66.26 -62.43 1.48 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.7 m -66.03 122.01 78.98 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 121.366 0.603 . . . . 0.0 112.506 -178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.7 130.74 36.5 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.688 2.258 . . . . 0.0 110.767 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.33 -20.61 39.6 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.068 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.572 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 79.9 m -88.64 83.51 6.75 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.056 0.455 . . . . 0.0 110.287 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.09 135.4 54.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.692 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.495 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 8.8 t -59.84 136.55 58.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 0.0 110.708 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 20' ' ' ASN . 14.6 t -140.72 -163.96 1.64 Allowed 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -46.73 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.828 0.705 . . . . 0.0 112.04 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 18' ' ' SER . 19.2 p30 49.59 23.26 0.9 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.978 1.311 . . . . 0.0 111.939 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.437 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 12.9 mmtp -150.16 145.11 26.1 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.427 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.572 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 32.8 m -88.41 130.4 35.18 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 45.2 p -114.47 134.42 55.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.007 0.432 . . . . 0.0 110.959 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.584 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.0 ttm180 -89.71 101.12 13.81 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 59.89 35.12 21.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.589 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.72 -14.62 64.54 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.397 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.0 tp -89.22 116.37 66.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.478 0.639 . . . . 0.0 111.148 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.466 ' HA ' HG23 ' A' ' 23' ' ' THR . 63.0 Cg_endo -75.08 56.4 4.29 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.028 2.485 . . . . 0.0 112.435 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.314 -0.955 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.962 -179.254 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 21.4 m . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.069 0.462 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.05 -38.87 2.01 Favored Glycine 0 C--O 1.238 0.367 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.873 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.472 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 18.8 mm-40 -54.43 161.74 1.32 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.215 0.606 . . . . 0.0 112.222 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -110.59 155.03 22.92 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.895 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.595 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -99.01 134.63 41.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 178.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.5 t -79.11 55.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.894 0.854 . . . . 0.0 109.478 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.48 -43.93 1.58 Allowed Glycine 0 C--N 1.314 -0.683 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.876 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.03 32.79 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.203 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.595 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.7 p -136.6 138.8 41.6 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 50.3 m -125.12 128.47 48.48 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.205 0.526 . . . . 0.0 110.804 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -70.41 -30.09 66.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.088 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.496 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 1.3 m -73.62 119.46 76.12 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 120.764 0.316 . . . . 0.0 110.623 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.3 Cg_endo -56.64 131.72 47.35 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.693 2.262 . . . . 0.0 112.524 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.52 -7.22 69.61 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.371 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.2 m -94.15 123.0 37.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.268 0.556 . . . . 0.0 111.432 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.43 145.49 24.42 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.059 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.8 t -65.41 135.07 54.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.941 0.4 . . . . 0.0 111.117 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 37.2 m -141.31 -174.5 4.04 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -47.5 86.0 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.542 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 59.0 t30 56.62 21.02 5.4 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.665 0.786 . . . . 0.0 111.322 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.542 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 7.9 mmtm -150.8 141.54 22.75 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 69.2 m -89.59 129.99 35.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.7 p -115.01 137.18 52.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.068 0.461 . . . . 0.0 111.489 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HG2' ' OD1' ' A' ' 25' ' ' ASN . 41.6 ttm180 -96.15 113.42 25.02 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.405 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 5.5 p-10 47.59 37.2 6.25 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.088 0.868 . . . . 0.0 111.218 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.16 -16.1 60.54 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.816 -0.629 . . . . 0.0 114.012 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.1 tp -90.86 116.49 66.53 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 117.592 0.696 . . . . 0.0 111.498 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -76.85 58.67 6.13 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.079 2.519 . . . . 0.0 112.372 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.315 -0.914 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.097 -179.004 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 121.137 0.494 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.73 -37.92 2.11 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.595 -0.73 . . . . 0.0 113.378 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -55.86 154.7 6.89 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.347 0.594 . . . . 0.0 111.681 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.49 HG21 ' O ' ' A' ' 20' ' ' ASN . 2.9 p -104.8 153.75 20.91 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.302 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.61 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.8 p -102.07 133.1 47.44 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.14 0.495 . . . . 0.0 110.705 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 t -78.55 54.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.979 0.895 . . . . 0.0 109.615 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.85 -42.71 1.83 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.98 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.72 36.45 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.321 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.526 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 9.9 p -136.17 139.73 43.07 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 122.623 -0.339 . . . . 0.0 110.244 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.61 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 99.7 m -135.33 137.65 42.62 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.67 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -67.56 -57.28 6.75 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 35.1 m -62.38 119.89 53.97 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 121.237 0.541 . . . . 0.0 111.898 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -59.82 129.64 31.51 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.671 2.247 . . . . 0.0 111.082 179.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.04 49.08 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.569 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 23' ' ' THR . 68.3 m -88.71 105.58 17.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.068 0.461 . . . . 0.0 110.363 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -81.93 145.08 30.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 t -64.09 137.13 57.83 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 20' ' ' ASN . 17.4 t -140.85 -166.76 2.22 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -45.8 80.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.49 ' O ' HG21 ' A' ' 4' ' ' THR . 28.8 t-20 60.41 13.98 4.45 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.385 0.674 . . . . 0.0 111.175 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.457 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 10.1 mmtp -149.45 147.3 28.08 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 121.962 -0.461 . . . . 0.0 111.969 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.406 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 50.6 m -88.51 134.4 33.87 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.456 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 65.8 p -122.48 136.77 54.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.795 0.331 . . . . 0.0 110.802 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -89.04 99.42 12.41 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 58.44 38.28 25.65 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.879 0.737 . . . . 0.0 109.911 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.61 -13.99 66.16 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.192 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.589 ' HG ' HG11 ' A' ' 29' ' ' VAL . 17.5 tp -87.99 112.58 50.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 117.533 0.666 . . . . 0.0 110.986 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 3.0 Cg_exo -75.93 57.36 5.1 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.587 2.858 . . . . 0.0 113.053 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.589 HG11 ' HG ' ' A' ' 27' ' ' LEU . 16.1 m . . . . . 0 C--N 1.315 -0.921 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.772 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.482 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 32.6 m . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 121.103 0.477 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.52 -41.17 2.48 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.888 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -56.28 160.1 3.19 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.637 0.732 . . . . 0.0 112.399 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.569 HG21 ' O ' ' A' ' 20' ' ' ASN . 20.9 p -116.82 152.77 33.73 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.205 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.571 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -95.31 132.49 40.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.09 0.471 . . . . 0.0 110.732 178.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 t -79.46 54.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.95 0.881 . . . . 0.0 109.625 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.84 -43.87 1.63 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.103 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.41 33.91 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.411 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.571 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.7 p -136.3 138.06 41.33 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.629 -0.336 . . . . 0.0 110.374 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.475 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 62.6 m -130.24 128.79 42.34 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.198 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -71.03 -34.15 71.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.465 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.509 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 2.5 m -73.14 117.22 58.24 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 120.96 0.409 . . . . 0.0 110.979 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.14 131.62 46.31 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.794 2.329 . . . . 0.0 112.298 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.32 -11.58 69.3 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.929 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 64.2 m -89.57 106.93 18.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.438 0.619 . . . . 0.0 111.455 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.95 137.89 40.62 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.4 t -67.49 124.49 23.36 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.334 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.532 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 62.8 m -125.89 -166.73 1.6 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.656 ' H ' ' HD3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -45.49 82.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -179.129 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.569 ' O ' HG21 ' A' ' 4' ' ' THR . 14.6 t-20 57.22 20.65 5.88 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.177 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.408 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 33.1 mmtm -150.68 144.28 25.09 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 122.008 -0.432 . . . . 0.0 111.643 -178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 38.4 m -87.8 127.35 35.33 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.467 HG23 ' HA ' ' A' ' 28' ' ' PRO . 61.9 p -128.38 140.93 51.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.393 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.482 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 91.6 mtt180 -92.88 103.69 16.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 59.39 35.69 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.669 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.71 -14.84 64.4 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.534 -0.757 . . . . 0.0 113.31 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.1 tp -82.06 114.99 54.85 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 117.311 0.556 . . . . 0.0 111.079 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.467 ' HA ' HG23 ' A' ' 23' ' ' THR . 72.5 Cg_endo -79.75 60.74 7.95 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.038 2.492 . . . . 0.0 112.411 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.61 -179.34 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.538 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 25.5 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.282 0.563 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.66 -38.74 3.17 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.435 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -56.35 161.9 2.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.552 0.691 . . . . 0.0 112.04 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.54 HG22 ' O ' ' A' ' 20' ' ' ASN . 16.5 p -114.23 151.07 33.37 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.606 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -95.08 117.99 31.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.353 0.597 . . . . 0.0 110.612 178.471 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -88.32 54.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.959 0.885 . . . . 0.0 110.099 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.68 42.7 0.61 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.388 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.55 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 68.83 32.13 73.57 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.726 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.549 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.2 p -135.09 140.18 45.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.742 0.306 . . . . 0.0 110.263 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 72.5 m -132.53 133.64 44.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.366 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -69.29 -42.56 75.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.754 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.5 m -68.87 118.26 59.3 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 121.033 0.444 . . . . 0.0 111.572 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.41 131.44 42.83 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.803 2.335 . . . . 0.0 111.873 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.98 -19.17 55.41 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.932 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.548 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.4 m -89.62 104.79 17.32 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.217 0.532 . . . . 0.0 111.066 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 p -81.24 143.56 32.2 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.634 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.55 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 13.5 t -62.59 135.02 57.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.813 0.339 . . . . 0.0 110.677 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 20' ' ' ASN . 40.1 m -141.82 -171.55 3.37 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -46.83 89.36 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.608 0.567 . . . . 0.0 111.931 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.54 ' O ' HG22 ' A' ' 4' ' ' THR . 17.8 p30 48.5 24.22 0.72 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.816 1.246 . . . . 0.0 112.268 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.6 mmtm -150.58 144.13 25.09 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 122.342 0.257 . . . . 0.0 111.449 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.548 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 60.2 m -89.35 128.02 35.86 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 41.0 p -110.57 133.01 53.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.244 0.545 . . . . 0.0 111.428 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.538 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 50.7 ttp180 -90.28 102.66 15.38 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 59.26 37.49 23.65 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.812 0.695 . . . . 0.0 109.703 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.47 -14.24 65.73 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.674 -0.693 . . . . 0.0 113.568 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.3 tp -91.4 114.08 60.59 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 117.601 0.7 . . . . 0.0 111.128 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -74.26 56.2 3.74 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.18 2.587 . . . . 0.0 112.656 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.314 -0.973 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.353 -179.035 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 46.0 m . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.037 0.446 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.0 -36.58 2.34 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.738 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.44 158.22 4.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.294 0.568 . . . . 0.0 112.148 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 20' ' ' ASN . 1.6 p -107.63 156.18 19.33 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.855 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.572 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 4.5 p -108.82 132.4 54.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.367 0.603 . . . . 0.0 111.106 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.65 54.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.671 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.15 -41.4 2.14 Favored Glycine 0 C--N 1.315 -0.633 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.219 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.75 36.34 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.223 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 9.2 p -136.41 139.64 42.6 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.572 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 66.9 m -134.35 137.61 44.28 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.126 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -65.81 -57.77 7.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.8 m -64.59 115.6 21.6 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.282 0.563 . . . . 0.0 111.641 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.75 128.07 26.76 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.66 2.24 . . . . 0.0 111.074 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.38 -22.96 25.83 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.301 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 68.2 m -89.58 118.46 29.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.937 0.399 . . . . 0.0 110.254 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -89.68 147.84 23.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.2 t -66.47 134.57 52.73 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.682 0.277 . . . . 0.0 110.437 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.443 ' HB3' ' HD2' ' A' ' 21' ' ' LYS . 10.0 t -137.77 -177.51 4.84 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.449 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -48.87 91.91 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.715 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.557 ' O ' HG23 ' A' ' 4' ' ' THR . 39.9 t30 62.14 11.07 4.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.459 1.104 . . . . 0.0 113.008 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -155.19 151.37 28.09 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.558 -0.714 . . . . 0.0 112.419 179.23 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 47.1 m -88.89 133.19 34.37 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.9 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 37.4 p -117.75 138.48 52.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.053 0.454 . . . . 0.0 110.754 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.4 ttt85 -91.65 98.87 11.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.3 t30 58.57 37.48 25.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.663 0.744 . . . . 0.0 109.137 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.04 -20.66 49.93 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.521 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.444 HD21 HG23 ' A' ' 29' ' ' VAL . 16.2 tp -81.95 114.09 47.96 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 117.46 0.63 . . . . 0.0 111.028 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -77.16 56.45 5.45 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.918 2.412 . . . . 0.0 113.45 -179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.444 HG23 HD21 ' A' ' 27' ' ' LEU . 15.5 m . . . . . 0 C--N 1.313 -1.009 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.751 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.547 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 1.6 m . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.596 0.236 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.74 -37.24 0.73 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.456 -0.402 . . . . 0.0 113.824 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.438 ' H ' ' C ' ' A' ' 1' ' ' CYS . 47.2 mm-40 -57.25 164.01 1.95 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.298 0.57 . . . . 0.0 112.449 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.419 HG22 ' O ' ' A' ' 20' ' ' ASN . 1.2 p -104.95 153.95 20.74 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.698 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.558 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -96.45 137.13 35.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.72 178.485 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.9 t -78.83 55.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.93 0.872 . . . . 0.0 109.413 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.68 -42.77 1.81 Allowed Glycine 0 C--N 1.314 -0.641 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.722 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.61 34.22 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.01 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.558 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 9.1 p -136.75 140.12 42.35 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.3 m -127.17 133.98 50.23 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.908 0.385 . . . . 0.0 110.553 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -60.42 -45.42 93.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.118 -177.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.547 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 8.7 m -77.52 112.45 24.15 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-O 120.951 0.405 . . . . 0.0 111.438 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.9 Cg_endo -57.56 127.5 25.61 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.526 2.151 . . . . 0.0 111.379 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.68 -24.65 14.74 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.429 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 74.3 m -92.42 118.52 31.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.356 0.598 . . . . 0.0 111.498 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 p -84.08 143.24 29.85 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.434 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.9 t -63.17 133.43 54.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.717 0.294 . . . . 0.0 110.812 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 27.8 m -138.69 -176.1 4.36 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -48.31 88.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.541 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 8.0 m120 54.17 23.12 3.98 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.783 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 10.4 mmtm -150.98 138.4 19.49 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 1' ' ' CYS . 69.1 m -89.8 121.35 31.86 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 57.0 p -109.61 137.47 47.39 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.111 0.481 . . . . 0.0 111.295 -178.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -88.79 92.79 9.35 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 57.57 44.04 21.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.26 -177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.18 -21.79 43.33 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.441 -0.799 . . . . 0.0 113.603 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.736 ' HG ' HG13 ' A' ' 29' ' ' VAL . 18.4 tp -83.19 110.94 26.9 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 117.558 0.679 . . . . 0.0 111.151 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_exo -73.32 63.27 4.39 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 123.341 2.694 . . . . 0.0 113.076 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.736 HG13 ' HG ' ' A' ' 27' ' ' LEU . 8.3 m . . . . . 0 C--N 1.319 -0.732 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.449 -0.521 0 CA-C-O 120.996 0.427 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.54 -38.76 2.64 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.929 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.93 156.85 10.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.377 0.608 . . . . 0.0 112.031 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.509 HG23 ' O ' ' A' ' 20' ' ' ASN . 20.4 p -113.19 151.22 31.23 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.742 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.593 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.2 p -98.11 131.35 44.57 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.172 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 t -78.38 55.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.627 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.92 -42.03 2.02 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.869 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.421 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . -179.79 36.08 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.058 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.541 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 10.6 p -136.32 139.04 42.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.88 0.371 . . . . 0.0 110.997 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 89.6 m -135.38 140.73 45.22 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.33 -52.07 8.59 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.454 HG22 ' SG ' ' A' ' 15' ' ' CYS . 54.1 m -61.84 118.08 34.99 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-O 121.48 0.657 . . . . 0.0 111.834 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.89 130.84 41.98 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.11 2.54 . . . . 0.0 112.015 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.49 -20.09 49.87 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.03 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.454 ' SG ' HG22 ' A' ' 12' ' ' THR . 62.5 m -89.47 110.97 21.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.195 0.521 . . . . 0.0 110.802 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 t -85.85 145.72 27.06 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 8.5 t -64.32 131.74 48.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.006 0.432 . . . . 0.0 109.97 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.0 m -132.65 179.43 6.15 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.4 ' O ' ' HG3' ' A' ' 21' ' ' LYS . 17.7 mtpp -47.9 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.509 ' O ' HG23 ' A' ' 4' ' ' THR . 7.1 m120 63.83 7.82 3.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.676 178.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.402 ' O ' ' HD2' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -154.84 152.44 29.81 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.551 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 33.5 m -88.87 136.74 32.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.095 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.5 p -128.36 145.03 51.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.07 0.462 . . . . 0.0 110.629 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 ttm-85 -89.12 90.95 8.6 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 57.25 43.08 24.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.386 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.421 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 99.68 -24.16 33.3 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.421 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.407 ' HG ' HG11 ' A' ' 29' ' ' VAL . 16.2 tp -78.41 111.26 17.59 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 117.401 0.6 . . . . 0.0 110.968 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 71.8 Cg_endo -79.0 57.79 6.63 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.986 2.457 . . . . 0.0 113.344 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.407 HG11 ' HG ' ' A' ' 27' ' ' LEU . 19.1 m . . . . . 0 C--N 1.315 -0.901 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.407 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.468 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 39.3 m . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 120.91 0.386 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.33 -33.7 2.48 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.268 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.9 172.51 0.4 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.915 0.864 . . . . 0.0 112.561 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 20' ' ' ASN . 2.0 p -126.65 156.07 41.59 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.284 -1.326 . . . . 0.0 111.74 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.625 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -102.88 115.01 29.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.192 0.52 . . . . 0.0 110.578 178.527 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 t -89.97 54.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.855 0.835 . . . . 0.0 110.049 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.97 42.84 0.5 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.365 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.36 29.6 73.17 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.734 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.625 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.9 p -135.17 140.28 45.23 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m -127.05 129.7 48.53 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.769 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -69.51 -34.05 73.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.983 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.45 HG21 ' SG ' ' A' ' 15' ' ' CYS . 4.4 m -70.34 117.68 57.06 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-O 120.903 0.382 . . . . 0.0 111.116 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 13.2 Cg_endo -57.34 130.52 39.69 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.971 2.447 . . . . 0.0 112.697 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.3 -15.01 60.9 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.684 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.45 ' SG ' HG21 ' A' ' 12' ' ' THR . 42.2 m -92.73 123.4 35.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.158 0.504 . . . . 0.0 111.397 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.6 t -95.13 154.44 17.18 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 t -67.89 139.5 56.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.067 0.46 . . . . 0.0 110.716 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 20' ' ' ASN . 41.7 m -144.25 -172.52 3.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -48.16 86.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.456 ' O ' HG22 ' A' ' 4' ' ' THR . 8.7 m120 54.36 22.11 3.58 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.729 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 26.6 mmtp -151.41 149.98 29.92 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 120.466 0.174 . . . . 0.0 111.318 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.409 ' O ' ' HB2' ' A' ' 1' ' ' CYS . 60.8 m -93.56 130.06 39.57 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.0 p -118.46 138.61 52.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.892 0.377 . . . . 0.0 110.535 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.3 ttp180 -103.87 112.43 25.39 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.11 32.08 19.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.584 0.707 . . . . 0.0 109.115 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.05 -10.4 73.05 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.292 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.2 tp -90.53 116.57 66.7 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 117.147 0.473 . . . . 0.0 111.12 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -77.15 56.93 5.64 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.205 2.603 . . . . 0.0 112.286 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.314 -0.957 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.859 -179.148 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 121.344 0.593 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.47 -41.11 2.78 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.488 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -60.14 161.78 6.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.4 0.619 . . . . 0.0 112.041 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.499 HG21 ' O ' ' A' ' 20' ' ' ASN . 22.4 p -111.69 151.79 28.48 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.031 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.615 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -93.26 115.49 28.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.228 0.537 . . . . 0.0 110.66 178.363 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -87.28 54.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.9 0.857 . . . . 0.0 110.05 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.5 42.64 0.68 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.467 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.428 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.86 29.95 70.63 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.464 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.615 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 14.9 p -130.34 140.73 50.61 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 50.6 m -135.17 131.55 36.9 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.787 0.327 . . . . 0.0 111.166 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -74.54 -32.34 62.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.771 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.664 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -63.06 121.83 71.45 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-O 120.89 0.376 . . . . 0.0 110.516 -179.475 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -57.5 122.74 12.29 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.711 2.274 . . . . 0.0 113.53 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.46 12.1 84.15 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.019 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.664 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 96.0 m -100.3 115.26 29.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.546 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 p -84.09 139.33 32.54 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.521 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.428 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 9.0 t -62.76 135.87 57.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.733 0.301 . . . . 0.0 110.763 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 20' ' ' ASN . 15.7 t -140.49 -168.74 2.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -46.4 80.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.499 ' O ' HG21 ' A' ' 4' ' ' THR . 4.7 m120 57.56 22.07 7.78 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.338 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.407 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 32.2 mmtm -150.95 145.55 25.66 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.499 -178.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 40.6 m -88.47 138.81 31.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.7 p -128.92 140.29 51.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -177.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.611 ' HB3' ' NH1' ' A' ' 24' ' ' ARG . 3.6 mtp-105 -89.09 95.36 10.28 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 m120 57.85 33.53 23.32 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.724 0.64 . . . . 0.0 109.868 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.83 -24.47 23.43 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.187 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.737 ' HG ' HG12 ' A' ' 29' ' ' VAL . 18.7 tp -78.89 111.98 23.92 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 117.317 0.558 . . . . 0.0 111.219 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.0 57.82 6.28 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.111 2.541 . . . . 0.0 113.843 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.737 HG12 ' HG ' ' A' ' 27' ' ' LEU . 15.8 m . . . . . 0 C--N 1.314 -0.97 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.691 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 120.989 0.423 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.01 -37.89 2.37 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.537 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.475 ' HG3' ' HG1' ' A' ' 12' ' ' THR . 20.7 mm-40 -58.96 165.13 2.55 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.535 0.683 . . . . 0.0 112.45 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 20' ' ' ASN . 7.3 p -115.68 153.41 31.38 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.067 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.581 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.5 p -101.92 133.56 46.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.184 0.516 . . . . 0.0 110.842 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.53 54.02 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.914 0.864 . . . . 0.0 109.681 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.63 -43.23 1.73 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.03 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.74 35.61 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.355 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.559 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 10.2 p -136.2 139.78 43.05 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 56.8 m -133.6 129.77 37.42 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.109 0.481 . . . . 0.0 111.229 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -75.69 -26.83 57.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.767 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.56 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.8 OUTLIER -72.14 121.49 84.8 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-O 120.93 0.395 . . . . 0.0 110.569 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.4 Cg_endo -56.99 129.41 34.35 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.598 2.199 . . . . 0.0 112.768 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.24 10.07 85.51 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.555 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.56 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 86.1 m -103.82 117.53 34.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.672 0.736 . . . . 0.0 111.596 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.84 140.44 30.42 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.926 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.7 t -64.25 135.96 56.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.74 0.305 . . . . 0.0 110.421 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 20' ' ' ASN . 13.4 t -137.58 -167.11 2.06 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -47.48 86.31 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.585 ' O ' HG22 ' A' ' 4' ' ' THR . 6.6 m120 56.78 15.78 2.38 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.125 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 62.2 mmtt -150.27 150.26 31.27 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.43 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 46.1 m -88.45 131.48 34.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.827 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 42.7 p -122.92 137.55 54.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 -179.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.415 ' HG2' ' OD1' ' A' ' 25' ' ' ASN . 43.3 ttm180 -93.88 113.48 25.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.415 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 5.6 p-10 47.39 36.97 5.42 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.163 0.914 . . . . 0.0 111.274 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.23 -13.65 64.42 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.744 -0.662 . . . . 0.0 114.072 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 tp -91.42 118.12 68.23 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 117.506 0.653 . . . . 0.0 111.529 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.63 58.34 6.35 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.073 2.515 . . . . 0.0 112.24 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--N 1.316 -0.856 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.865 -179.048 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 23.1 m . . . . . 0 C--O 1.223 -0.327 0 CA-C-O 121.317 0.58 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.05 -39.36 3.03 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.406 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -57.28 165.67 1.37 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.239 0.543 . . . . 0.0 112.071 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.81 178.4 4.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.97 178.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -120.08 119.91 34.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.322 0.582 . . . . 0.0 110.774 179.089 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 t -87.35 54.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.935 0.874 . . . . 0.0 109.979 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.14 42.59 0.64 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.347 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.568 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.0 32.46 73.26 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.781 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 14.1 p -135.03 139.51 44.86 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 110.439 179.472 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 69.2 m -128.07 132.86 49.01 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.056 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -71.81 -45.16 62.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.953 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.0 m -59.89 116.61 17.77 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.561 -178.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -57.43 128.5 29.69 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.064 2.509 . . . . 0.0 112.643 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.61 -20.04 52.18 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.945 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 57.3 m -89.66 118.5 29.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.325 0.583 . . . . 0.0 111.112 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.88 145.24 25.54 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.568 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 15.2 t -62.26 133.3 54.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.949 0.404 . . . . 0.0 111.012 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 20' ' ' ASN . 35.1 m -141.58 -170.73 3.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -47.39 83.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 18' ' ' SER . 18.1 t30 55.83 22.9 5.96 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.999 0.92 . . . . 0.0 111.026 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 28.7 mmtp -151.48 144.04 24.26 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.678 -179.135 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.608 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 66.7 m -89.43 127.62 35.85 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.503 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 43.9 p -108.51 133.79 52.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.972 0.415 . . . . 0.0 111.015 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.572 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 44.6 ttt-85 -97.21 110.94 23.38 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.15 30.78 20.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.79 0.681 . . . . 0.0 109.543 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.37 -14.01 65.78 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.42 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 tp -91.8 116.55 66.66 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.546 0.673 . . . . 0.0 111.296 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -75.11 56.52 4.34 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.071 2.514 . . . . 0.0 112.627 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.445 -178.832 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 1.7 m . . . . . 0 C--O 1.225 -0.187 0 CA-C-O 120.898 0.38 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.53 -27.75 1.28 Allowed Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.256 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 1' ' ' CYS . 6.5 mt-10 -58.64 172.02 0.56 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.67 0.788 . . . . 0.0 112.011 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.34 -179.91 3.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.09 178.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -128.74 134.59 48.49 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.218 0.532 . . . . 0.0 111.538 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 t -80.82 53.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.911 0.862 . . . . 0.0 109.372 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.02 -43.97 1.6 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.011 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.83 35.65 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.282 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.532 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 8.9 p -136.13 140.88 44.01 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.794 -0.239 . . . . 0.0 110.507 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 66.1 m -129.83 143.38 50.78 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.973 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.9 m120 -61.32 -56.85 15.74 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.552 HG21 ' NH2' ' A' ' 24' ' ' ARG . 76.3 m -70.74 116.09 42.38 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 121.374 0.606 . . . . 0.0 111.945 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.76 129.92 34.47 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.631 2.221 . . . . 0.0 110.766 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.87 -28.0 10.4 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.063 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.629 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 34.6 m -88.81 112.22 22.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.583 0.706 . . . . 0.0 110.9 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.43 142.52 34.24 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.979 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.5 t -62.18 124.24 20.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.804 0.335 . . . . 0.0 110.474 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 13.0 m -126.76 -175.78 3.51 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -48.49 85.51 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 18' ' ' SER . 79.5 m-20 60.69 14.89 5.35 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.037 0.935 . . . . 0.0 111.974 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' O ' ' HB2' ' A' ' 18' ' ' SER . 50.7 mmtt -147.82 141.27 25.35 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.629 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 50.0 m -89.41 127.47 35.83 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 62.1 p -119.84 136.69 54.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.855 0.359 . . . . 0.0 110.954 -179.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.552 ' NH2' HG21 ' A' ' 12' ' ' THR . 13.9 ptp180 -99.68 109.99 22.42 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.36 34.09 22.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.141 -177.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.28 -14.94 64.1 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.596 -0.729 . . . . 0.0 113.577 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 28.5 tp -82.88 112.12 35.31 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 117.288 0.544 . . . . 0.0 111.343 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 6.2 Cg_exo -78.65 59.4 7.21 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.578 2.852 . . . . 0.0 112.204 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.315 -0.901 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.589 -178.896 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.628 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 25.9 m . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 121.2 0.524 . . . . 0.0 111.418 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.6 -40.14 2.85 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.539 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -58.0 162.18 3.52 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.89 0.852 . . . . 0.0 112.489 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 20' ' ' ASN . 28.5 p -119.84 150.61 40.17 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.444 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.591 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.7 p -92.79 114.93 27.62 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.454 0.645 . . . . 0.0 110.91 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -86.94 54.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.058 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.02 42.91 0.69 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.409 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.571 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.92 31.26 69.83 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.664 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.591 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 12.7 p -132.96 139.23 47.2 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.909 0.385 . . . . 0.0 110.588 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.507 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 67.3 m -135.65 136.92 41.35 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.804 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -75.03 -48.91 21.7 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.468 HG22 ' SG ' ' A' ' 15' ' ' CYS . 16.2 m -60.0 118.34 31.75 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.768 -178.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -57.94 131.29 42.77 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.948 2.432 . . . . 0.0 112.258 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.13 -16.05 61.82 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.233 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.9 m -88.7 108.39 19.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.238 0.542 . . . . 0.0 110.944 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -83.99 146.11 28.16 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.571 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 9.8 t -65.89 121.79 15.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.833 0.349 . . . . 0.0 110.188 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 20' ' ' ASN . 6.8 m -122.53 -170.61 2.11 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -49.47 85.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.561 ' O ' HG23 ' A' ' 4' ' ' THR . 7.0 m120 56.11 23.01 6.46 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.525 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.43 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 26.1 mmtp -151.07 143.95 24.52 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.623 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.4 m -89.76 132.87 34.99 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.478 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 79.8 p -128.75 141.71 51.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.847 0.356 . . . . 0.0 111.297 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.628 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 71.4 mtp180 -88.68 96.94 10.86 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 m120 58.63 34.35 23.77 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.81 0.694 . . . . 0.0 110.01 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.402 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 103.88 -20.15 42.0 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.059 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.623 ' HG ' HG11 ' A' ' 29' ' ' VAL . 17.5 tp -81.83 111.06 23.32 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 117.358 0.579 . . . . 0.0 110.947 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.402 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 72.8 Cg_endo -78.46 57.37 6.25 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.187 2.591 . . . . 0.0 113.454 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.623 HG11 ' HG ' ' A' ' 27' ' ' LEU . 15.8 m . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.313 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.476 ' SG ' ' HG2' ' A' ' 24' ' ' ARG . 14.5 m . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 121.338 0.59 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.62 -40.09 2.73 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.813 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.9 163.03 4.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.444 0.64 . . . . 0.0 112.289 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 20' ' ' ASN . 27.2 p -111.93 151.88 28.69 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.676 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.2 p -96.41 114.95 26.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.358 0.599 . . . . 0.0 110.499 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -87.35 55.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.984 0.897 . . . . 0.0 110.09 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.93 42.8 0.7 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.525 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.48 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.82 30.19 70.55 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.632 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.635 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 15.2 p -129.79 139.97 51.14 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 52.2 m -135.4 132.35 37.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.013 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -73.63 -35.49 65.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.32 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.639 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -61.56 121.79 66.47 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.35 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 11.1 Cg_endo -56.18 125.52 19.35 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.002 2.468 . . . . 0.0 113.579 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.22 8.52 83.53 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 114.699 -1.137 . . . . 0.0 113.641 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.639 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 90.5 m -93.33 117.26 29.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.865 0.832 . . . . 0.0 111.209 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 p -81.68 138.69 35.23 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.945 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.48 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.3 t -64.79 135.8 56.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.885 0.374 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 20' ' ' ASN . 46.0 m -141.02 -170.98 3.16 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -46.74 83.18 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.626 ' O ' HG22 ' A' ' 4' ' ' THR . 15.5 t-20 58.76 18.94 6.41 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.073 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -150.49 145.39 25.97 Favored 'General case' 0 C--O 1.223 -0.306 0 O-C-N 121.958 -0.464 . . . . 0.0 111.926 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 36.3 m -88.66 134.63 33.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.4 p -121.37 141.32 51.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.507 ' HG2' ' SG ' ' A' ' 15' ' ' CYS . 10.6 mmm180 -91.46 93.83 9.18 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 m120 58.38 36.46 25.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.053 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.26 -23.82 32.11 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.215 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.3 tp -81.04 114.39 48.38 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 117.41 0.605 . . . . 0.0 111.353 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.51 59.39 5.51 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.325 2.684 . . . . 0.0 112.283 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--N 1.317 -0.847 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.993 -179.133 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 37.3 m . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 121.117 0.484 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.57 38.82 79.01 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.121 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.745 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 5.0 pt-20 -137.84 160.22 39.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.699 0.285 . . . . 0.0 110.512 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 20' ' ' ASN . 15.1 p -113.9 150.81 33.13 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.155 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -94.92 132.05 40.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.107 0.48 . . . . 0.0 110.758 178.56 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.33 53.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.978 0.894 . . . . 0.0 109.767 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.25 -44.05 1.59 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.868 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.72 34.76 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.246 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 12.9 p -136.22 138.77 42.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 122.734 -0.274 . . . . 0.0 110.411 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.494 ' HB3' ' OE2' ' A' ' 3' ' ' GLU . 90.9 m -128.28 133.68 48.8 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -65.99 -50.8 63.01 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.5 m -69.05 114.85 26.22 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 121.153 0.502 . . . . 0.0 111.208 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.18 125.1 16.64 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.269 1.979 . . . . 0.0 110.965 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.69 -19.68 28.13 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.477 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.5 m -89.23 115.34 26.66 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.254 0.55 . . . . 0.0 110.517 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 p -83.63 134.04 34.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.933 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t -63.33 123.12 17.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.902 0.382 . . . . 0.0 110.252 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 20' ' ' ASN . 13.7 m -120.96 -168.8 1.72 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -47.59 83.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.556 ' O ' HG22 ' A' ' 4' ' ' THR . 28.9 t-20 61.04 15.14 5.92 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.314 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 7.1 mmtp -148.36 138.78 22.72 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 121.91 -0.494 . . . . 0.0 111.539 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.745 ' HB2' ' HG3' ' A' ' 3' ' ' GLU . 38.5 m -88.37 125.44 34.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.4 p -116.8 142.36 47.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.814 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.421 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 28.7 ttt85 -91.51 100.43 13.19 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.9 t30 59.36 40.87 20.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.717 0.77 . . . . 0.0 109.484 -177.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.57 -12.39 65.38 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.613 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.632 ' HG ' HG13 ' A' ' 29' ' ' VAL . 16.2 tp -91.38 113.48 58.63 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 117.442 0.621 . . . . 0.0 110.778 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.97 56.94 3.76 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.429 2.752 . . . . 0.0 113.001 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.632 HG13 ' HG ' ' A' ' 27' ' ' LEU . 13.5 m . . . . . 0 C--N 1.315 -0.9 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.8 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 48.6 m . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.026 0.441 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.87 -36.56 2.32 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.689 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 23.1 mt-10 -57.88 173.88 0.29 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 5' ' ' CYS . 0.6 OUTLIER -122.92 -178.44 3.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.881 178.325 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.611 ' H ' HG22 ' A' ' 4' ' ' THR . 0.8 OUTLIER -129.18 134.81 48.18 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.191 0.519 . . . . 0.0 111.25 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -79.85 53.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.996 0.903 . . . . 0.0 109.58 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.27 -44.28 1.54 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.735 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.3 35.78 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.2 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 10.7 p -136.03 139.83 43.4 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.646 -0.326 . . . . 0.0 110.748 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.4 m -131.15 136.83 48.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -70.72 -50.79 32.49 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.411 ' HA ' ' HD2' ' A' ' 13' ' ' PRO . 28.4 m -59.79 117.82 26.47 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 121.286 0.565 . . . . 0.0 111.818 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 13.7 Cg_endo -56.97 131.85 48.05 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.023 2.482 . . . . 0.0 112.3 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.96 -16.5 60.75 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.38 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 85.6 m -89.24 117.21 28.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.383 0.611 . . . . 0.0 111.273 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.66 142.91 27.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.218 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.6 t -63.37 134.23 55.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.84 0.352 . . . . 0.0 110.722 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 20' ' ' ASN . 36.6 m -142.18 -171.3 3.35 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -46.57 83.71 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.509 ' O ' HG23 ' A' ' 4' ' ' THR . 74.9 m-20 56.9 19.69 4.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.72 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 25.9 mmtm -150.94 145.59 25.7 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 44.7 m -89.16 133.09 34.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 28' ' ' PRO . 80.5 p -125.45 143.49 50.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.983 0.42 . . . . 0.0 111.807 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.4 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 59.5 mtt85 -88.7 93.35 9.54 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 56.46 36.92 28.32 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.889 0.743 . . . . 0.0 109.714 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.69 -26.94 14.39 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.313 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.7 tp -76.74 110.58 12.15 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 117.39 0.595 . . . . 0.0 111.505 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.497 ' HA ' HG22 ' A' ' 23' ' ' THR . 5.6 Cg_exo -78.74 57.43 6.37 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.578 2.852 . . . . 0.0 112.681 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 C--N 1.315 -0.933 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.889 -179.414 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.29 0.567 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.82 -36.16 2.31 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.677 -0.692 . . . . 0.0 113.527 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -56.58 160.4 3.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.447 0.641 . . . . 0.0 112.239 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 20' ' ' ASN . 13.4 p -113.03 151.39 30.73 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.551 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.2 p -97.68 114.42 26.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.496 0.665 . . . . 0.0 110.825 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.3 55.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.109 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.66 43.23 0.9 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.418 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.556 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.57 30.4 68.8 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.66 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 17.0 p -129.04 138.79 52.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.799 0.333 . . . . 0.0 110.21 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 80.9 m -135.38 140.37 44.94 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.087 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -72.72 -56.52 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 23.9 m -58.98 117.64 22.93 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 121.206 0.527 . . . . 0.0 111.79 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 38.9 Cg_exo -59.49 129.85 32.98 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.811 2.34 . . . . 0.0 111.458 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.63 -17.3 57.75 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.859 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 86.0 m -88.47 100.02 12.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.372 0.606 . . . . 0.0 110.86 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -74.71 138.11 42.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.666 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.556 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.6 t -63.02 127.45 31.29 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.895 0.379 . . . . 0.0 110.597 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 20' ' ' ASN . 14.4 m -127.15 -167.08 1.68 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -49.1 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.619 ' O ' HG22 ' A' ' 4' ' ' THR . 31.3 t30 58.56 21.28 8.46 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.004 0.921 . . . . 0.0 111.092 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 62.1 mmtt -150.42 143.08 24.57 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 29.4 m -88.98 130.69 35.42 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 53.4 p -119.64 137.55 53.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.804 0.335 . . . . 0.0 110.522 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -88.0 97.24 10.85 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 m120 59.1 38.49 23.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.839 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.12 -15.87 62.15 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.268 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.599 ' HG ' HG13 ' A' ' 29' ' ' VAL . 17.5 tp -86.73 111.52 40.5 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 117.322 0.561 . . . . 0.0 110.755 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.435 ' HA ' HG22 ' A' ' 23' ' ' THR . 68.3 Cg_endo -75.58 56.87 4.73 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.154 2.57 . . . . 0.0 113.469 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.599 HG13 ' HG ' ' A' ' 27' ' ' LEU . 14.8 m . . . . . 0 C--N 1.314 -0.944 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.515 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 28.1 m . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.299 0.571 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.79 -34.84 2.52 Favored Glycine 0 C--O 1.238 0.391 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.836 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -59.82 172.46 0.73 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.448 0.642 . . . . 0.0 112.211 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -121.23 179.45 4.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.637 179.062 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -124.64 118.82 27.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.35 0.595 . . . . 0.0 111.208 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -89.48 54.53 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.883 0.849 . . . . 0.0 109.859 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.97 42.4 0.61 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.389 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.412 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.42 31.0 71.06 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.756 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 13.5 p -131.95 139.4 48.68 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 58.0 m -128.6 141.53 51.33 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.747 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -66.73 -56.71 9.31 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m -62.98 118.62 44.26 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 121.168 0.509 . . . . 0.0 111.599 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.61 129.77 32.4 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.644 2.229 . . . . 0.0 111.307 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.71 -18.9 54.34 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.621 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 73.6 m -89.15 105.45 17.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 110.843 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.54 140.62 38.51 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.424 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.412 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 7.0 t -63.52 132.1 50.23 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.159 0.287 . . . . 0.0 110.472 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 20' ' ' ASN . 10.1 t -138.35 -167.83 2.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -46.77 81.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.555 ' O ' HG23 ' A' ' 4' ' ' THR . 44.6 t30 58.13 18.07 5.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.695 0.798 . . . . 0.0 111.079 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt -150.71 144.31 25.08 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.917 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 36.2 m -88.53 130.61 35.19 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.443 HG22 ' CA ' ' A' ' 28' ' ' PRO . 64.3 p -115.21 133.57 55.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.828 0.347 . . . . 0.0 110.553 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 57.3 ttp180 -94.29 105.05 17.03 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.78 40.08 19.98 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.91 -10.96 63.64 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.704 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.601 ' HG ' HG13 ' A' ' 29' ' ' VAL . 16.4 tp -91.26 113.46 58.45 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 117.52 0.66 . . . . 0.0 110.827 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.443 ' CA ' HG22 ' A' ' 23' ' ' THR . 68.3 Cg_endo -75.93 56.21 4.7 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.203 2.602 . . . . 0.0 113.359 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.601 HG13 ' HG ' ' A' ' 27' ' ' LEU . 14.9 m . . . . . 0 C--N 1.313 -0.985 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.647 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 38.7 m . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 121.115 0.484 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.79 -38.38 2.34 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.857 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.71 155.85 12.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.25 0.547 . . . . 0.0 111.798 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 20' ' ' ASN . 25.1 p -105.55 152.19 23.37 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.028 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.639 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.5 p -100.42 133.02 45.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.244 0.545 . . . . 0.0 110.883 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.66 54.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.952 0.882 . . . . 0.0 109.695 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.42 -41.6 2.11 Favored Glycine 0 C--N 1.315 -0.612 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.994 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.4 36.21 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.203 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.2 p -136.09 138.86 42.52 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 122.671 -0.311 . . . . 0.0 110.531 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.639 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 69.1 m -135.79 134.31 38.81 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.077 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -67.54 -54.78 17.11 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -62.19 116.16 20.54 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 121.255 0.55 . . . . 0.0 111.503 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.79 129.83 35.46 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.746 2.297 . . . . 0.0 111.775 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.74 -17.16 56.87 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.113 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 82.6 m -89.14 109.6 20.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.16 0.505 . . . . 0.0 110.83 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 p -80.36 139.46 36.55 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.631 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.0 t -63.71 135.94 57.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.451 . . . . 0.0 110.536 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.539 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 21.8 m -136.64 177.56 7.75 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -49.79 95.03 0.01 OUTLIER 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.552 ' O ' HG22 ' A' ' 4' ' ' THR . 9.1 m120 66.71 7.06 4.91 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.498 1.119 . . . . 0.0 113.674 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.539 ' HD2' ' HB2' ' A' ' 18' ' ' SER . 0.0 OUTLIER -154.79 151.52 28.75 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 118.685 0.675 . . . . 0.0 112.732 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.2 m -88.94 136.95 32.74 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 28' ' ' PRO . 56.1 p -125.94 141.75 51.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.017 0.437 . . . . 0.0 111.5 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.8 ttm-85 -93.85 97.31 10.31 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.89 42.45 19.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.34 -20.95 40.56 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.53 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.1 tp -79.11 113.37 35.45 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 117.614 0.707 . . . . 0.0 111.276 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 6.1 Cg_exo -77.75 57.68 6.13 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.237 2.624 . . . . 0.0 112.329 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--N 1.314 -0.964 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.981 -179.168 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 60.1 m . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.988 0.423 . . . . 0.0 111.282 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.02 -33.85 2.17 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.124 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.429 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 9.6 mt-10 -54.59 155.01 4.35 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.943 0.497 . . . . 0.0 111.691 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 20' ' ' ASN . 15.9 p -111.35 149.41 31.19 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.827 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.2 p -97.97 116.25 29.82 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.421 0.629 . . . . 0.0 110.823 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 t -86.42 55.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.093 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.95 43.14 0.88 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.508 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.5 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.73 30.71 68.12 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.539 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 16.1 p -129.23 138.48 51.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 90.1 m -135.67 140.34 44.4 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.124 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -66.26 -62.43 1.48 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.5 HG21 ' NH2' ' A' ' 24' ' ' ARG . 55.7 m -66.03 122.01 78.98 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 121.366 0.603 . . . . 0.0 112.506 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.7 130.74 36.5 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.688 2.258 . . . . 0.0 110.767 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.33 -20.61 39.6 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.068 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 79.9 m -88.64 83.51 6.75 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.056 0.455 . . . . 0.0 110.287 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.09 135.4 54.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.692 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.5 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 8.8 t -59.84 136.55 58.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 0.0 110.708 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 20' ' ' ASN . 14.6 t -140.72 -163.96 1.64 Allowed 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -46.73 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.828 0.705 . . . . 0.0 112.04 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.532 ' O ' HG22 ' A' ' 4' ' ' THR . 19.2 p30 49.59 23.26 0.9 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.978 1.311 . . . . 0.0 111.939 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 12.9 mmtp -150.16 145.11 26.1 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.427 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 32.8 m -88.41 130.4 35.18 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 45.2 p -114.47 134.42 55.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.007 0.432 . . . . 0.0 110.959 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.588 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.0 ttm180 -89.71 101.12 13.81 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 59.89 35.12 21.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.589 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.72 -14.62 64.54 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.397 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.0 tp -89.22 116.37 66.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.478 0.639 . . . . 0.0 111.148 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.402 ' CA ' HG22 ' A' ' 23' ' ' THR . 63.0 Cg_endo -75.08 56.4 4.29 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.028 2.485 . . . . 0.0 112.435 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.314 -0.955 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.962 -179.254 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 21.4 m . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.069 0.462 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.05 -38.87 2.01 Favored Glycine 0 C--O 1.238 0.367 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.873 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.484 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 18.8 mm-40 -54.43 161.74 1.32 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.215 0.606 . . . . 0.0 112.222 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -110.59 155.03 22.92 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.895 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -99.01 134.63 41.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 178.373 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.5 t -79.11 55.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.894 0.854 . . . . 0.0 109.478 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.48 -43.93 1.58 Allowed Glycine 0 C--N 1.314 -0.683 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.876 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.03 32.79 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.203 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.7 p -136.6 138.8 41.6 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 50.3 m -125.12 128.47 48.48 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.205 0.526 . . . . 0.0 110.804 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -70.41 -30.09 66.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.088 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.519 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 1.3 m -73.62 119.46 76.12 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 120.764 0.316 . . . . 0.0 110.623 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.3 Cg_endo -56.64 131.72 47.35 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.693 2.262 . . . . 0.0 112.524 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.52 -7.22 69.61 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.371 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.2 m -94.15 123.0 37.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.268 0.556 . . . . 0.0 111.432 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.43 145.49 24.42 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.059 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.8 t -65.41 135.07 54.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.941 0.4 . . . . 0.0 111.117 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 37.2 m -141.31 -174.5 4.04 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -47.5 86.0 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 59.0 t30 56.62 21.02 5.4 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.665 0.786 . . . . 0.0 111.322 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 7.9 mmtm -150.8 141.54 22.75 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 69.2 m -89.59 129.99 35.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.502 HG22 ' CA ' ' A' ' 28' ' ' PRO . 42.7 p -115.01 137.18 52.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.068 0.461 . . . . 0.0 111.489 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HG2' ' OD1' ' A' ' 25' ' ' ASN . 41.6 ttm180 -96.15 113.42 25.02 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.419 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 5.5 p-10 47.59 37.2 6.25 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.088 0.868 . . . . 0.0 111.218 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.16 -16.1 60.54 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.816 -0.629 . . . . 0.0 114.012 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.1 tp -90.86 116.49 66.53 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 117.592 0.696 . . . . 0.0 111.498 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.502 ' CA ' HG22 ' A' ' 23' ' ' THR . 72.7 Cg_endo -76.85 58.67 6.13 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.079 2.519 . . . . 0.0 112.372 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.315 -0.914 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.097 -179.004 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 121.137 0.494 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.73 -37.92 2.11 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.595 -0.73 . . . . 0.0 113.378 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -55.86 154.7 6.89 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.347 0.594 . . . . 0.0 111.681 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 20' ' ' ASN . 2.9 p -104.8 153.75 20.91 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.302 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.621 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.8 p -102.07 133.1 47.44 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.14 0.495 . . . . 0.0 110.705 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 t -78.55 54.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.979 0.895 . . . . 0.0 109.615 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.85 -42.71 1.83 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.98 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.72 36.45 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.321 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 9.9 p -136.17 139.73 43.07 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 122.623 -0.339 . . . . 0.0 110.244 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.621 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 99.7 m -135.33 137.65 42.62 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.67 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -67.56 -57.28 6.75 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 35.1 m -62.38 119.89 53.97 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 121.237 0.541 . . . . 0.0 111.898 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 28.1 Cg_exo -59.82 129.64 31.51 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.671 2.247 . . . . 0.0 111.082 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.04 49.08 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.569 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 68.3 m -88.71 105.58 17.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.068 0.461 . . . . 0.0 110.363 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -81.93 145.08 30.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 t -64.09 137.13 57.83 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 20' ' ' ASN . 17.4 t -140.85 -166.76 2.22 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -45.8 80.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.622 ' O ' HG22 ' A' ' 4' ' ' THR . 28.8 t-20 60.41 13.98 4.45 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.385 0.674 . . . . 0.0 111.175 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 10.1 mmtp -149.45 147.3 28.08 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 121.962 -0.461 . . . . 0.0 111.969 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 50.6 m -88.51 134.4 33.87 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.482 HG22 ' HA ' ' A' ' 28' ' ' PRO . 65.8 p -122.48 136.77 54.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.795 0.331 . . . . 0.0 110.802 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -89.04 99.42 12.41 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 58.44 38.28 25.65 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.879 0.737 . . . . 0.0 109.911 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.61 -13.99 66.16 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.192 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.64 ' HG ' HG13 ' A' ' 29' ' ' VAL . 17.5 tp -87.99 112.58 50.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 117.533 0.666 . . . . 0.0 110.986 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.482 ' HA ' HG22 ' A' ' 23' ' ' THR . 3.0 Cg_exo -75.93 57.36 5.1 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.587 2.858 . . . . 0.0 113.053 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.64 HG13 ' HG ' ' A' ' 27' ' ' LEU . 16.1 m . . . . . 0 C--N 1.315 -0.921 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.772 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.484 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 32.6 m . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 121.103 0.477 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.52 -41.17 2.48 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.888 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -56.28 160.1 3.19 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.637 0.732 . . . . 0.0 112.399 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 20' ' ' ASN . 20.9 p -116.82 152.77 33.73 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.205 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -95.31 132.49 40.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.09 0.471 . . . . 0.0 110.732 178.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 t -79.46 54.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.95 0.881 . . . . 0.0 109.625 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.84 -43.87 1.63 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.103 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.41 33.91 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.411 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.7 p -136.3 138.06 41.33 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.629 -0.336 . . . . 0.0 110.374 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 62.6 m -130.24 128.79 42.34 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.198 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -71.03 -34.15 71.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.465 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.526 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 2.5 m -73.14 117.22 58.24 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 120.96 0.409 . . . . 0.0 110.979 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.14 131.62 46.31 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.794 2.329 . . . . 0.0 112.298 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.32 -11.58 69.3 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.929 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 64.2 m -89.57 106.93 18.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.438 0.619 . . . . 0.0 111.455 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.95 137.89 40.62 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.4 t -67.49 124.49 23.36 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.334 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.563 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 62.8 m -125.89 -166.73 1.6 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.718 ' H ' ' HD3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -45.49 82.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -179.129 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.538 ' O ' HG22 ' A' ' 4' ' ' THR . 14.6 t-20 57.22 20.65 5.88 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.177 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -150.68 144.28 25.09 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 122.008 -0.432 . . . . 0.0 111.643 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 38.4 m -87.8 127.35 35.33 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 28' ' ' PRO . 61.9 p -128.38 140.93 51.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.393 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.484 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 91.6 mtt180 -92.88 103.69 16.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 59.39 35.69 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.669 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.71 -14.84 64.4 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.534 -0.757 . . . . 0.0 113.31 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.1 tp -82.06 114.99 54.85 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 117.311 0.556 . . . . 0.0 111.079 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.566 ' HA ' HG22 ' A' ' 23' ' ' THR . 72.5 Cg_endo -79.75 60.74 7.95 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.038 2.492 . . . . 0.0 112.411 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.61 -179.34 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 25.5 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.282 0.563 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.66 -38.74 3.17 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.435 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -56.35 161.9 2.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.552 0.691 . . . . 0.0 112.04 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 20' ' ' ASN . 16.5 p -114.23 151.07 33.37 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.606 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -95.08 117.99 31.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.353 0.597 . . . . 0.0 110.612 178.471 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -88.32 54.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.959 0.885 . . . . 0.0 110.099 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.68 42.7 0.61 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.388 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.556 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 68.83 32.13 73.57 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.726 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.2 p -135.09 140.18 45.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.742 0.306 . . . . 0.0 110.263 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 72.5 m -132.53 133.64 44.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.366 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -69.29 -42.56 75.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.754 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 8.5 m -68.87 118.26 59.3 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 121.033 0.444 . . . . 0.0 111.572 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 31.6 Cg_exo -58.41 131.44 42.83 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.803 2.335 . . . . 0.0 111.873 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.98 -19.17 55.41 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.932 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.4 m -89.62 104.79 17.32 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.217 0.532 . . . . 0.0 111.066 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 p -81.24 143.56 32.2 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.634 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.556 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 13.5 t -62.59 135.02 57.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.813 0.339 . . . . 0.0 110.677 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 20' ' ' ASN . 40.1 m -141.82 -171.55 3.37 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -46.83 89.36 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.608 0.567 . . . . 0.0 111.931 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.62 ' O ' HG22 ' A' ' 4' ' ' THR . 17.8 p30 48.5 24.22 0.72 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.816 1.246 . . . . 0.0 112.268 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.6 mmtm -150.58 144.13 25.09 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 122.342 0.257 . . . . 0.0 111.449 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 60.2 m -89.35 128.02 35.86 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 41.0 p -110.57 133.01 53.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.244 0.545 . . . . 0.0 111.428 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.551 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 50.7 ttp180 -90.28 102.66 15.38 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 59.26 37.49 23.65 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.812 0.695 . . . . 0.0 109.703 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.47 -14.24 65.73 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.674 -0.693 . . . . 0.0 113.568 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.3 tp -91.4 114.08 60.59 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 117.601 0.7 . . . . 0.0 111.128 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.512 ' CA ' HG22 ' A' ' 23' ' ' THR . 61.3 Cg_endo -74.26 56.2 3.74 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.18 2.587 . . . . 0.0 112.656 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.314 -0.973 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.353 -179.035 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 46.0 m . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.037 0.446 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.0 -36.58 2.34 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.738 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.44 158.22 4.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.294 0.568 . . . . 0.0 112.148 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 20' ' ' ASN . 1.6 p -107.63 156.18 19.33 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.855 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.58 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 4.5 p -108.82 132.4 54.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.367 0.603 . . . . 0.0 111.106 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.65 54.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.671 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.15 -41.4 2.14 Favored Glycine 0 C--N 1.315 -0.633 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.219 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.75 36.34 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.223 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 9.2 p -136.41 139.64 42.6 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 66.9 m -134.35 137.61 44.28 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.126 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -65.81 -57.77 7.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.8 m -64.59 115.6 21.6 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.282 0.563 . . . . 0.0 111.641 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.75 128.07 26.76 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.66 2.24 . . . . 0.0 111.074 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.38 -22.96 25.83 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.301 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 68.2 m -89.58 118.46 29.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.937 0.399 . . . . 0.0 110.254 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -89.68 147.84 23.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.2 t -66.47 134.57 52.73 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.682 0.277 . . . . 0.0 110.437 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.459 ' HB3' ' HD2' ' A' ' 21' ' ' LYS . 10.0 t -137.77 -177.51 4.84 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.474 ' H ' ' HD3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -48.87 91.91 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.715 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.542 ' O ' HG22 ' A' ' 4' ' ' THR . 39.9 t30 62.14 11.07 4.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.459 1.104 . . . . 0.0 113.008 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -155.19 151.37 28.09 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.558 -0.714 . . . . 0.0 112.419 179.23 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 47.1 m -88.89 133.19 34.37 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.9 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.46 HG22 ' CA ' ' A' ' 28' ' ' PRO . 37.4 p -117.75 138.48 52.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.053 0.454 . . . . 0.0 110.754 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.4 ttt85 -91.65 98.87 11.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.3 t30 58.57 37.48 25.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.663 0.744 . . . . 0.0 109.137 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.04 -20.66 49.93 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.521 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.598 ' HG ' HG13 ' A' ' 29' ' ' VAL . 16.2 tp -81.95 114.09 47.96 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 117.46 0.63 . . . . 0.0 111.028 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.46 ' CA ' HG22 ' A' ' 23' ' ' THR . 72.2 Cg_endo -77.16 56.45 5.45 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.918 2.412 . . . . 0.0 113.45 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.598 HG13 ' HG ' ' A' ' 27' ' ' LEU . 15.5 m . . . . . 0 C--N 1.313 -1.009 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.751 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.558 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 1.6 m . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.596 0.236 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.74 -37.24 0.73 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.456 -0.402 . . . . 0.0 113.824 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 1' ' ' CYS . 47.2 mm-40 -57.25 164.01 1.95 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.298 0.57 . . . . 0.0 112.449 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -104.95 153.95 20.74 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.698 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -96.45 137.13 35.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.72 178.485 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.9 t -78.83 55.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.93 0.872 . . . . 0.0 109.413 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.68 -42.77 1.81 Allowed Glycine 0 C--N 1.314 -0.641 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.722 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.61 34.22 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.01 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 9.1 p -136.75 140.12 42.35 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.3 m -127.17 133.98 50.23 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.908 0.385 . . . . 0.0 110.553 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -60.42 -45.42 93.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.118 -177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.558 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 8.7 m -77.52 112.45 24.15 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-O 120.951 0.405 . . . . 0.0 111.438 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.9 Cg_endo -57.56 127.5 25.61 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.526 2.151 . . . . 0.0 111.379 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.68 -24.65 14.74 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.429 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 74.3 m -92.42 118.52 31.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.356 0.598 . . . . 0.0 111.498 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 p -84.08 143.24 29.85 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.434 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.9 t -63.17 133.43 54.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.717 0.294 . . . . 0.0 110.812 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 27.8 m -138.69 -176.1 4.36 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -48.31 88.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.534 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 8.0 m120 54.17 23.12 3.98 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.783 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 10.4 mmtm -150.98 138.4 19.49 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 69.1 m -89.8 121.35 31.86 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 28' ' ' PRO . 57.0 p -109.61 137.47 47.39 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.111 0.481 . . . . 0.0 111.295 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -88.79 92.79 9.35 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.57 44.04 21.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.26 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.18 -21.79 43.33 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.441 -0.799 . . . . 0.0 113.603 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.659 ' HG ' HG13 ' A' ' 29' ' ' VAL . 18.4 tp -83.19 110.94 26.9 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 117.558 0.679 . . . . 0.0 111.151 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 7.1 Cg_exo -73.32 63.27 4.39 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 123.341 2.694 . . . . 0.0 113.076 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.659 HG13 ' HG ' ' A' ' 27' ' ' LEU . 8.3 m . . . . . 0 C--N 1.319 -0.732 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.449 -0.521 0 CA-C-O 120.996 0.427 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.54 -38.76 2.64 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.929 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.93 156.85 10.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.377 0.608 . . . . 0.0 112.031 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 20' ' ' ASN . 20.4 p -113.19 151.22 31.23 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.742 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.597 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.2 p -98.11 131.35 44.57 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.172 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 t -78.38 55.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.627 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.92 -42.03 2.02 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.869 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.426 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . -179.79 36.08 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.058 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 10.6 p -136.32 139.04 42.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.88 0.371 . . . . 0.0 110.997 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.597 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 89.6 m -135.38 140.73 45.22 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -79.33 -52.07 8.59 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 m -61.84 118.08 34.99 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-O 121.48 0.657 . . . . 0.0 111.834 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.89 130.84 41.98 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.11 2.54 . . . . 0.0 112.015 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.49 -20.09 49.87 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.03 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 62.5 m -89.47 110.97 21.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.195 0.521 . . . . 0.0 110.802 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 t -85.85 145.72 27.06 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.426 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 8.5 t -64.32 131.74 48.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.006 0.432 . . . . 0.0 109.97 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.427 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 11.0 m -132.65 179.43 6.15 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 19' ' ' LYS . 17.7 mtpp -47.9 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.473 ' O ' HG22 ' A' ' 4' ' ' THR . 7.1 m120 63.83 7.82 3.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.676 178.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.427 ' HD2' ' HB2' ' A' ' 18' ' ' SER . 0.0 OUTLIER -154.84 152.44 29.81 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.551 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 33.5 m -88.87 136.74 32.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.095 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.407 HG22 ' HA ' ' A' ' 28' ' ' PRO . 82.5 p -128.36 145.03 51.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.07 0.462 . . . . 0.0 110.629 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 ttm-85 -89.12 90.95 8.6 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 57.25 43.08 24.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.386 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 99.68 -24.16 33.3 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.421 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.566 ' HG ' HG13 ' A' ' 29' ' ' VAL . 16.2 tp -78.41 111.26 17.59 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 117.401 0.6 . . . . 0.0 110.968 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 71.8 Cg_endo -79.0 57.79 6.63 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.986 2.457 . . . . 0.0 113.344 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.566 HG13 ' HG ' ' A' ' 27' ' ' LEU . 19.1 m . . . . . 0 C--N 1.315 -0.901 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.407 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 39.3 m . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 120.91 0.386 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.33 -33.7 2.48 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.268 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.9 172.51 0.4 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.915 0.864 . . . . 0.0 112.561 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 20' ' ' ASN . 2.0 p -126.65 156.07 41.59 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.284 -1.326 . . . . 0.0 111.74 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -102.88 115.01 29.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.192 0.52 . . . . 0.0 110.578 178.527 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 t -89.97 54.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.855 0.835 . . . . 0.0 110.049 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.97 42.84 0.5 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.365 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.36 29.6 73.17 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.734 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.9 p -135.17 140.28 45.23 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m -127.05 129.7 48.53 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.769 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -69.51 -34.05 73.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.983 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.453 ' HA ' ' HD2' ' A' ' 13' ' ' PRO . 4.4 m -70.34 117.68 57.06 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-O 120.903 0.382 . . . . 0.0 111.116 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 13.2 Cg_endo -57.34 130.52 39.69 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.971 2.447 . . . . 0.0 112.697 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.3 -15.01 60.9 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.684 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 42.2 m -92.73 123.4 35.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.158 0.504 . . . . 0.0 111.397 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.6 t -95.13 154.44 17.18 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 t -67.89 139.5 56.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.067 0.46 . . . . 0.0 110.716 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 20' ' ' ASN . 41.7 m -144.25 -172.52 3.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -48.16 86.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.526 ' O ' HG22 ' A' ' 4' ' ' THR . 8.7 m120 54.36 22.11 3.58 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.729 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 26.6 mmtp -151.41 149.98 29.92 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 120.466 0.174 . . . . 0.0 111.318 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 60.8 m -93.56 130.06 39.57 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.447 HG22 ' CA ' ' A' ' 28' ' ' PRO . 76.0 p -118.46 138.61 52.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.892 0.377 . . . . 0.0 110.535 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.486 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.3 ttp180 -103.87 112.43 25.39 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 61.11 32.08 19.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.584 0.707 . . . . 0.0 109.115 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.05 -10.4 73.05 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.292 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.2 tp -90.53 116.57 66.7 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 117.147 0.473 . . . . 0.0 111.12 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.447 ' CA ' HG22 ' A' ' 23' ' ' THR . 74.5 Cg_endo -77.15 56.93 5.64 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.205 2.603 . . . . 0.0 112.286 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.314 -0.957 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.859 -179.148 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 121.344 0.593 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.47 -41.11 2.78 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.488 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -60.14 161.78 6.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.4 0.619 . . . . 0.0 112.041 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 20' ' ' ASN . 22.4 p -111.69 151.79 28.48 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.031 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -93.26 115.49 28.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.228 0.537 . . . . 0.0 110.66 178.363 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -87.28 54.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.9 0.857 . . . . 0.0 110.05 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.5 42.64 0.68 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.467 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.433 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.86 29.95 70.63 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.464 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 14.9 p -130.34 140.73 50.61 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 50.6 m -135.17 131.55 36.9 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.787 0.327 . . . . 0.0 111.166 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -74.54 -32.34 62.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.771 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.69 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -63.06 121.83 71.45 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-O 120.89 0.376 . . . . 0.0 110.516 -179.475 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.0 Cg_endo -57.5 122.74 12.29 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.711 2.274 . . . . 0.0 113.53 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.46 12.1 84.15 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.019 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.69 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 96.0 m -100.3 115.26 29.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.546 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 p -84.09 139.33 32.54 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.521 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.433 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 9.0 t -62.76 135.87 57.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.733 0.301 . . . . 0.0 110.763 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 20' ' ' ASN . 15.7 t -140.49 -168.74 2.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -46.4 80.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.627 ' O ' HG22 ' A' ' 4' ' ' THR . 78.6 m-20 57.56 22.07 7.78 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.338 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -150.95 145.55 25.66 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.499 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 40.6 m -88.47 138.81 31.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.496 HG22 ' CA ' ' A' ' 28' ' ' PRO . 32.7 p -128.92 140.29 51.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.623 ' HG2' ' SG ' ' A' ' 15' ' ' CYS . 3.6 mtp-105 -89.09 95.36 10.28 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 m120 57.85 33.53 23.32 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.724 0.64 . . . . 0.0 109.868 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.83 -24.47 23.43 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.187 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HG ' HG13 ' A' ' 29' ' ' VAL . 18.7 tp -78.89 111.98 23.92 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 117.317 0.558 . . . . 0.0 111.219 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.496 ' CA ' HG22 ' A' ' 23' ' ' THR . 73.0 Cg_endo -78.0 57.82 6.28 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.111 2.541 . . . . 0.0 113.843 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.591 HG13 ' HG ' ' A' ' 27' ' ' LEU . 15.8 m . . . . . 0 C--N 1.314 -0.97 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.691 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 120.989 0.423 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.01 -37.89 2.37 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.537 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -58.96 165.13 2.55 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.535 0.683 . . . . 0.0 112.45 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 20' ' ' ASN . 7.3 p -115.68 153.41 31.38 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.067 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.588 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.5 p -101.92 133.56 46.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.184 0.516 . . . . 0.0 110.842 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.53 54.02 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.914 0.864 . . . . 0.0 109.681 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.63 -43.23 1.73 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.03 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.74 35.61 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.355 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 10.2 p -136.2 139.78 43.05 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.588 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 56.8 m -133.6 129.77 37.42 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.109 0.481 . . . . 0.0 111.229 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -75.69 -26.83 57.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.767 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.582 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.8 OUTLIER -72.14 121.49 84.8 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-O 120.93 0.395 . . . . 0.0 110.569 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.4 Cg_endo -56.99 129.41 34.35 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.598 2.199 . . . . 0.0 112.768 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.24 10.07 85.51 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.555 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.582 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 86.1 m -103.82 117.53 34.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.672 0.736 . . . . 0.0 111.596 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.84 140.44 30.42 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.926 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.7 t -64.25 135.96 56.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.74 0.305 . . . . 0.0 110.421 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 20' ' ' ASN . 13.4 t -137.58 -167.11 2.06 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -47.48 86.31 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.617 ' O ' HG22 ' A' ' 4' ' ' THR . 6.6 m120 56.78 15.78 2.38 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.125 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 62.2 mmtt -150.27 150.26 31.27 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 46.1 m -88.45 131.48 34.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.827 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 28' ' ' PRO . 42.7 p -122.92 137.55 54.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HG2' ' OD1' ' A' ' 25' ' ' ASN . 43.3 ttm180 -93.88 113.48 25.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.427 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 5.6 p-10 47.39 36.97 5.42 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.163 0.914 . . . . 0.0 111.274 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.23 -13.65 64.42 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.744 -0.662 . . . . 0.0 114.072 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.43 HD12 ' HD2' ' A' ' 28' ' ' PRO . 26.9 tp -91.42 118.12 68.23 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 117.506 0.653 . . . . 0.0 111.529 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.511 ' HA ' HG22 ' A' ' 23' ' ' THR . 74.3 Cg_endo -77.63 58.34 6.35 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.073 2.515 . . . . 0.0 112.24 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--N 1.316 -0.856 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.865 -179.048 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.583 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 23.1 m . . . . . 0 C--O 1.223 -0.327 0 CA-C-O 121.317 0.58 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.05 -39.36 3.03 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.406 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -57.28 165.67 1.37 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.239 0.543 . . . . 0.0 112.071 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -113.81 178.4 4.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.97 178.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -120.08 119.91 34.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.322 0.582 . . . . 0.0 110.774 179.089 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 t -87.35 54.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.935 0.874 . . . . 0.0 109.979 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.14 42.59 0.64 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.347 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.576 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.0 32.46 73.26 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.781 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 14.1 p -135.03 139.51 44.86 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 110.439 179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 69.2 m -128.07 132.86 49.01 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.056 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -71.81 -45.16 62.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.953 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 13' ' ' PRO . 5.0 m -59.89 116.61 17.77 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.561 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.5 Cg_endo -57.43 128.5 29.69 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.064 2.509 . . . . 0.0 112.643 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.61 -20.04 52.18 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.945 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 57.3 m -89.66 118.5 29.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.325 0.583 . . . . 0.0 111.112 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.88 145.24 25.54 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.576 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 15.2 t -62.26 133.3 54.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.949 0.404 . . . . 0.0 111.012 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 20' ' ' ASN . 35.1 m -141.58 -170.73 3.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -47.39 83.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.437 ' O ' HG23 ' A' ' 4' ' ' THR . 18.1 t30 55.83 22.9 5.96 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.999 0.92 . . . . 0.0 111.026 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -151.48 144.04 24.26 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.678 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 66.7 m -89.43 127.62 35.85 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.56 HG22 ' CA ' ' A' ' 28' ' ' PRO . 43.9 p -108.51 133.79 52.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.972 0.415 . . . . 0.0 111.015 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.583 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 44.6 ttt-85 -97.21 110.94 23.38 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.15 30.78 20.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.79 0.681 . . . . 0.0 109.543 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.37 -14.01 65.78 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.42 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 tp -91.8 116.55 66.66 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.546 0.673 . . . . 0.0 111.296 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.56 ' CA ' HG22 ' A' ' 23' ' ' THR . 62.2 Cg_endo -75.11 56.52 4.34 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.071 2.514 . . . . 0.0 112.627 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.445 -178.832 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 1.7 m . . . . . 0 C--O 1.225 -0.187 0 CA-C-O 120.898 0.38 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.53 -27.75 1.28 Allowed Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.256 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 1' ' ' CYS . 6.5 mt-10 -58.64 172.02 0.56 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.67 0.788 . . . . 0.0 112.011 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -118.34 -179.91 3.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.09 178.127 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -128.74 134.59 48.49 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.218 0.532 . . . . 0.0 111.538 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 t -80.82 53.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.911 0.862 . . . . 0.0 109.372 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.02 -43.97 1.6 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.011 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.83 35.65 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.282 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 8.9 p -136.13 140.88 44.01 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.794 -0.239 . . . . 0.0 110.507 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 66.1 m -129.83 143.38 50.78 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.973 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASN . . . . . 0.404 ' HB2' ' OE1' ' A' ' 3' ' ' GLU . 5.9 m120 -61.32 -56.85 15.74 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.553 HG21 ' NH2' ' A' ' 24' ' ' ARG . 76.3 m -70.74 116.09 42.38 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 121.374 0.606 . . . . 0.0 111.945 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.76 129.92 34.47 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.631 2.221 . . . . 0.0 110.766 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.87 -28.0 10.4 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.063 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 34.6 m -88.81 112.22 22.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.583 0.706 . . . . 0.0 110.9 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.43 142.52 34.24 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.979 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.5 t -62.18 124.24 20.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.804 0.335 . . . . 0.0 110.474 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 13.0 m -126.76 -175.78 3.51 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -48.49 85.51 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 18' ' ' SER . 79.5 m-20 60.69 14.89 5.35 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.037 0.935 . . . . 0.0 111.974 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 18' ' ' SER . 50.7 mmtt -147.82 141.27 25.35 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 50.0 m -89.41 127.47 35.83 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.594 HG22 ' HA ' ' A' ' 28' ' ' PRO . 62.1 p -119.84 136.69 54.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.855 0.359 . . . . 0.0 110.954 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.553 ' NH2' HG21 ' A' ' 12' ' ' THR . 13.9 ptp180 -99.68 109.99 22.42 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 59.36 34.09 22.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.141 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.28 -14.94 64.1 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.596 -0.729 . . . . 0.0 113.577 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 28.5 tp -82.88 112.12 35.31 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 117.288 0.544 . . . . 0.0 111.343 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.594 ' HA ' HG22 ' A' ' 23' ' ' THR . 6.2 Cg_exo -78.65 59.4 7.21 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.578 2.852 . . . . 0.0 112.204 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.315 -0.901 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.589 -178.896 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.637 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 25.9 m . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 121.2 0.524 . . . . 0.0 111.418 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.6 -40.14 2.85 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.539 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -58.0 162.18 3.52 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.89 0.852 . . . . 0.0 112.489 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 20' ' ' ASN . 28.5 p -119.84 150.61 40.17 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.444 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.7 p -92.79 114.93 27.62 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.454 0.645 . . . . 0.0 110.91 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -86.94 54.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.058 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.02 42.91 0.69 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.409 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.577 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.92 31.26 69.83 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.664 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.61 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 12.7 p -132.96 139.23 47.2 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.909 0.385 . . . . 0.0 110.588 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 67.3 m -135.65 136.92 41.35 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.804 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -75.03 -48.91 21.7 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.446 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 16.2 m -60.0 118.34 31.75 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.768 -178.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 15.3 Cg_endo -57.94 131.29 42.77 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.948 2.432 . . . . 0.0 112.258 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.13 -16.05 61.82 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.233 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.9 m -88.7 108.39 19.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.238 0.542 . . . . 0.0 110.944 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -83.99 146.11 28.16 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.577 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 9.8 t -65.89 121.79 15.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.833 0.349 . . . . 0.0 110.188 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 20' ' ' ASN . 6.8 m -122.53 -170.61 2.11 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -49.47 85.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.555 ' O ' HG22 ' A' ' 4' ' ' THR . 7.0 m120 56.11 23.01 6.46 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.525 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.413 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 26.1 mmtp -151.07 143.95 24.52 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.4 m -89.76 132.87 34.99 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 79.8 p -128.75 141.71 51.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.847 0.356 . . . . 0.0 111.297 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.637 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 71.4 mtp180 -88.68 96.94 10.86 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 58.63 34.35 23.77 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.81 0.694 . . . . 0.0 110.01 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.409 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 103.88 -20.15 42.0 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.059 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.602 ' HG ' HG13 ' A' ' 29' ' ' VAL . 17.5 tp -81.83 111.06 23.32 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 117.358 0.579 . . . . 0.0 110.947 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.476 ' HA ' HG22 ' A' ' 23' ' ' THR . 72.8 Cg_endo -78.46 57.37 6.25 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.187 2.591 . . . . 0.0 113.454 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.602 HG13 ' HG ' ' A' ' 27' ' ' LEU . 15.8 m . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.313 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.476 ' SG ' ' HG2' ' A' ' 24' ' ' ARG . 14.5 m . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 121.338 0.59 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.62 -40.09 2.73 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.813 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.9 163.03 4.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.444 0.64 . . . . 0.0 112.289 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 20' ' ' ASN . 27.2 p -111.93 151.88 28.69 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.676 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.2 p -96.41 114.95 26.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.358 0.599 . . . . 0.0 110.499 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -87.35 55.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.984 0.897 . . . . 0.0 110.09 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.93 42.8 0.7 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.525 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.48 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.82 30.19 70.55 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.632 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.635 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 15.2 p -129.79 139.97 51.14 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 52.2 m -135.4 132.35 37.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.013 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -73.63 -35.49 65.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.32 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.639 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -61.56 121.79 66.47 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.35 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 11.1 Cg_endo -56.18 125.52 19.35 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.002 2.468 . . . . 0.0 113.579 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.22 8.52 83.53 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 114.699 -1.137 . . . . 0.0 113.641 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.639 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 90.5 m -93.33 117.26 29.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.865 0.832 . . . . 0.0 111.209 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 p -81.68 138.69 35.23 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.945 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.48 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.3 t -64.79 135.8 56.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.885 0.374 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 20' ' ' ASN . 46.0 m -141.02 -170.98 3.16 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -46.74 83.18 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.626 ' O ' HG22 ' A' ' 4' ' ' THR . 15.5 t-20 58.76 18.94 6.41 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.073 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -150.49 145.39 25.97 Favored 'General case' 0 C--O 1.223 -0.306 0 O-C-N 121.958 -0.464 . . . . 0.0 111.926 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 36.3 m -88.66 134.63 33.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.4 p -121.37 141.32 51.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.507 ' HG2' ' SG ' ' A' ' 15' ' ' CYS . 10.6 mmm180 -91.46 93.83 9.18 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 m120 58.38 36.46 25.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.053 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.26 -23.82 32.11 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.215 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.3 tp -81.04 114.39 48.38 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 117.41 0.605 . . . . 0.0 111.353 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.51 59.39 5.51 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.325 2.684 . . . . 0.0 112.283 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--N 1.317 -0.847 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.993 -179.133 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 37.3 m . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 121.117 0.484 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.57 38.82 79.01 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.121 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.745 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 5.0 pt-20 -137.84 160.22 39.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.699 0.285 . . . . 0.0 110.512 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 20' ' ' ASN . 15.1 p -113.9 150.81 33.13 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.155 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -94.92 132.05 40.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.107 0.48 . . . . 0.0 110.758 178.56 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.33 53.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.978 0.894 . . . . 0.0 109.767 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.25 -44.05 1.59 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.868 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.72 34.76 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.246 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 12.9 p -136.22 138.77 42.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 122.734 -0.274 . . . . 0.0 110.411 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.494 ' HB3' ' OE2' ' A' ' 3' ' ' GLU . 90.9 m -128.28 133.68 48.8 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -65.99 -50.8 63.01 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.5 m -69.05 114.85 26.22 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 121.153 0.502 . . . . 0.0 111.208 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.18 125.1 16.64 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.269 1.979 . . . . 0.0 110.965 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.69 -19.68 28.13 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.477 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.5 m -89.23 115.34 26.66 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.254 0.55 . . . . 0.0 110.517 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 p -83.63 134.04 34.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.933 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t -63.33 123.12 17.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.902 0.382 . . . . 0.0 110.252 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 20' ' ' ASN . 13.7 m -120.96 -168.8 1.72 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -47.59 83.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.556 ' O ' HG22 ' A' ' 4' ' ' THR . 28.9 t-20 61.04 15.14 5.92 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.314 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 7.1 mmtp -148.36 138.78 22.72 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 121.91 -0.494 . . . . 0.0 111.539 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.745 ' HB2' ' HG3' ' A' ' 3' ' ' GLU . 38.5 m -88.37 125.44 34.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.4 p -116.8 142.36 47.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.814 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.421 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 28.7 ttt85 -91.51 100.43 13.19 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.9 t30 59.36 40.87 20.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.717 0.77 . . . . 0.0 109.484 -177.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.57 -12.39 65.38 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.613 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.632 ' HG ' HG13 ' A' ' 29' ' ' VAL . 16.2 tp -91.38 113.48 58.63 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 117.442 0.621 . . . . 0.0 110.778 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.97 56.94 3.76 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.429 2.752 . . . . 0.0 113.001 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.632 HG13 ' HG ' ' A' ' 27' ' ' LEU . 13.5 m . . . . . 0 C--N 1.315 -0.9 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.8 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 48.6 m . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.026 0.441 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.87 -36.56 2.32 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.689 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 23.1 mt-10 -57.88 173.88 0.29 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 5' ' ' CYS . 0.6 OUTLIER -122.92 -178.44 3.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.881 178.325 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.611 ' H ' HG22 ' A' ' 4' ' ' THR . 0.8 OUTLIER -129.18 134.81 48.18 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.191 0.519 . . . . 0.0 111.25 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -79.85 53.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.996 0.903 . . . . 0.0 109.58 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.27 -44.28 1.54 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.735 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.3 35.78 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.2 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 10.7 p -136.03 139.83 43.4 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.646 -0.326 . . . . 0.0 110.748 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.4 m -131.15 136.83 48.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -70.72 -50.79 32.49 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.411 ' HA ' ' HD2' ' A' ' 13' ' ' PRO . 28.4 m -59.79 117.82 26.47 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 121.286 0.565 . . . . 0.0 111.818 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 13.7 Cg_endo -56.97 131.85 48.05 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.023 2.482 . . . . 0.0 112.3 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.96 -16.5 60.75 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.38 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 85.6 m -89.24 117.21 28.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.383 0.611 . . . . 0.0 111.273 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.66 142.91 27.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.218 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.6 t -63.37 134.23 55.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.84 0.352 . . . . 0.0 110.722 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 20' ' ' ASN . 36.6 m -142.18 -171.3 3.35 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -46.57 83.71 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.509 ' O ' HG23 ' A' ' 4' ' ' THR . 74.9 m-20 56.9 19.69 4.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.72 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 25.9 mmtm -150.94 145.59 25.7 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 44.7 m -89.16 133.09 34.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 28' ' ' PRO . 80.5 p -125.45 143.49 50.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.983 0.42 . . . . 0.0 111.807 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.4 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 59.5 mtt85 -88.7 93.35 9.54 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.3 t-20 56.46 36.92 28.32 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.889 0.743 . . . . 0.0 109.714 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.69 -26.94 14.39 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.313 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.7 tp -76.74 110.58 12.15 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 117.39 0.595 . . . . 0.0 111.505 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.497 ' HA ' HG22 ' A' ' 23' ' ' THR . 5.6 Cg_exo -78.74 57.43 6.37 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.578 2.852 . . . . 0.0 112.681 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 C--N 1.315 -0.933 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.889 -179.414 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.29 0.567 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.82 -36.16 2.31 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.677 -0.692 . . . . 0.0 113.527 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -56.58 160.4 3.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.447 0.641 . . . . 0.0 112.239 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 20' ' ' ASN . 13.4 p -113.03 151.39 30.73 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.551 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.2 p -97.68 114.42 26.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.496 0.665 . . . . 0.0 110.825 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.3 55.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.109 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.66 43.23 0.9 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.418 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.556 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.57 30.4 68.8 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.66 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 17.0 p -129.04 138.79 52.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.799 0.333 . . . . 0.0 110.21 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 80.9 m -135.38 140.37 44.94 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.087 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -72.72 -56.52 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 23.9 m -58.98 117.64 22.93 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 121.206 0.527 . . . . 0.0 111.79 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 38.9 Cg_exo -59.49 129.85 32.98 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.811 2.34 . . . . 0.0 111.458 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.63 -17.3 57.75 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.859 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 86.0 m -88.47 100.02 12.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.372 0.606 . . . . 0.0 110.86 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -74.71 138.11 42.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.666 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.556 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.6 t -63.02 127.45 31.29 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.895 0.379 . . . . 0.0 110.597 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 20' ' ' ASN . 14.4 m -127.15 -167.08 1.68 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -49.1 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.619 ' O ' HG22 ' A' ' 4' ' ' THR . 31.3 t30 58.56 21.28 8.46 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.004 0.921 . . . . 0.0 111.092 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 62.1 mmtt -150.42 143.08 24.57 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 29.4 m -88.98 130.69 35.42 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 53.4 p -119.64 137.55 53.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.804 0.335 . . . . 0.0 110.522 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -88.0 97.24 10.85 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 m120 59.1 38.49 23.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.839 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.12 -15.87 62.15 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.268 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.599 ' HG ' HG13 ' A' ' 29' ' ' VAL . 17.5 tp -86.73 111.52 40.5 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 117.322 0.561 . . . . 0.0 110.755 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.435 ' HA ' HG22 ' A' ' 23' ' ' THR . 68.3 Cg_endo -75.58 56.87 4.73 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.154 2.57 . . . . 0.0 113.469 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.599 HG13 ' HG ' ' A' ' 27' ' ' LEU . 14.8 m . . . . . 0 C--N 1.314 -0.944 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.515 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 28.1 m . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.299 0.571 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.79 -34.84 2.52 Favored Glycine 0 C--O 1.238 0.391 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.836 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -59.82 172.46 0.73 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.448 0.642 . . . . 0.0 112.211 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -121.23 179.45 4.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.637 179.062 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -124.64 118.82 27.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.35 0.595 . . . . 0.0 111.208 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -89.48 54.53 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.883 0.849 . . . . 0.0 109.859 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.97 42.4 0.61 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.389 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.412 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.42 31.0 71.06 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.756 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 13.5 p -131.95 139.4 48.68 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 58.0 m -128.6 141.53 51.33 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.747 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -66.73 -56.71 9.31 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m -62.98 118.62 44.26 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 121.168 0.509 . . . . 0.0 111.599 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.61 129.77 32.4 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.644 2.229 . . . . 0.0 111.307 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.71 -18.9 54.34 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.621 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 73.6 m -89.15 105.45 17.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 110.843 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.54 140.62 38.51 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.424 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.412 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 7.0 t -63.52 132.1 50.23 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.159 0.287 . . . . 0.0 110.472 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 20' ' ' ASN . 10.1 t -138.35 -167.83 2.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -46.77 81.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.555 ' O ' HG23 ' A' ' 4' ' ' THR . 44.6 t30 58.13 18.07 5.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.695 0.798 . . . . 0.0 111.079 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt -150.71 144.31 25.08 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.917 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 36.2 m -88.53 130.61 35.19 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.443 HG22 ' CA ' ' A' ' 28' ' ' PRO . 64.3 p -115.21 133.57 55.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.828 0.347 . . . . 0.0 110.553 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 57.3 ttp180 -94.29 105.05 17.03 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 59.78 40.08 19.98 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.91 -10.96 63.64 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.704 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.601 ' HG ' HG13 ' A' ' 29' ' ' VAL . 16.4 tp -91.26 113.46 58.45 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 117.52 0.66 . . . . 0.0 110.827 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.443 ' CA ' HG22 ' A' ' 23' ' ' THR . 68.3 Cg_endo -75.93 56.21 4.7 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.203 2.602 . . . . 0.0 113.359 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.601 HG13 ' HG ' ' A' ' 27' ' ' LEU . 14.9 m . . . . . 0 C--N 1.313 -0.985 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.647 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 38.7 m . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 121.115 0.484 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.79 -38.38 2.34 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.857 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.71 155.85 12.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.25 0.547 . . . . 0.0 111.798 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 20' ' ' ASN . 25.1 p -105.55 152.19 23.37 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.028 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.639 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.5 p -100.42 133.02 45.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.244 0.545 . . . . 0.0 110.883 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.66 54.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.952 0.882 . . . . 0.0 109.695 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.42 -41.6 2.11 Favored Glycine 0 C--N 1.315 -0.612 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.994 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.4 36.21 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.203 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.2 p -136.09 138.86 42.52 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 122.671 -0.311 . . . . 0.0 110.531 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.639 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 69.1 m -135.79 134.31 38.81 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.077 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -67.54 -54.78 17.11 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -62.19 116.16 20.54 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 121.255 0.55 . . . . 0.0 111.503 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.79 129.83 35.46 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.746 2.297 . . . . 0.0 111.775 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.74 -17.16 56.87 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.113 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 82.6 m -89.14 109.6 20.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.16 0.505 . . . . 0.0 110.83 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 p -80.36 139.46 36.55 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.631 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.0 t -63.71 135.94 57.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.451 . . . . 0.0 110.536 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.539 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 21.8 m -136.64 177.56 7.75 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -49.79 95.03 0.01 OUTLIER 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.552 ' O ' HG22 ' A' ' 4' ' ' THR . 9.1 m120 66.71 7.06 4.91 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.498 1.119 . . . . 0.0 113.674 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.539 ' HD2' ' HB2' ' A' ' 18' ' ' SER . 0.0 OUTLIER -154.79 151.52 28.75 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 118.685 0.675 . . . . 0.0 112.732 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.2 m -88.94 136.95 32.74 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 28' ' ' PRO . 56.1 p -125.94 141.75 51.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.017 0.437 . . . . 0.0 111.5 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.8 ttm-85 -93.85 97.31 10.31 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 58.89 42.45 19.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.34 -20.95 40.56 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.53 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.1 tp -79.11 113.37 35.45 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 117.614 0.707 . . . . 0.0 111.276 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 6.1 Cg_exo -77.75 57.68 6.13 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.237 2.624 . . . . 0.0 112.329 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--N 1.314 -0.964 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.981 -179.168 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 60.1 m . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.988 0.423 . . . . 0.0 111.282 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.02 -33.85 2.17 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.124 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.429 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 9.6 mt-10 -54.59 155.01 4.35 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.943 0.497 . . . . 0.0 111.691 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 20' ' ' ASN . 15.9 p -111.35 149.41 31.19 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.827 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.2 p -97.97 116.25 29.82 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.421 0.629 . . . . 0.0 110.823 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 t -86.42 55.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.093 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.95 43.14 0.88 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.508 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.5 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.73 30.71 68.12 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.539 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 16.1 p -129.23 138.48 51.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 90.1 m -135.67 140.34 44.4 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.124 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -66.26 -62.43 1.48 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.5 HG21 ' NH2' ' A' ' 24' ' ' ARG . 55.7 m -66.03 122.01 78.98 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 121.366 0.603 . . . . 0.0 112.506 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.7 130.74 36.5 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.688 2.258 . . . . 0.0 110.767 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.33 -20.61 39.6 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.068 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 79.9 m -88.64 83.51 6.75 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.056 0.455 . . . . 0.0 110.287 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.09 135.4 54.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.692 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.5 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 8.8 t -59.84 136.55 58.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 0.0 110.708 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 20' ' ' ASN . 14.6 t -140.72 -163.96 1.64 Allowed 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -46.73 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.828 0.705 . . . . 0.0 112.04 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.532 ' O ' HG22 ' A' ' 4' ' ' THR . 19.2 p30 49.59 23.26 0.9 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.978 1.311 . . . . 0.0 111.939 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 12.9 mmtp -150.16 145.11 26.1 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.427 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 32.8 m -88.41 130.4 35.18 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 45.2 p -114.47 134.42 55.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.007 0.432 . . . . 0.0 110.959 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.588 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.0 ttm180 -89.71 101.12 13.81 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 59.89 35.12 21.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.589 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.72 -14.62 64.54 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.397 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.0 tp -89.22 116.37 66.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.478 0.639 . . . . 0.0 111.148 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.402 ' CA ' HG22 ' A' ' 23' ' ' THR . 63.0 Cg_endo -75.08 56.4 4.29 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.028 2.485 . . . . 0.0 112.435 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.314 -0.955 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.962 -179.254 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 21.4 m . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.069 0.462 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.05 -38.87 2.01 Favored Glycine 0 C--O 1.238 0.367 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.873 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.484 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 18.8 mm-40 -54.43 161.74 1.32 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.215 0.606 . . . . 0.0 112.222 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -110.59 155.03 22.92 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.895 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -99.01 134.63 41.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 178.373 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.5 t -79.11 55.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.894 0.854 . . . . 0.0 109.478 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.48 -43.93 1.58 Allowed Glycine 0 C--N 1.314 -0.683 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.876 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.03 32.79 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.203 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.7 p -136.6 138.8 41.6 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 50.3 m -125.12 128.47 48.48 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.205 0.526 . . . . 0.0 110.804 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -70.41 -30.09 66.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.088 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.519 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 1.3 m -73.62 119.46 76.12 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 120.764 0.316 . . . . 0.0 110.623 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.3 Cg_endo -56.64 131.72 47.35 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.693 2.262 . . . . 0.0 112.524 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.52 -7.22 69.61 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.371 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.2 m -94.15 123.0 37.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.268 0.556 . . . . 0.0 111.432 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.43 145.49 24.42 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.059 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.8 t -65.41 135.07 54.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.941 0.4 . . . . 0.0 111.117 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 37.2 m -141.31 -174.5 4.04 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -47.5 86.0 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 59.0 t30 56.62 21.02 5.4 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.665 0.786 . . . . 0.0 111.322 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 7.9 mmtm -150.8 141.54 22.75 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 69.2 m -89.59 129.99 35.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.502 HG22 ' CA ' ' A' ' 28' ' ' PRO . 42.7 p -115.01 137.18 52.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.068 0.461 . . . . 0.0 111.489 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HG2' ' OD1' ' A' ' 25' ' ' ASN . 41.6 ttm180 -96.15 113.42 25.02 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.419 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 5.5 p-10 47.59 37.2 6.25 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.088 0.868 . . . . 0.0 111.218 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.16 -16.1 60.54 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.816 -0.629 . . . . 0.0 114.012 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.1 tp -90.86 116.49 66.53 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 117.592 0.696 . . . . 0.0 111.498 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.502 ' CA ' HG22 ' A' ' 23' ' ' THR . 72.7 Cg_endo -76.85 58.67 6.13 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.079 2.519 . . . . 0.0 112.372 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.315 -0.914 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.097 -179.004 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 121.137 0.494 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.73 -37.92 2.11 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.595 -0.73 . . . . 0.0 113.378 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -55.86 154.7 6.89 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.347 0.594 . . . . 0.0 111.681 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 20' ' ' ASN . 2.9 p -104.8 153.75 20.91 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.302 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.621 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.8 p -102.07 133.1 47.44 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.14 0.495 . . . . 0.0 110.705 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 t -78.55 54.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.979 0.895 . . . . 0.0 109.615 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.85 -42.71 1.83 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.98 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.72 36.45 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.321 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 9.9 p -136.17 139.73 43.07 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 122.623 -0.339 . . . . 0.0 110.244 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.621 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 99.7 m -135.33 137.65 42.62 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.67 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -67.56 -57.28 6.75 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 35.1 m -62.38 119.89 53.97 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 121.237 0.541 . . . . 0.0 111.898 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 28.1 Cg_exo -59.82 129.64 31.51 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.671 2.247 . . . . 0.0 111.082 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.04 49.08 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.569 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 68.3 m -88.71 105.58 17.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.068 0.461 . . . . 0.0 110.363 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -81.93 145.08 30.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 t -64.09 137.13 57.83 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 20' ' ' ASN . 17.4 t -140.85 -166.76 2.22 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -45.8 80.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.622 ' O ' HG22 ' A' ' 4' ' ' THR . 28.8 t-20 60.41 13.98 4.45 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.385 0.674 . . . . 0.0 111.175 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 10.1 mmtp -149.45 147.3 28.08 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 121.962 -0.461 . . . . 0.0 111.969 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 50.6 m -88.51 134.4 33.87 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.482 HG22 ' HA ' ' A' ' 28' ' ' PRO . 65.8 p -122.48 136.77 54.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.795 0.331 . . . . 0.0 110.802 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -89.04 99.42 12.41 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 58.44 38.28 25.65 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.879 0.737 . . . . 0.0 109.911 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.61 -13.99 66.16 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.192 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.64 ' HG ' HG13 ' A' ' 29' ' ' VAL . 17.5 tp -87.99 112.58 50.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 117.533 0.666 . . . . 0.0 110.986 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.482 ' HA ' HG22 ' A' ' 23' ' ' THR . 3.0 Cg_exo -75.93 57.36 5.1 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.587 2.858 . . . . 0.0 113.053 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.64 HG13 ' HG ' ' A' ' 27' ' ' LEU . 16.1 m . . . . . 0 C--N 1.315 -0.921 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.772 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.484 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 32.6 m . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 121.103 0.477 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.52 -41.17 2.48 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.888 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -56.28 160.1 3.19 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.637 0.732 . . . . 0.0 112.399 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 20' ' ' ASN . 20.9 p -116.82 152.77 33.73 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.205 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -95.31 132.49 40.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.09 0.471 . . . . 0.0 110.732 178.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 t -79.46 54.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.95 0.881 . . . . 0.0 109.625 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.84 -43.87 1.63 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.103 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.41 33.91 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.411 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.7 p -136.3 138.06 41.33 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.629 -0.336 . . . . 0.0 110.374 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 62.6 m -130.24 128.79 42.34 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.198 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -71.03 -34.15 71.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.465 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.526 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 2.5 m -73.14 117.22 58.24 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 120.96 0.409 . . . . 0.0 110.979 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.14 131.62 46.31 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.794 2.329 . . . . 0.0 112.298 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.32 -11.58 69.3 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.929 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 64.2 m -89.57 106.93 18.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.438 0.619 . . . . 0.0 111.455 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.95 137.89 40.62 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.4 t -67.49 124.49 23.36 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.334 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.563 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 62.8 m -125.89 -166.73 1.6 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.718 ' H ' ' HD3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -45.49 82.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -179.129 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.538 ' O ' HG22 ' A' ' 4' ' ' THR . 14.6 t-20 57.22 20.65 5.88 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.177 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -150.68 144.28 25.09 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 122.008 -0.432 . . . . 0.0 111.643 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 38.4 m -87.8 127.35 35.33 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 28' ' ' PRO . 61.9 p -128.38 140.93 51.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.393 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.484 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 91.6 mtt180 -92.88 103.69 16.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 59.39 35.69 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.669 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.71 -14.84 64.4 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.534 -0.757 . . . . 0.0 113.31 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.1 tp -82.06 114.99 54.85 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 117.311 0.556 . . . . 0.0 111.079 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.566 ' HA ' HG22 ' A' ' 23' ' ' THR . 72.5 Cg_endo -79.75 60.74 7.95 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.038 2.492 . . . . 0.0 112.411 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.61 -179.34 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 25.5 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.282 0.563 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.66 -38.74 3.17 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.435 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -56.35 161.9 2.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.552 0.691 . . . . 0.0 112.04 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 20' ' ' ASN . 16.5 p -114.23 151.07 33.37 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.606 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -95.08 117.99 31.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.353 0.597 . . . . 0.0 110.612 178.471 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -88.32 54.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.959 0.885 . . . . 0.0 110.099 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.68 42.7 0.61 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.388 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.556 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 68.83 32.13 73.57 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.726 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.2 p -135.09 140.18 45.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.742 0.306 . . . . 0.0 110.263 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 72.5 m -132.53 133.64 44.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.366 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -69.29 -42.56 75.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.754 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 8.5 m -68.87 118.26 59.3 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 121.033 0.444 . . . . 0.0 111.572 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 31.6 Cg_exo -58.41 131.44 42.83 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.803 2.335 . . . . 0.0 111.873 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.98 -19.17 55.41 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.932 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.4 m -89.62 104.79 17.32 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.217 0.532 . . . . 0.0 111.066 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 p -81.24 143.56 32.2 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.634 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.556 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 13.5 t -62.59 135.02 57.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.813 0.339 . . . . 0.0 110.677 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 20' ' ' ASN . 40.1 m -141.82 -171.55 3.37 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -46.83 89.36 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.608 0.567 . . . . 0.0 111.931 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.62 ' O ' HG22 ' A' ' 4' ' ' THR . 17.8 p30 48.5 24.22 0.72 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.816 1.246 . . . . 0.0 112.268 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.6 mmtm -150.58 144.13 25.09 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 122.342 0.257 . . . . 0.0 111.449 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 60.2 m -89.35 128.02 35.86 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 41.0 p -110.57 133.01 53.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.244 0.545 . . . . 0.0 111.428 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.551 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 50.7 ttp180 -90.28 102.66 15.38 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 59.26 37.49 23.65 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.812 0.695 . . . . 0.0 109.703 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.47 -14.24 65.73 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.674 -0.693 . . . . 0.0 113.568 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.3 tp -91.4 114.08 60.59 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 117.601 0.7 . . . . 0.0 111.128 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.512 ' CA ' HG22 ' A' ' 23' ' ' THR . 61.3 Cg_endo -74.26 56.2 3.74 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.18 2.587 . . . . 0.0 112.656 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.314 -0.973 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.353 -179.035 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 46.0 m . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.037 0.446 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.0 -36.58 2.34 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.738 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.44 158.22 4.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.294 0.568 . . . . 0.0 112.148 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 20' ' ' ASN . 1.6 p -107.63 156.18 19.33 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.855 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.58 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 4.5 p -108.82 132.4 54.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.367 0.603 . . . . 0.0 111.106 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.65 54.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.671 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.15 -41.4 2.14 Favored Glycine 0 C--N 1.315 -0.633 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.219 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.75 36.34 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.223 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 9.2 p -136.41 139.64 42.6 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 66.9 m -134.35 137.61 44.28 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.126 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -65.81 -57.77 7.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.8 m -64.59 115.6 21.6 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.282 0.563 . . . . 0.0 111.641 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.75 128.07 26.76 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.66 2.24 . . . . 0.0 111.074 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.38 -22.96 25.83 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.301 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 68.2 m -89.58 118.46 29.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.937 0.399 . . . . 0.0 110.254 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -89.68 147.84 23.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.2 t -66.47 134.57 52.73 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.682 0.277 . . . . 0.0 110.437 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.459 ' HB3' ' HD2' ' A' ' 21' ' ' LYS . 10.0 t -137.77 -177.51 4.84 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.474 ' H ' ' HD3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -48.87 91.91 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.715 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.542 ' O ' HG22 ' A' ' 4' ' ' THR . 39.9 t30 62.14 11.07 4.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.459 1.104 . . . . 0.0 113.008 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -155.19 151.37 28.09 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.558 -0.714 . . . . 0.0 112.419 179.23 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 47.1 m -88.89 133.19 34.37 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.9 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.46 HG22 ' CA ' ' A' ' 28' ' ' PRO . 37.4 p -117.75 138.48 52.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.053 0.454 . . . . 0.0 110.754 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.4 ttt85 -91.65 98.87 11.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.3 t30 58.57 37.48 25.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.663 0.744 . . . . 0.0 109.137 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.04 -20.66 49.93 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.521 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.598 ' HG ' HG13 ' A' ' 29' ' ' VAL . 16.2 tp -81.95 114.09 47.96 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 117.46 0.63 . . . . 0.0 111.028 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.46 ' CA ' HG22 ' A' ' 23' ' ' THR . 72.2 Cg_endo -77.16 56.45 5.45 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.918 2.412 . . . . 0.0 113.45 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.598 HG13 ' HG ' ' A' ' 27' ' ' LEU . 15.5 m . . . . . 0 C--N 1.313 -1.009 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.751 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.558 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 1.6 m . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.596 0.236 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.74 -37.24 0.73 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.456 -0.402 . . . . 0.0 113.824 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 1' ' ' CYS . 47.2 mm-40 -57.25 164.01 1.95 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.298 0.57 . . . . 0.0 112.449 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -104.95 153.95 20.74 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.698 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -96.45 137.13 35.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.72 178.485 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.9 t -78.83 55.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.93 0.872 . . . . 0.0 109.413 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.68 -42.77 1.81 Allowed Glycine 0 C--N 1.314 -0.641 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.722 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.61 34.22 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.01 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 9.1 p -136.75 140.12 42.35 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.3 m -127.17 133.98 50.23 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.908 0.385 . . . . 0.0 110.553 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -60.42 -45.42 93.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.118 -177.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.558 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 8.7 m -77.52 112.45 24.15 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-O 120.951 0.405 . . . . 0.0 111.438 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.9 Cg_endo -57.56 127.5 25.61 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.526 2.151 . . . . 0.0 111.379 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.68 -24.65 14.74 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.429 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 74.3 m -92.42 118.52 31.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.356 0.598 . . . . 0.0 111.498 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 p -84.08 143.24 29.85 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.434 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.9 t -63.17 133.43 54.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.717 0.294 . . . . 0.0 110.812 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 27.8 m -138.69 -176.1 4.36 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -48.31 88.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.534 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 8.0 m120 54.17 23.12 3.98 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.783 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 10.4 mmtm -150.98 138.4 19.49 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 69.1 m -89.8 121.35 31.86 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 28' ' ' PRO . 57.0 p -109.61 137.47 47.39 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.111 0.481 . . . . 0.0 111.295 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -88.79 92.79 9.35 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.57 44.04 21.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.26 -177.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.18 -21.79 43.33 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.441 -0.799 . . . . 0.0 113.603 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.659 ' HG ' HG13 ' A' ' 29' ' ' VAL . 18.4 tp -83.19 110.94 26.9 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 117.558 0.679 . . . . 0.0 111.151 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 7.1 Cg_exo -73.32 63.27 4.39 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 123.341 2.694 . . . . 0.0 113.076 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.659 HG13 ' HG ' ' A' ' 27' ' ' LEU . 8.3 m . . . . . 0 C--N 1.319 -0.732 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.449 -0.521 0 CA-C-O 120.996 0.427 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.54 -38.76 2.64 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.929 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.93 156.85 10.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.377 0.608 . . . . 0.0 112.031 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 20' ' ' ASN . 20.4 p -113.19 151.22 31.23 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.742 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.597 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.2 p -98.11 131.35 44.57 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.172 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 t -78.38 55.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.627 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.92 -42.03 2.02 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.869 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.426 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . -179.79 36.08 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.058 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 10.6 p -136.32 139.04 42.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.88 0.371 . . . . 0.0 110.997 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.597 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 89.6 m -135.38 140.73 45.22 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -79.33 -52.07 8.59 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 m -61.84 118.08 34.99 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-O 121.48 0.657 . . . . 0.0 111.834 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.89 130.84 41.98 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.11 2.54 . . . . 0.0 112.015 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.49 -20.09 49.87 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.03 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 62.5 m -89.47 110.97 21.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.195 0.521 . . . . 0.0 110.802 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 t -85.85 145.72 27.06 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.426 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 8.5 t -64.32 131.74 48.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.006 0.432 . . . . 0.0 109.97 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.427 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 11.0 m -132.65 179.43 6.15 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 19' ' ' LYS . 17.7 mtpp -47.9 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.473 ' O ' HG22 ' A' ' 4' ' ' THR . 7.1 m120 63.83 7.82 3.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.676 178.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.427 ' HD2' ' HB2' ' A' ' 18' ' ' SER . 0.0 OUTLIER -154.84 152.44 29.81 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.551 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 33.5 m -88.87 136.74 32.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.095 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.407 HG22 ' HA ' ' A' ' 28' ' ' PRO . 82.5 p -128.36 145.03 51.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.07 0.462 . . . . 0.0 110.629 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 ttm-85 -89.12 90.95 8.6 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 57.25 43.08 24.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.386 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 99.68 -24.16 33.3 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.421 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.566 ' HG ' HG13 ' A' ' 29' ' ' VAL . 16.2 tp -78.41 111.26 17.59 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 117.401 0.6 . . . . 0.0 110.968 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 71.8 Cg_endo -79.0 57.79 6.63 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.986 2.457 . . . . 0.0 113.344 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.566 HG13 ' HG ' ' A' ' 27' ' ' LEU . 19.1 m . . . . . 0 C--N 1.315 -0.901 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.407 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 39.3 m . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 120.91 0.386 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.33 -33.7 2.48 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.268 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.9 172.51 0.4 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.915 0.864 . . . . 0.0 112.561 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 20' ' ' ASN . 2.0 p -126.65 156.07 41.59 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.284 -1.326 . . . . 0.0 111.74 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -102.88 115.01 29.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.192 0.52 . . . . 0.0 110.578 178.527 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 t -89.97 54.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.855 0.835 . . . . 0.0 110.049 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.97 42.84 0.5 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.365 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.36 29.6 73.17 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.734 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.9 p -135.17 140.28 45.23 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m -127.05 129.7 48.53 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.769 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -69.51 -34.05 73.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.983 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.453 ' HA ' ' HD2' ' A' ' 13' ' ' PRO . 4.4 m -70.34 117.68 57.06 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-O 120.903 0.382 . . . . 0.0 111.116 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 13.2 Cg_endo -57.34 130.52 39.69 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.971 2.447 . . . . 0.0 112.697 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.3 -15.01 60.9 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.684 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 42.2 m -92.73 123.4 35.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.158 0.504 . . . . 0.0 111.397 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.6 t -95.13 154.44 17.18 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 t -67.89 139.5 56.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.067 0.46 . . . . 0.0 110.716 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 20' ' ' ASN . 41.7 m -144.25 -172.52 3.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -48.16 86.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.526 ' O ' HG22 ' A' ' 4' ' ' THR . 8.7 m120 54.36 22.11 3.58 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.729 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 26.6 mmtp -151.41 149.98 29.92 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 120.466 0.174 . . . . 0.0 111.318 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 60.8 m -93.56 130.06 39.57 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.447 HG22 ' CA ' ' A' ' 28' ' ' PRO . 76.0 p -118.46 138.61 52.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.892 0.377 . . . . 0.0 110.535 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.486 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.3 ttp180 -103.87 112.43 25.39 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.5 t-20 61.11 32.08 19.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.584 0.707 . . . . 0.0 109.115 -177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.05 -10.4 73.05 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.292 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.2 tp -90.53 116.57 66.7 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 117.147 0.473 . . . . 0.0 111.12 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.447 ' CA ' HG22 ' A' ' 23' ' ' THR . 74.5 Cg_endo -77.15 56.93 5.64 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.205 2.603 . . . . 0.0 112.286 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.314 -0.957 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.859 -179.148 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 121.344 0.593 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.47 -41.11 2.78 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.488 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -60.14 161.78 6.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.4 0.619 . . . . 0.0 112.041 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 20' ' ' ASN . 22.4 p -111.69 151.79 28.48 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.031 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -93.26 115.49 28.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.228 0.537 . . . . 0.0 110.66 178.363 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -87.28 54.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.9 0.857 . . . . 0.0 110.05 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.5 42.64 0.68 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.467 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.86 29.95 70.63 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.464 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 14.9 p -130.34 140.73 50.61 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 50.6 m -135.17 131.55 36.9 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.787 0.327 . . . . 0.0 111.166 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -74.54 -32.34 62.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.771 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.69 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -63.06 121.83 71.45 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-O 120.89 0.376 . . . . 0.0 110.516 -179.475 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.0 Cg_endo -57.5 122.74 12.29 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.711 2.274 . . . . 0.0 113.53 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.46 12.1 84.15 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.019 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.69 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 96.0 m -100.3 115.26 29.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.546 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 p -84.09 139.33 32.54 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.521 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.433 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 9.0 t -62.76 135.87 57.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.733 0.301 . . . . 0.0 110.763 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 20' ' ' ASN . 15.7 t -140.49 -168.74 2.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -46.4 80.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.627 ' O ' HG22 ' A' ' 4' ' ' THR . 78.6 m-20 57.56 22.07 7.78 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.338 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -150.95 145.55 25.66 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.499 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 40.6 m -88.47 138.81 31.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.496 HG22 ' CA ' ' A' ' 28' ' ' PRO . 32.7 p -128.92 140.29 51.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.623 ' HG2' ' SG ' ' A' ' 15' ' ' CYS . 3.6 mtp-105 -89.09 95.36 10.28 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 m120 57.85 33.53 23.32 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.724 0.64 . . . . 0.0 109.868 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.83 -24.47 23.43 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.187 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HG ' HG13 ' A' ' 29' ' ' VAL . 18.7 tp -78.89 111.98 23.92 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 117.317 0.558 . . . . 0.0 111.219 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.496 ' CA ' HG22 ' A' ' 23' ' ' THR . 73.0 Cg_endo -78.0 57.82 6.28 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.111 2.541 . . . . 0.0 113.843 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.591 HG13 ' HG ' ' A' ' 27' ' ' LEU . 15.8 m . . . . . 0 C--N 1.314 -0.97 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.691 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 120.989 0.423 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.01 -37.89 2.37 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.537 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -58.96 165.13 2.55 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.535 0.683 . . . . 0.0 112.45 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 20' ' ' ASN . 7.3 p -115.68 153.41 31.38 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.067 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.588 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.5 p -101.92 133.56 46.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.184 0.516 . . . . 0.0 110.842 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.53 54.02 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.914 0.864 . . . . 0.0 109.681 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.63 -43.23 1.73 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.03 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.74 35.61 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.355 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 10.2 p -136.2 139.78 43.05 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.588 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 56.8 m -133.6 129.77 37.42 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.109 0.481 . . . . 0.0 111.229 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -75.69 -26.83 57.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.767 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.582 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.8 OUTLIER -72.14 121.49 84.8 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-O 120.93 0.395 . . . . 0.0 110.569 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.4 Cg_endo -56.99 129.41 34.35 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.598 2.199 . . . . 0.0 112.768 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.24 10.07 85.51 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.555 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.582 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 86.1 m -103.82 117.53 34.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.672 0.736 . . . . 0.0 111.596 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.84 140.44 30.42 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.926 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.7 t -64.25 135.96 56.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.74 0.305 . . . . 0.0 110.421 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 20' ' ' ASN . 13.4 t -137.58 -167.11 2.06 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -47.48 86.31 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.617 ' O ' HG22 ' A' ' 4' ' ' THR . 6.6 m120 56.78 15.78 2.38 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.125 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 62.2 mmtt -150.27 150.26 31.27 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 46.1 m -88.45 131.48 34.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.827 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 28' ' ' PRO . 42.7 p -122.92 137.55 54.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HG2' ' OD1' ' A' ' 25' ' ' ASN . 43.3 ttm180 -93.88 113.48 25.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.427 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 5.6 p-10 47.39 36.97 5.42 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.163 0.914 . . . . 0.0 111.274 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.23 -13.65 64.42 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.744 -0.662 . . . . 0.0 114.072 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.43 HD12 ' HD2' ' A' ' 28' ' ' PRO . 26.9 tp -91.42 118.12 68.23 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 117.506 0.653 . . . . 0.0 111.529 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.511 ' HA ' HG22 ' A' ' 23' ' ' THR . 74.3 Cg_endo -77.63 58.34 6.35 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.073 2.515 . . . . 0.0 112.24 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--N 1.316 -0.856 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.865 -179.048 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.583 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 23.1 m . . . . . 0 C--O 1.223 -0.327 0 CA-C-O 121.317 0.58 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.05 -39.36 3.03 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.406 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -57.28 165.67 1.37 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.239 0.543 . . . . 0.0 112.071 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -113.81 178.4 4.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.97 178.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -120.08 119.91 34.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.322 0.582 . . . . 0.0 110.774 179.089 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 t -87.35 54.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.935 0.874 . . . . 0.0 109.979 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.14 42.59 0.64 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.347 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.576 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.0 32.46 73.26 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.781 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 14.1 p -135.03 139.51 44.86 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 110.439 179.472 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 69.2 m -128.07 132.86 49.01 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.056 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -71.81 -45.16 62.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.953 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 13' ' ' PRO . 5.0 m -59.89 116.61 17.77 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.561 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.5 Cg_endo -57.43 128.5 29.69 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.064 2.509 . . . . 0.0 112.643 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.61 -20.04 52.18 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.945 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 57.3 m -89.66 118.5 29.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.325 0.583 . . . . 0.0 111.112 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.88 145.24 25.54 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.576 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 15.2 t -62.26 133.3 54.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.949 0.404 . . . . 0.0 111.012 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 20' ' ' ASN . 35.1 m -141.58 -170.73 3.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -47.39 83.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.437 ' O ' HG23 ' A' ' 4' ' ' THR . 18.1 t30 55.83 22.9 5.96 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.999 0.92 . . . . 0.0 111.026 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -151.48 144.04 24.26 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.678 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 66.7 m -89.43 127.62 35.85 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.56 HG22 ' CA ' ' A' ' 28' ' ' PRO . 43.9 p -108.51 133.79 52.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.972 0.415 . . . . 0.0 111.015 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.583 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 44.6 ttt-85 -97.21 110.94 23.38 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.15 30.78 20.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.79 0.681 . . . . 0.0 109.543 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.37 -14.01 65.78 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.42 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 tp -91.8 116.55 66.66 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.546 0.673 . . . . 0.0 111.296 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.56 ' CA ' HG22 ' A' ' 23' ' ' THR . 62.2 Cg_endo -75.11 56.52 4.34 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.071 2.514 . . . . 0.0 112.627 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.445 -178.832 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 1.7 m . . . . . 0 C--O 1.225 -0.187 0 CA-C-O 120.898 0.38 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.53 -27.75 1.28 Allowed Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.256 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 1' ' ' CYS . 6.5 mt-10 -58.64 172.02 0.56 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.67 0.788 . . . . 0.0 112.011 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -118.34 -179.91 3.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.09 178.127 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -128.74 134.59 48.49 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.218 0.532 . . . . 0.0 111.538 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 t -80.82 53.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.911 0.862 . . . . 0.0 109.372 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.02 -43.97 1.6 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.011 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.83 35.65 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.282 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 8.9 p -136.13 140.88 44.01 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.794 -0.239 . . . . 0.0 110.507 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 66.1 m -129.83 143.38 50.78 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.973 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.404 ' HB2' ' OE1' ' A' ' 3' ' ' GLU . 5.9 m120 -61.32 -56.85 15.74 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.553 HG21 ' NH2' ' A' ' 24' ' ' ARG . 76.3 m -70.74 116.09 42.38 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 121.374 0.606 . . . . 0.0 111.945 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.76 129.92 34.47 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.631 2.221 . . . . 0.0 110.766 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.87 -28.0 10.4 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.063 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 34.6 m -88.81 112.22 22.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.583 0.706 . . . . 0.0 110.9 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.43 142.52 34.24 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.979 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.5 t -62.18 124.24 20.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.804 0.335 . . . . 0.0 110.474 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 13.0 m -126.76 -175.78 3.51 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -48.49 85.51 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 18' ' ' SER . 79.5 m-20 60.69 14.89 5.35 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.037 0.935 . . . . 0.0 111.974 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 18' ' ' SER . 50.7 mmtt -147.82 141.27 25.35 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 50.0 m -89.41 127.47 35.83 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.594 HG22 ' HA ' ' A' ' 28' ' ' PRO . 62.1 p -119.84 136.69 54.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.855 0.359 . . . . 0.0 110.954 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.553 ' NH2' HG21 ' A' ' 12' ' ' THR . 13.9 ptp180 -99.68 109.99 22.42 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 59.36 34.09 22.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.141 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.28 -14.94 64.1 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.596 -0.729 . . . . 0.0 113.577 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 28.5 tp -82.88 112.12 35.31 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 117.288 0.544 . . . . 0.0 111.343 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.594 ' HA ' HG22 ' A' ' 23' ' ' THR . 6.2 Cg_exo -78.65 59.4 7.21 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.578 2.852 . . . . 0.0 112.204 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.315 -0.901 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.589 -178.896 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.637 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 25.9 m . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 121.2 0.524 . . . . 0.0 111.418 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.6 -40.14 2.85 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.539 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -58.0 162.18 3.52 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.89 0.852 . . . . 0.0 112.489 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 20' ' ' ASN . 28.5 p -119.84 150.61 40.17 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.444 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.7 p -92.79 114.93 27.62 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.454 0.645 . . . . 0.0 110.91 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -86.94 54.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.058 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.02 42.91 0.69 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.409 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.577 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.92 31.26 69.83 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.664 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.61 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 12.7 p -132.96 139.23 47.2 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.909 0.385 . . . . 0.0 110.588 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 67.3 m -135.65 136.92 41.35 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.804 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -75.03 -48.91 21.7 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.446 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 16.2 m -60.0 118.34 31.75 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.768 -178.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 15.3 Cg_endo -57.94 131.29 42.77 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.948 2.432 . . . . 0.0 112.258 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.13 -16.05 61.82 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.233 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.9 m -88.7 108.39 19.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.238 0.542 . . . . 0.0 110.944 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -83.99 146.11 28.16 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.577 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 9.8 t -65.89 121.79 15.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.833 0.349 . . . . 0.0 110.188 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 20' ' ' ASN . 6.8 m -122.53 -170.61 2.11 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -49.47 85.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.555 ' O ' HG22 ' A' ' 4' ' ' THR . 7.0 m120 56.11 23.01 6.46 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.525 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.413 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 26.1 mmtp -151.07 143.95 24.52 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.4 m -89.76 132.87 34.99 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 79.8 p -128.75 141.71 51.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.847 0.356 . . . . 0.0 111.297 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.637 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 71.4 mtp180 -88.68 96.94 10.86 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 58.63 34.35 23.77 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.81 0.694 . . . . 0.0 110.01 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.409 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 103.88 -20.15 42.0 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.059 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.602 ' HG ' HG13 ' A' ' 29' ' ' VAL . 17.5 tp -81.83 111.06 23.32 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 117.358 0.579 . . . . 0.0 110.947 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.476 ' HA ' HG22 ' A' ' 23' ' ' THR . 72.8 Cg_endo -78.46 57.37 6.25 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.187 2.591 . . . . 0.0 113.454 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.602 HG13 ' HG ' ' A' ' 27' ' ' LEU . 15.8 m . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.313 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.476 ' SG ' ' HG2' ' A' ' 24' ' ' ARG . 14.5 m . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 121.338 0.59 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.62 -40.09 2.73 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.813 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.9 163.03 4.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.444 0.64 . . . . 0.0 112.289 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 20' ' ' ASN . 27.2 p -111.93 151.88 28.69 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.676 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.2 p -96.41 114.95 26.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.358 0.599 . . . . 0.0 110.499 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -87.35 55.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.984 0.897 . . . . 0.0 110.09 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.93 42.8 0.7 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.525 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.48 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.82 30.19 70.55 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.632 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.635 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 15.2 p -129.79 139.97 51.14 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 52.2 m -135.4 132.35 37.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.013 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -73.63 -35.49 65.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.32 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.639 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -61.56 121.79 66.47 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.35 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 11.1 Cg_endo -56.18 125.52 19.35 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.002 2.468 . . . . 0.0 113.579 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.22 8.52 83.53 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 114.699 -1.137 . . . . 0.0 113.641 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.639 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 90.5 m -93.33 117.26 29.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.865 0.832 . . . . 0.0 111.209 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 p -81.68 138.69 35.23 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.945 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.48 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.3 t -64.79 135.8 56.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.885 0.374 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 20' ' ' ASN . 46.0 m -141.02 -170.98 3.16 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -46.74 83.18 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.626 ' O ' HG22 ' A' ' 4' ' ' THR . 15.5 t-20 58.76 18.94 6.41 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.073 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -150.49 145.39 25.97 Favored 'General case' 0 C--O 1.223 -0.306 0 O-C-N 121.958 -0.464 . . . . 0.0 111.926 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 36.3 m -88.66 134.63 33.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.4 p -121.37 141.32 51.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.507 ' HG2' ' SG ' ' A' ' 15' ' ' CYS . 10.6 mmm180 -91.46 93.83 9.18 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 m120 58.38 36.46 25.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.053 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.26 -23.82 32.11 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.215 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.3 tp -81.04 114.39 48.38 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 117.41 0.605 . . . . 0.0 111.353 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.51 59.39 5.51 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.325 2.684 . . . . 0.0 112.283 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--N 1.317 -0.847 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.993 -179.133 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 37.3 m . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 121.117 0.484 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.57 38.82 79.01 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.121 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.745 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 5.0 pt-20 -137.84 160.22 39.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.699 0.285 . . . . 0.0 110.512 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 20' ' ' ASN . 15.1 p -113.9 150.81 33.13 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.155 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -94.92 132.05 40.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.107 0.48 . . . . 0.0 110.758 178.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.33 53.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.978 0.894 . . . . 0.0 109.767 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.25 -44.05 1.59 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.868 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.72 34.76 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.246 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 12.9 p -136.22 138.77 42.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 122.734 -0.274 . . . . 0.0 110.411 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.494 ' HB3' ' OE2' ' A' ' 3' ' ' GLU . 90.9 m -128.28 133.68 48.8 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -65.99 -50.8 63.01 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.5 m -69.05 114.85 26.22 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 121.153 0.502 . . . . 0.0 111.208 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.18 125.1 16.64 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.269 1.979 . . . . 0.0 110.965 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.69 -19.68 28.13 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.477 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.5 m -89.23 115.34 26.66 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.254 0.55 . . . . 0.0 110.517 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 p -83.63 134.04 34.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.933 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t -63.33 123.12 17.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.902 0.382 . . . . 0.0 110.252 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 20' ' ' ASN . 13.7 m -120.96 -168.8 1.72 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -47.59 83.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.556 ' O ' HG22 ' A' ' 4' ' ' THR . 28.9 t-20 61.04 15.14 5.92 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.314 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 7.1 mmtp -148.36 138.78 22.72 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 121.91 -0.494 . . . . 0.0 111.539 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.745 ' HB2' ' HG3' ' A' ' 3' ' ' GLU . 38.5 m -88.37 125.44 34.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.4 p -116.8 142.36 47.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.814 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.421 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 28.7 ttt85 -91.51 100.43 13.19 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.9 t30 59.36 40.87 20.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.717 0.77 . . . . 0.0 109.484 -177.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.57 -12.39 65.38 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.613 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.632 ' HG ' HG13 ' A' ' 29' ' ' VAL . 16.2 tp -91.38 113.48 58.63 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 117.442 0.621 . . . . 0.0 110.778 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.97 56.94 3.76 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.429 2.752 . . . . 0.0 113.001 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.632 HG13 ' HG ' ' A' ' 27' ' ' LEU . 13.5 m . . . . . 0 C--N 1.315 -0.9 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.8 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 48.6 m . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.026 0.441 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.87 -36.56 2.32 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.689 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 23.1 mt-10 -57.88 173.88 0.29 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 5' ' ' CYS . 0.6 OUTLIER -122.92 -178.44 3.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.881 178.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.611 ' H ' HG22 ' A' ' 4' ' ' THR . 0.8 OUTLIER -129.18 134.81 48.18 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.191 0.519 . . . . 0.0 111.25 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -79.85 53.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.996 0.903 . . . . 0.0 109.58 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.27 -44.28 1.54 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.735 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.3 35.78 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.2 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 10.7 p -136.03 139.83 43.4 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.646 -0.326 . . . . 0.0 110.748 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.4 m -131.15 136.83 48.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -70.72 -50.79 32.49 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.411 ' HA ' ' HD2' ' A' ' 13' ' ' PRO . 28.4 m -59.79 117.82 26.47 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 121.286 0.565 . . . . 0.0 111.818 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 13.7 Cg_endo -56.97 131.85 48.05 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.023 2.482 . . . . 0.0 112.3 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.96 -16.5 60.75 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.38 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 85.6 m -89.24 117.21 28.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.383 0.611 . . . . 0.0 111.273 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.66 142.91 27.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.218 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.6 t -63.37 134.23 55.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.84 0.352 . . . . 0.0 110.722 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 20' ' ' ASN . 36.6 m -142.18 -171.3 3.35 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -46.57 83.71 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.509 ' O ' HG23 ' A' ' 4' ' ' THR . 4.2 m120 56.9 19.69 4.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.72 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 25.9 mmtm -150.94 145.59 25.7 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 44.7 m -89.16 133.09 34.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 28' ' ' PRO . 80.5 p -125.45 143.49 50.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.983 0.42 . . . . 0.0 111.807 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.4 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 59.5 mtt85 -88.7 93.35 9.54 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 56.46 36.92 28.32 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.889 0.743 . . . . 0.0 109.714 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.69 -26.94 14.39 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.313 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.7 tp -76.74 110.58 12.15 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 117.39 0.595 . . . . 0.0 111.505 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.497 ' HA ' HG22 ' A' ' 23' ' ' THR . 5.6 Cg_exo -78.74 57.43 6.37 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.578 2.852 . . . . 0.0 112.681 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 C--N 1.315 -0.933 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.889 -179.414 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.29 0.567 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.82 -36.16 2.31 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.677 -0.692 . . . . 0.0 113.527 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -56.58 160.4 3.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.447 0.641 . . . . 0.0 112.239 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 20' ' ' ASN . 13.4 p -113.03 151.39 30.73 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.551 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.2 p -97.68 114.42 26.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.496 0.665 . . . . 0.0 110.825 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.3 55.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.109 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.66 43.23 0.9 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.418 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.556 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.57 30.4 68.8 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.66 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 17.0 p -129.04 138.79 52.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.799 0.333 . . . . 0.0 110.21 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 80.9 m -135.38 140.37 44.94 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.087 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -72.72 -56.52 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 23.9 m -58.98 117.64 22.93 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 121.206 0.527 . . . . 0.0 111.79 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 38.9 Cg_exo -59.49 129.85 32.98 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.811 2.34 . . . . 0.0 111.458 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.63 -17.3 57.75 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.859 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 86.0 m -88.47 100.02 12.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.372 0.606 . . . . 0.0 110.86 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -74.71 138.11 42.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.666 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.556 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.6 t -63.02 127.45 31.29 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.895 0.379 . . . . 0.0 110.597 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 20' ' ' ASN . 14.4 m -127.15 -167.08 1.68 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -49.1 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.619 ' O ' HG22 ' A' ' 4' ' ' THR . 31.3 t30 58.56 21.28 8.46 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.004 0.921 . . . . 0.0 111.092 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 62.1 mmtt -150.42 143.08 24.57 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 29.4 m -88.98 130.69 35.42 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 53.4 p -119.64 137.55 53.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.804 0.335 . . . . 0.0 110.522 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -88.0 97.24 10.85 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 m120 59.1 38.49 23.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.839 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.12 -15.87 62.15 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.268 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.599 ' HG ' HG13 ' A' ' 29' ' ' VAL . 17.5 tp -86.73 111.52 40.5 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 117.322 0.561 . . . . 0.0 110.755 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.435 ' HA ' HG22 ' A' ' 23' ' ' THR . 68.3 Cg_endo -75.58 56.87 4.73 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.154 2.57 . . . . 0.0 113.469 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.599 HG13 ' HG ' ' A' ' 27' ' ' LEU . 14.8 m . . . . . 0 C--N 1.314 -0.944 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.515 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 28.1 m . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.299 0.571 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.79 -34.84 2.52 Favored Glycine 0 C--O 1.238 0.391 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.836 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -59.82 172.46 0.73 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.448 0.642 . . . . 0.0 112.211 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -121.23 179.45 4.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.637 179.062 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -124.64 118.82 27.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.35 0.595 . . . . 0.0 111.208 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -89.48 54.53 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.883 0.849 . . . . 0.0 109.859 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.97 42.4 0.61 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.389 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.412 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.42 31.0 71.06 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.756 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 13.5 p -131.95 139.4 48.68 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 58.0 m -128.6 141.53 51.33 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.747 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -66.73 -56.71 9.31 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m -62.98 118.62 44.26 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 121.168 0.509 . . . . 0.0 111.599 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.61 129.77 32.4 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.644 2.229 . . . . 0.0 111.307 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.71 -18.9 54.34 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.621 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 73.6 m -89.15 105.45 17.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 110.843 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.54 140.62 38.51 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.424 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.412 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 7.0 t -63.52 132.1 50.23 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.159 0.287 . . . . 0.0 110.472 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 20' ' ' ASN . 10.1 t -138.35 -167.83 2.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -46.77 81.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.555 ' O ' HG23 ' A' ' 4' ' ' THR . 44.6 t30 58.13 18.07 5.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.695 0.798 . . . . 0.0 111.079 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt -150.71 144.31 25.08 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.917 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 36.2 m -88.53 130.61 35.19 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.443 HG22 ' CA ' ' A' ' 28' ' ' PRO . 64.3 p -115.21 133.57 55.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.828 0.347 . . . . 0.0 110.553 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 57.3 ttp180 -94.29 105.05 17.03 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 59.78 40.08 19.98 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.91 -10.96 63.64 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.704 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.601 ' HG ' HG13 ' A' ' 29' ' ' VAL . 16.4 tp -91.26 113.46 58.45 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 117.52 0.66 . . . . 0.0 110.827 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.443 ' CA ' HG22 ' A' ' 23' ' ' THR . 68.3 Cg_endo -75.93 56.21 4.7 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.203 2.602 . . . . 0.0 113.359 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.601 HG13 ' HG ' ' A' ' 27' ' ' LEU . 14.9 m . . . . . 0 C--N 1.313 -0.985 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.647 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 38.7 m . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 121.115 0.484 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.79 -38.38 2.34 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.857 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.71 155.85 12.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.25 0.547 . . . . 0.0 111.798 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 20' ' ' ASN . 25.1 p -105.55 152.19 23.37 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.028 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.639 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.5 p -100.42 133.02 45.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.244 0.545 . . . . 0.0 110.883 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.66 54.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.952 0.882 . . . . 0.0 109.695 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.42 -41.6 2.11 Favored Glycine 0 C--N 1.315 -0.612 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.994 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.4 36.21 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.203 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.2 p -136.09 138.86 42.52 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 122.671 -0.311 . . . . 0.0 110.531 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.639 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 69.1 m -135.79 134.31 38.81 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.077 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -67.54 -54.78 17.11 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -62.19 116.16 20.54 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 121.255 0.55 . . . . 0.0 111.503 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.79 129.83 35.46 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.746 2.297 . . . . 0.0 111.775 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.74 -17.16 56.87 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.113 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 82.6 m -89.14 109.6 20.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.16 0.505 . . . . 0.0 110.83 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 p -80.36 139.46 36.55 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.631 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.0 t -63.71 135.94 57.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.451 . . . . 0.0 110.536 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.539 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 21.8 m -136.64 177.56 7.75 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -49.79 95.03 0.01 OUTLIER 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.552 ' O ' HG22 ' A' ' 4' ' ' THR . 9.1 m120 66.71 7.06 4.91 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.498 1.119 . . . . 0.0 113.674 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.539 ' HD2' ' HB2' ' A' ' 18' ' ' SER . 0.0 OUTLIER -154.79 151.52 28.75 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 118.685 0.675 . . . . 0.0 112.732 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.2 m -88.94 136.95 32.74 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 28' ' ' PRO . 56.1 p -125.94 141.75 51.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.017 0.437 . . . . 0.0 111.5 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.8 ttm-85 -93.85 97.31 10.31 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 58.89 42.45 19.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.34 -20.95 40.56 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.53 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.1 tp -79.11 113.37 35.45 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 117.614 0.707 . . . . 0.0 111.276 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 6.1 Cg_exo -77.75 57.68 6.13 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.237 2.624 . . . . 0.0 112.329 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--N 1.314 -0.964 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.981 -179.168 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 60.1 m . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.988 0.423 . . . . 0.0 111.282 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.02 -33.85 2.17 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.124 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.429 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 9.6 mt-10 -54.59 155.01 4.35 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.943 0.497 . . . . 0.0 111.691 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 20' ' ' ASN . 15.9 p -111.35 149.41 31.19 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.827 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.2 p -97.97 116.25 29.82 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.421 0.629 . . . . 0.0 110.823 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 t -86.42 55.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.093 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.95 43.14 0.88 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.508 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.5 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.73 30.71 68.12 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.539 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 16.1 p -129.23 138.48 51.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 90.1 m -135.67 140.34 44.4 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.124 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -66.26 -62.43 1.48 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.5 HG21 ' NH2' ' A' ' 24' ' ' ARG . 55.7 m -66.03 122.01 78.98 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 121.366 0.603 . . . . 0.0 112.506 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.7 130.74 36.5 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.688 2.258 . . . . 0.0 110.767 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.33 -20.61 39.6 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.068 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 79.9 m -88.64 83.51 6.75 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.056 0.455 . . . . 0.0 110.287 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.09 135.4 54.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.692 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.5 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 8.8 t -59.84 136.55 58.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 0.0 110.708 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 20' ' ' ASN . 14.6 t -140.72 -163.96 1.64 Allowed 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -46.73 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.828 0.705 . . . . 0.0 112.04 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.532 ' O ' HG22 ' A' ' 4' ' ' THR . 19.2 p30 49.59 23.26 0.9 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.978 1.311 . . . . 0.0 111.939 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 12.9 mmtp -150.16 145.11 26.1 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.427 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 32.8 m -88.41 130.4 35.18 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 45.2 p -114.47 134.42 55.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.007 0.432 . . . . 0.0 110.959 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.588 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.0 ttm180 -89.71 101.12 13.81 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 59.89 35.12 21.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.589 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.72 -14.62 64.54 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.397 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.0 tp -89.22 116.37 66.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.478 0.639 . . . . 0.0 111.148 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.402 ' CA ' HG22 ' A' ' 23' ' ' THR . 63.0 Cg_endo -75.08 56.4 4.29 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.028 2.485 . . . . 0.0 112.435 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.314 -0.955 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.962 -179.254 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 21.4 m . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.069 0.462 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.05 -38.87 2.01 Favored Glycine 0 C--O 1.238 0.367 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.873 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.484 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 18.8 mm-40 -54.43 161.74 1.32 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.215 0.606 . . . . 0.0 112.222 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -110.59 155.03 22.92 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.895 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -99.01 134.63 41.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 178.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.5 t -79.11 55.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.894 0.854 . . . . 0.0 109.478 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.48 -43.93 1.58 Allowed Glycine 0 C--N 1.314 -0.683 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.876 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.03 32.79 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.203 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.7 p -136.6 138.8 41.6 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 50.3 m -125.12 128.47 48.48 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.205 0.526 . . . . 0.0 110.804 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -70.41 -30.09 66.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.088 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.519 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 1.3 m -73.62 119.46 76.12 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 120.764 0.316 . . . . 0.0 110.623 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.3 Cg_endo -56.64 131.72 47.35 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.693 2.262 . . . . 0.0 112.524 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.52 -7.22 69.61 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.371 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.2 m -94.15 123.0 37.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.268 0.556 . . . . 0.0 111.432 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.43 145.49 24.42 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.059 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.8 t -65.41 135.07 54.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.941 0.4 . . . . 0.0 111.117 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 37.2 m -141.31 -174.5 4.04 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -47.5 86.0 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 59.0 t30 56.62 21.02 5.4 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.665 0.786 . . . . 0.0 111.322 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 7.9 mmtm -150.8 141.54 22.75 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 69.2 m -89.59 129.99 35.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.502 HG22 ' CA ' ' A' ' 28' ' ' PRO . 42.7 p -115.01 137.18 52.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.068 0.461 . . . . 0.0 111.489 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HG2' ' OD1' ' A' ' 25' ' ' ASN . 41.6 ttm180 -96.15 113.42 25.02 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.419 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 5.5 p-10 47.59 37.2 6.25 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.088 0.868 . . . . 0.0 111.218 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.16 -16.1 60.54 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.816 -0.629 . . . . 0.0 114.012 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.1 tp -90.86 116.49 66.53 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 117.592 0.696 . . . . 0.0 111.498 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.502 ' CA ' HG22 ' A' ' 23' ' ' THR . 72.7 Cg_endo -76.85 58.67 6.13 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.079 2.519 . . . . 0.0 112.372 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.315 -0.914 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.097 -179.004 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 121.137 0.494 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.73 -37.92 2.11 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.595 -0.73 . . . . 0.0 113.378 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -55.86 154.7 6.89 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.347 0.594 . . . . 0.0 111.681 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 20' ' ' ASN . 2.9 p -104.8 153.75 20.91 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.302 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.621 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.8 p -102.07 133.1 47.44 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.14 0.495 . . . . 0.0 110.705 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 t -78.55 54.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.979 0.895 . . . . 0.0 109.615 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.85 -42.71 1.83 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.98 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.72 36.45 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.321 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 9.9 p -136.17 139.73 43.07 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 122.623 -0.339 . . . . 0.0 110.244 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.621 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 99.7 m -135.33 137.65 42.62 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.67 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -67.56 -57.28 6.75 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 35.1 m -62.38 119.89 53.97 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 121.237 0.541 . . . . 0.0 111.898 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 28.1 Cg_exo -59.82 129.64 31.51 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.671 2.247 . . . . 0.0 111.082 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.04 49.08 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.569 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 68.3 m -88.71 105.58 17.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.068 0.461 . . . . 0.0 110.363 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -81.93 145.08 30.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 t -64.09 137.13 57.83 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 20' ' ' ASN . 17.4 t -140.85 -166.76 2.22 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -45.8 80.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.622 ' O ' HG22 ' A' ' 4' ' ' THR . 28.8 t-20 60.41 13.98 4.45 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.385 0.674 . . . . 0.0 111.175 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 10.1 mmtp -149.45 147.3 28.08 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 121.962 -0.461 . . . . 0.0 111.969 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 50.6 m -88.51 134.4 33.87 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.482 HG22 ' HA ' ' A' ' 28' ' ' PRO . 65.8 p -122.48 136.77 54.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.795 0.331 . . . . 0.0 110.802 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -89.04 99.42 12.41 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 58.44 38.28 25.65 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.879 0.737 . . . . 0.0 109.911 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.61 -13.99 66.16 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.192 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.64 ' HG ' HG13 ' A' ' 29' ' ' VAL . 17.5 tp -87.99 112.58 50.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 117.533 0.666 . . . . 0.0 110.986 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.482 ' HA ' HG22 ' A' ' 23' ' ' THR . 3.0 Cg_exo -75.93 57.36 5.1 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.587 2.858 . . . . 0.0 113.053 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.64 HG13 ' HG ' ' A' ' 27' ' ' LEU . 16.1 m . . . . . 0 C--N 1.315 -0.921 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.772 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.484 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 32.6 m . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 121.103 0.477 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.52 -41.17 2.48 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.888 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -56.28 160.1 3.19 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.637 0.732 . . . . 0.0 112.399 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 20' ' ' ASN . 20.9 p -116.82 152.77 33.73 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.205 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -95.31 132.49 40.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.09 0.471 . . . . 0.0 110.732 178.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 t -79.46 54.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.95 0.881 . . . . 0.0 109.625 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.84 -43.87 1.63 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.103 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.41 33.91 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.411 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.7 p -136.3 138.06 41.33 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.629 -0.336 . . . . 0.0 110.374 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 62.6 m -130.24 128.79 42.34 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.198 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -71.03 -34.15 71.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.465 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.526 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 2.5 m -73.14 117.22 58.24 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 120.96 0.409 . . . . 0.0 110.979 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.14 131.62 46.31 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.794 2.329 . . . . 0.0 112.298 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.32 -11.58 69.3 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.929 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 64.2 m -89.57 106.93 18.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.438 0.619 . . . . 0.0 111.455 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.95 137.89 40.62 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.4 t -67.49 124.49 23.36 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.334 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.563 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 62.8 m -125.89 -166.73 1.6 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.718 ' H ' ' HD3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -45.49 82.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -179.129 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.538 ' O ' HG22 ' A' ' 4' ' ' THR . 14.6 t-20 57.22 20.65 5.88 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.177 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -150.68 144.28 25.09 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 122.008 -0.432 . . . . 0.0 111.643 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 38.4 m -87.8 127.35 35.33 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 28' ' ' PRO . 61.9 p -128.38 140.93 51.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.393 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.484 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 91.6 mtt180 -92.88 103.69 16.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 59.39 35.69 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.669 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.71 -14.84 64.4 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.534 -0.757 . . . . 0.0 113.31 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.1 tp -82.06 114.99 54.85 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 117.311 0.556 . . . . 0.0 111.079 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.566 ' HA ' HG22 ' A' ' 23' ' ' THR . 72.5 Cg_endo -79.75 60.74 7.95 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.038 2.492 . . . . 0.0 112.411 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.61 -179.34 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 25.5 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.282 0.563 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.66 -38.74 3.17 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.435 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -56.35 161.9 2.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.552 0.691 . . . . 0.0 112.04 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 20' ' ' ASN . 16.5 p -114.23 151.07 33.37 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.606 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -95.08 117.99 31.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.353 0.597 . . . . 0.0 110.612 178.471 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -88.32 54.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.959 0.885 . . . . 0.0 110.099 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.68 42.7 0.61 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.388 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.556 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 68.83 32.13 73.57 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.726 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.2 p -135.09 140.18 45.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.742 0.306 . . . . 0.0 110.263 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 72.5 m -132.53 133.64 44.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.366 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -69.29 -42.56 75.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.754 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 8.5 m -68.87 118.26 59.3 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 121.033 0.444 . . . . 0.0 111.572 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 31.6 Cg_exo -58.41 131.44 42.83 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.803 2.335 . . . . 0.0 111.873 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.98 -19.17 55.41 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.932 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.4 m -89.62 104.79 17.32 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.217 0.532 . . . . 0.0 111.066 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 p -81.24 143.56 32.2 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.634 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.556 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 13.5 t -62.59 135.02 57.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.813 0.339 . . . . 0.0 110.677 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 20' ' ' ASN . 40.1 m -141.82 -171.55 3.37 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -46.83 89.36 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.608 0.567 . . . . 0.0 111.931 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.62 ' O ' HG22 ' A' ' 4' ' ' THR . 17.8 p30 48.5 24.22 0.72 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.816 1.246 . . . . 0.0 112.268 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.6 mmtm -150.58 144.13 25.09 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 122.342 0.257 . . . . 0.0 111.449 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 60.2 m -89.35 128.02 35.86 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 41.0 p -110.57 133.01 53.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.244 0.545 . . . . 0.0 111.428 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.551 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 50.7 ttp180 -90.28 102.66 15.38 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 59.26 37.49 23.65 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.812 0.695 . . . . 0.0 109.703 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.47 -14.24 65.73 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.674 -0.693 . . . . 0.0 113.568 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.3 tp -91.4 114.08 60.59 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 117.601 0.7 . . . . 0.0 111.128 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.512 ' CA ' HG22 ' A' ' 23' ' ' THR . 61.3 Cg_endo -74.26 56.2 3.74 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.18 2.587 . . . . 0.0 112.656 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.314 -0.973 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.353 -179.035 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 46.0 m . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.037 0.446 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.0 -36.58 2.34 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.738 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.44 158.22 4.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.294 0.568 . . . . 0.0 112.148 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 20' ' ' ASN . 1.6 p -107.63 156.18 19.33 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.855 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.58 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 4.5 p -108.82 132.4 54.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.367 0.603 . . . . 0.0 111.106 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.65 54.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.671 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.15 -41.4 2.14 Favored Glycine 0 C--N 1.315 -0.633 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.219 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.75 36.34 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.223 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 9.2 p -136.41 139.64 42.6 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 66.9 m -134.35 137.61 44.28 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.126 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -65.81 -57.77 7.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.8 m -64.59 115.6 21.6 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.282 0.563 . . . . 0.0 111.641 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.75 128.07 26.76 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.66 2.24 . . . . 0.0 111.074 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.38 -22.96 25.83 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.301 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 68.2 m -89.58 118.46 29.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.937 0.399 . . . . 0.0 110.254 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -89.68 147.84 23.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.2 t -66.47 134.57 52.73 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.682 0.277 . . . . 0.0 110.437 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.459 ' HB3' ' HD2' ' A' ' 21' ' ' LYS . 10.0 t -137.77 -177.51 4.84 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.474 ' H ' ' HD3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -48.87 91.91 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.542 ' O ' HG22 ' A' ' 4' ' ' THR . 39.9 t30 62.14 11.07 4.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.459 1.104 . . . . 0.0 113.008 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -155.19 151.37 28.09 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.558 -0.714 . . . . 0.0 112.419 179.23 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 47.1 m -88.89 133.19 34.37 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.9 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.46 HG22 ' CA ' ' A' ' 28' ' ' PRO . 37.4 p -117.75 138.48 52.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.053 0.454 . . . . 0.0 110.754 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.4 ttt85 -91.65 98.87 11.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.3 t30 58.57 37.48 25.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.663 0.744 . . . . 0.0 109.137 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.04 -20.66 49.93 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.521 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.598 ' HG ' HG13 ' A' ' 29' ' ' VAL . 16.2 tp -81.95 114.09 47.96 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 117.46 0.63 . . . . 0.0 111.028 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.46 ' CA ' HG22 ' A' ' 23' ' ' THR . 72.2 Cg_endo -77.16 56.45 5.45 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.918 2.412 . . . . 0.0 113.45 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.598 HG13 ' HG ' ' A' ' 27' ' ' LEU . 15.5 m . . . . . 0 C--N 1.313 -1.009 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.751 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.558 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 1.6 m . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.596 0.236 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.74 -37.24 0.73 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.456 -0.402 . . . . 0.0 113.824 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 1' ' ' CYS . 47.2 mm-40 -57.25 164.01 1.95 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.298 0.57 . . . . 0.0 112.449 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -104.95 153.95 20.74 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.698 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -96.45 137.13 35.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.72 178.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.9 t -78.83 55.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.93 0.872 . . . . 0.0 109.413 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.68 -42.77 1.81 Allowed Glycine 0 C--N 1.314 -0.641 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.722 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.61 34.22 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.01 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 9.1 p -136.75 140.12 42.35 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.3 m -127.17 133.98 50.23 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.908 0.385 . . . . 0.0 110.553 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -60.42 -45.42 93.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.118 -177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.558 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 8.7 m -77.52 112.45 24.15 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-O 120.951 0.405 . . . . 0.0 111.438 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.9 Cg_endo -57.56 127.5 25.61 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.526 2.151 . . . . 0.0 111.379 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.68 -24.65 14.74 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.429 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 74.3 m -92.42 118.52 31.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.356 0.598 . . . . 0.0 111.498 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 p -84.08 143.24 29.85 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.434 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.9 t -63.17 133.43 54.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.717 0.294 . . . . 0.0 110.812 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 27.8 m -138.69 -176.1 4.36 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -48.31 88.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.534 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 8.0 m120 54.17 23.12 3.98 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.783 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 10.4 mmtm -150.98 138.4 19.49 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 69.1 m -89.8 121.35 31.86 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 28' ' ' PRO . 57.0 p -109.61 137.47 47.39 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.111 0.481 . . . . 0.0 111.295 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -88.79 92.79 9.35 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 57.57 44.04 21.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.26 -177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.18 -21.79 43.33 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.441 -0.799 . . . . 0.0 113.603 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.659 ' HG ' HG13 ' A' ' 29' ' ' VAL . 18.4 tp -83.19 110.94 26.9 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 117.558 0.679 . . . . 0.0 111.151 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 7.1 Cg_exo -73.32 63.27 4.39 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 123.341 2.694 . . . . 0.0 113.076 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.659 HG13 ' HG ' ' A' ' 27' ' ' LEU . 8.3 m . . . . . 0 C--N 1.319 -0.732 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.449 -0.521 0 CA-C-O 120.996 0.427 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.54 -38.76 2.64 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.929 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.93 156.85 10.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.377 0.608 . . . . 0.0 112.031 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 20' ' ' ASN . 20.4 p -113.19 151.22 31.23 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.742 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.597 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.2 p -98.11 131.35 44.57 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.172 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 t -78.38 55.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.627 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.92 -42.03 2.02 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.869 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.426 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . -179.79 36.08 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.058 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 10.6 p -136.32 139.04 42.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.88 0.371 . . . . 0.0 110.997 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.597 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 89.6 m -135.38 140.73 45.22 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.33 -52.07 8.59 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 m -61.84 118.08 34.99 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-O 121.48 0.657 . . . . 0.0 111.834 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.89 130.84 41.98 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.11 2.54 . . . . 0.0 112.015 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.49 -20.09 49.87 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.03 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 62.5 m -89.47 110.97 21.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.195 0.521 . . . . 0.0 110.802 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 t -85.85 145.72 27.06 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.426 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 8.5 t -64.32 131.74 48.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.006 0.432 . . . . 0.0 109.97 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.427 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 11.0 m -132.65 179.43 6.15 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 19' ' ' LYS . 17.7 mtpp -47.9 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.473 ' O ' HG22 ' A' ' 4' ' ' THR . 7.1 m120 63.83 7.82 3.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.676 178.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.427 ' HD2' ' HB2' ' A' ' 18' ' ' SER . 0.0 OUTLIER -154.84 152.44 29.81 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.551 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 33.5 m -88.87 136.74 32.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.095 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.407 HG22 ' HA ' ' A' ' 28' ' ' PRO . 82.5 p -128.36 145.03 51.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.07 0.462 . . . . 0.0 110.629 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 ttm-85 -89.12 90.95 8.6 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 57.25 43.08 24.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.386 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 99.68 -24.16 33.3 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.421 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.566 ' HG ' HG13 ' A' ' 29' ' ' VAL . 16.2 tp -78.41 111.26 17.59 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 117.401 0.6 . . . . 0.0 110.968 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 71.8 Cg_endo -79.0 57.79 6.63 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.986 2.457 . . . . 0.0 113.344 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.566 HG13 ' HG ' ' A' ' 27' ' ' LEU . 19.1 m . . . . . 0 C--N 1.315 -0.901 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.407 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 39.3 m . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 120.91 0.386 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.33 -33.7 2.48 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.268 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.9 172.51 0.4 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.915 0.864 . . . . 0.0 112.561 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 20' ' ' ASN . 2.0 p -126.65 156.07 41.59 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.284 -1.326 . . . . 0.0 111.74 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -102.88 115.01 29.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.192 0.52 . . . . 0.0 110.578 178.527 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 t -89.97 54.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.855 0.835 . . . . 0.0 110.049 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.97 42.84 0.5 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.365 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.36 29.6 73.17 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.734 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.9 p -135.17 140.28 45.23 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m -127.05 129.7 48.53 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.769 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -69.51 -34.05 73.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.983 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.453 ' HA ' ' HD2' ' A' ' 13' ' ' PRO . 4.4 m -70.34 117.68 57.06 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-O 120.903 0.382 . . . . 0.0 111.116 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 13.2 Cg_endo -57.34 130.52 39.69 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.971 2.447 . . . . 0.0 112.697 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.3 -15.01 60.9 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.684 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 42.2 m -92.73 123.4 35.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.158 0.504 . . . . 0.0 111.397 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.6 t -95.13 154.44 17.18 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 t -67.89 139.5 56.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.067 0.46 . . . . 0.0 110.716 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 20' ' ' ASN . 41.7 m -144.25 -172.52 3.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -48.16 86.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.526 ' O ' HG22 ' A' ' 4' ' ' THR . 8.7 m120 54.36 22.11 3.58 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.729 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 26.6 mmtp -151.41 149.98 29.92 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 120.466 0.174 . . . . 0.0 111.318 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 60.8 m -93.56 130.06 39.57 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.447 HG22 ' CA ' ' A' ' 28' ' ' PRO . 76.0 p -118.46 138.61 52.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.892 0.377 . . . . 0.0 110.535 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.486 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.3 ttp180 -103.87 112.43 25.39 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.11 32.08 19.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.584 0.707 . . . . 0.0 109.115 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.05 -10.4 73.05 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.292 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.2 tp -90.53 116.57 66.7 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 117.147 0.473 . . . . 0.0 111.12 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.447 ' CA ' HG22 ' A' ' 23' ' ' THR . 74.5 Cg_endo -77.15 56.93 5.64 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.205 2.603 . . . . 0.0 112.286 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.314 -0.957 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.859 -179.148 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 121.344 0.593 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.47 -41.11 2.78 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.488 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -60.14 161.78 6.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.4 0.619 . . . . 0.0 112.041 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 20' ' ' ASN . 22.4 p -111.69 151.79 28.48 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.031 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -93.26 115.49 28.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.228 0.537 . . . . 0.0 110.66 178.363 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -87.28 54.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.9 0.857 . . . . 0.0 110.05 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.5 42.64 0.68 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.467 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.433 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.86 29.95 70.63 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.464 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 14.9 p -130.34 140.73 50.61 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 50.6 m -135.17 131.55 36.9 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.787 0.327 . . . . 0.0 111.166 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -74.54 -32.34 62.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.771 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.69 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -63.06 121.83 71.45 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-O 120.89 0.376 . . . . 0.0 110.516 -179.475 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.0 Cg_endo -57.5 122.74 12.29 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.711 2.274 . . . . 0.0 113.53 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.46 12.1 84.15 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.019 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.69 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 96.0 m -100.3 115.26 29.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.546 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 p -84.09 139.33 32.54 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.521 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.433 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 9.0 t -62.76 135.87 57.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.733 0.301 . . . . 0.0 110.763 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 20' ' ' ASN . 15.7 t -140.49 -168.74 2.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -46.4 80.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.627 ' O ' HG22 ' A' ' 4' ' ' THR . 4.7 m120 57.56 22.07 7.78 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.338 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -150.95 145.55 25.66 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.499 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 40.6 m -88.47 138.81 31.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.496 HG22 ' CA ' ' A' ' 28' ' ' PRO . 32.7 p -128.92 140.29 51.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.623 ' HG2' ' SG ' ' A' ' 15' ' ' CYS . 3.6 mtp-105 -89.09 95.36 10.28 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 m120 57.85 33.53 23.32 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.724 0.64 . . . . 0.0 109.868 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.83 -24.47 23.43 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.187 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HG ' HG13 ' A' ' 29' ' ' VAL . 18.7 tp -78.89 111.98 23.92 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 117.317 0.558 . . . . 0.0 111.219 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.496 ' CA ' HG22 ' A' ' 23' ' ' THR . 73.0 Cg_endo -78.0 57.82 6.28 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.111 2.541 . . . . 0.0 113.843 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.591 HG13 ' HG ' ' A' ' 27' ' ' LEU . 15.8 m . . . . . 0 C--N 1.314 -0.97 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.691 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 120.989 0.423 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.01 -37.89 2.37 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.537 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -58.96 165.13 2.55 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.535 0.683 . . . . 0.0 112.45 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 20' ' ' ASN . 7.3 p -115.68 153.41 31.38 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.067 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.588 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.5 p -101.92 133.56 46.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.184 0.516 . . . . 0.0 110.842 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.53 54.02 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.914 0.864 . . . . 0.0 109.681 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.63 -43.23 1.73 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.03 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.74 35.61 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.355 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 10.2 p -136.2 139.78 43.05 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.588 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 56.8 m -133.6 129.77 37.42 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.109 0.481 . . . . 0.0 111.229 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -75.69 -26.83 57.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.767 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.582 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.8 OUTLIER -72.14 121.49 84.8 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-O 120.93 0.395 . . . . 0.0 110.569 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.4 Cg_endo -56.99 129.41 34.35 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.598 2.199 . . . . 0.0 112.768 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.24 10.07 85.51 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.555 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.582 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 86.1 m -103.82 117.53 34.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.672 0.736 . . . . 0.0 111.596 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.84 140.44 30.42 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.926 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.7 t -64.25 135.96 56.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.74 0.305 . . . . 0.0 110.421 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 20' ' ' ASN . 13.4 t -137.58 -167.11 2.06 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -47.48 86.31 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.617 ' O ' HG22 ' A' ' 4' ' ' THR . 6.6 m120 56.78 15.78 2.38 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.125 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 62.2 mmtt -150.27 150.26 31.27 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 46.1 m -88.45 131.48 34.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.827 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 28' ' ' PRO . 42.7 p -122.92 137.55 54.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HG2' ' OD1' ' A' ' 25' ' ' ASN . 43.3 ttm180 -93.88 113.48 25.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.427 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 5.6 p-10 47.39 36.97 5.42 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.163 0.914 . . . . 0.0 111.274 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.23 -13.65 64.42 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.744 -0.662 . . . . 0.0 114.072 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.43 HD12 ' HD2' ' A' ' 28' ' ' PRO . 26.9 tp -91.42 118.12 68.23 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 117.506 0.653 . . . . 0.0 111.529 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.511 ' HA ' HG22 ' A' ' 23' ' ' THR . 74.3 Cg_endo -77.63 58.34 6.35 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.073 2.515 . . . . 0.0 112.24 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--N 1.316 -0.856 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.865 -179.048 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.583 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 23.1 m . . . . . 0 C--O 1.223 -0.327 0 CA-C-O 121.317 0.58 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.05 -39.36 3.03 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.406 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -57.28 165.67 1.37 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.239 0.543 . . . . 0.0 112.071 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -113.81 178.4 4.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.97 178.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -120.08 119.91 34.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.322 0.582 . . . . 0.0 110.774 179.089 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 t -87.35 54.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.935 0.874 . . . . 0.0 109.979 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.14 42.59 0.64 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.347 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.576 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.0 32.46 73.26 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.781 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 14.1 p -135.03 139.51 44.86 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 110.439 179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 69.2 m -128.07 132.86 49.01 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.056 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -71.81 -45.16 62.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.953 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 13' ' ' PRO . 5.0 m -59.89 116.61 17.77 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.561 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.5 Cg_endo -57.43 128.5 29.69 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.064 2.509 . . . . 0.0 112.643 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.61 -20.04 52.18 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.945 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 57.3 m -89.66 118.5 29.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.325 0.583 . . . . 0.0 111.112 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.88 145.24 25.54 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.576 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 15.2 t -62.26 133.3 54.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.949 0.404 . . . . 0.0 111.012 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 20' ' ' ASN . 35.1 m -141.58 -170.73 3.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -47.39 83.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.437 ' O ' HG23 ' A' ' 4' ' ' THR . 18.1 t30 55.83 22.9 5.96 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.999 0.92 . . . . 0.0 111.026 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -151.48 144.04 24.26 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.678 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 66.7 m -89.43 127.62 35.85 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.56 HG22 ' CA ' ' A' ' 28' ' ' PRO . 43.9 p -108.51 133.79 52.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.972 0.415 . . . . 0.0 111.015 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.583 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 44.6 ttt-85 -97.21 110.94 23.38 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.15 30.78 20.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.79 0.681 . . . . 0.0 109.543 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.37 -14.01 65.78 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.42 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 tp -91.8 116.55 66.66 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.546 0.673 . . . . 0.0 111.296 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.56 ' CA ' HG22 ' A' ' 23' ' ' THR . 62.2 Cg_endo -75.11 56.52 4.34 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.071 2.514 . . . . 0.0 112.627 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.445 -178.832 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 1.7 m . . . . . 0 C--O 1.225 -0.187 0 CA-C-O 120.898 0.38 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.53 -27.75 1.28 Allowed Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.256 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 1' ' ' CYS . 6.5 mt-10 -58.64 172.02 0.56 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.67 0.788 . . . . 0.0 112.011 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -118.34 -179.91 3.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.09 178.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -128.74 134.59 48.49 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.218 0.532 . . . . 0.0 111.538 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 t -80.82 53.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.911 0.862 . . . . 0.0 109.372 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.02 -43.97 1.6 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.011 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.83 35.65 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.282 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 8.9 p -136.13 140.88 44.01 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.794 -0.239 . . . . 0.0 110.507 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 66.1 m -129.83 143.38 50.78 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.973 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . 0.404 ' HB2' ' OE1' ' A' ' 3' ' ' GLU . 5.9 m120 -61.32 -56.85 15.74 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.553 HG21 ' NH2' ' A' ' 24' ' ' ARG . 76.3 m -70.74 116.09 42.38 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 121.374 0.606 . . . . 0.0 111.945 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.76 129.92 34.47 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.631 2.221 . . . . 0.0 110.766 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.87 -28.0 10.4 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.063 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 34.6 m -88.81 112.22 22.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.583 0.706 . . . . 0.0 110.9 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.43 142.52 34.24 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.979 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.5 t -62.18 124.24 20.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.804 0.335 . . . . 0.0 110.474 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 13.0 m -126.76 -175.78 3.51 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -48.49 85.51 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 18' ' ' SER . 79.5 m-20 60.69 14.89 5.35 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.037 0.935 . . . . 0.0 111.974 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 18' ' ' SER . 50.7 mmtt -147.82 141.27 25.35 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 50.0 m -89.41 127.47 35.83 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.594 HG22 ' HA ' ' A' ' 28' ' ' PRO . 62.1 p -119.84 136.69 54.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.855 0.359 . . . . 0.0 110.954 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.553 ' NH2' HG21 ' A' ' 12' ' ' THR . 13.9 ptp180 -99.68 109.99 22.42 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.36 34.09 22.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.141 -177.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.28 -14.94 64.1 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.596 -0.729 . . . . 0.0 113.577 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 28.5 tp -82.88 112.12 35.31 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 117.288 0.544 . . . . 0.0 111.343 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.594 ' HA ' HG22 ' A' ' 23' ' ' THR . 6.2 Cg_exo -78.65 59.4 7.21 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.578 2.852 . . . . 0.0 112.204 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.315 -0.901 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.589 -178.896 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.637 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 25.9 m . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 121.2 0.524 . . . . 0.0 111.418 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.6 -40.14 2.85 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.539 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -58.0 162.18 3.52 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.89 0.852 . . . . 0.0 112.489 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 20' ' ' ASN . 28.5 p -119.84 150.61 40.17 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.444 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.7 p -92.79 114.93 27.62 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.454 0.645 . . . . 0.0 110.91 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -86.94 54.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.058 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.02 42.91 0.69 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.409 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.577 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.92 31.26 69.83 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.664 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.61 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 12.7 p -132.96 139.23 47.2 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.909 0.385 . . . . 0.0 110.588 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 67.3 m -135.65 136.92 41.35 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.804 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -75.03 -48.91 21.7 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.446 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 16.2 m -60.0 118.34 31.75 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.768 -178.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 15.3 Cg_endo -57.94 131.29 42.77 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.948 2.432 . . . . 0.0 112.258 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.13 -16.05 61.82 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.233 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.9 m -88.7 108.39 19.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.238 0.542 . . . . 0.0 110.944 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -83.99 146.11 28.16 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.577 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 9.8 t -65.89 121.79 15.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.833 0.349 . . . . 0.0 110.188 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 20' ' ' ASN . 6.8 m -122.53 -170.61 2.11 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -49.47 85.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.555 ' O ' HG22 ' A' ' 4' ' ' THR . 7.0 m120 56.11 23.01 6.46 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.525 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.413 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 26.1 mmtp -151.07 143.95 24.52 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.4 m -89.76 132.87 34.99 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 79.8 p -128.75 141.71 51.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.847 0.356 . . . . 0.0 111.297 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.637 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 71.4 mtp180 -88.68 96.94 10.86 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 m120 58.63 34.35 23.77 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.81 0.694 . . . . 0.0 110.01 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.409 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 103.88 -20.15 42.0 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.059 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.602 ' HG ' HG13 ' A' ' 29' ' ' VAL . 17.5 tp -81.83 111.06 23.32 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 117.358 0.579 . . . . 0.0 110.947 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.476 ' HA ' HG22 ' A' ' 23' ' ' THR . 72.8 Cg_endo -78.46 57.37 6.25 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.187 2.591 . . . . 0.0 113.454 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.602 HG13 ' HG ' ' A' ' 27' ' ' LEU . 15.8 m . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.313 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.476 ' SG ' ' HG2' ' A' ' 24' ' ' ARG . 14.5 m . . . . . 0 N--CA 1.456 -0.169 0 CA-C-O 121.338 0.59 . . . . 0.0 110.809 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.62 -40.09 2.73 Favored Glycine 0 N--CA 1.45 -0.433 0 CA-C-N 115.383 -0.826 . . . . 0.0 113.813 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -59.9 163.03 4.89 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.444 0.64 . . . . 0.0 112.289 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 20' ' ' ASN . 27.2 p -111.93 151.88 28.69 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.676 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.635 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.2 p -96.41 114.95 26.66 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.358 0.599 . . . . 0.0 110.499 178.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -87.35 55.14 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.984 0.897 . . . . 0.0 110.09 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.93 42.8 0.7 Allowed Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.525 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.48 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.82 30.19 70.55 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.085 -0.579 . . . . 0.0 112.632 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.635 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 15.2 p -129.79 139.97 51.14 Favored 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 52.2 m -135.4 132.35 37.41 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.013 -178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -73.63 -35.49 65.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.32 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.639 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -61.56 121.79 66.47 Favored Pre-proline 0 N--CA 1.442 -0.83 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.35 -179.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 11.1 Cg_endo -56.18 125.52 19.35 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.002 2.468 . . . . 0.0 113.579 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.22 8.52 83.53 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 114.699 -1.137 . . . . 0.0 113.641 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.639 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 90.5 m -93.33 117.26 29.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.865 0.832 . . . . 0.0 111.209 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.3 p -81.68 138.69 35.23 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.945 178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.48 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.3 t -64.79 135.8 56.2 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.885 0.374 . . . . 0.0 110.414 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 20' ' ' ASN . 46.0 m -141.02 -170.98 3.16 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -46.74 83.18 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.626 ' O ' HG22 ' A' ' 4' ' ' THR . 15.5 t-20 58.76 18.94 6.41 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.474 -0.785 . . . . 0.0 111.073 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.3 mmtm -150.49 145.39 25.97 Favored 'General case' 0 C--O 1.223 -0.306 0 O-C-N 121.958 -0.464 . . . . 0.0 111.926 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.61 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 36.3 m -88.66 134.63 33.84 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 41.4 p -121.37 141.32 51.07 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.507 ' HG2' ' SG ' ' A' ' 15' ' ' CYS . 10.6 mmm180 -91.46 93.83 9.18 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 177.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 m120 58.38 36.46 25.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.053 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 103.26 -23.82 32.11 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.745 -0.741 . . . . 0.0 113.215 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.3 tp -81.04 114.39 48.38 Favored Pre-proline 0 CA--C 1.531 0.238 0 CA-C-N 117.41 0.605 . . . . 0.0 111.353 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -75.51 59.39 5.51 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 123.325 2.684 . . . . 0.0 112.283 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 C--N 1.317 -0.847 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.993 -179.133 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 37.3 m . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 121.117 0.484 . . . . 0.0 110.962 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.57 38.82 79.01 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.573 -0.74 . . . . 0.0 113.121 179.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.745 ' HG3' ' HB2' ' A' ' 22' ' ' CYS . 5.0 pt-20 -137.84 160.22 39.87 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.699 0.285 . . . . 0.0 110.512 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.556 HG22 ' O ' ' A' ' 20' ' ' ASN . 15.1 p -113.9 150.81 33.13 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.155 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -94.92 132.05 40.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.107 0.48 . . . . 0.0 110.758 178.56 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -79.33 53.67 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 121.978 0.894 . . . . 0.0 109.767 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.25 -44.05 1.59 Allowed Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.868 -178.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.72 34.76 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.246 179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 12.9 p -136.22 138.77 42.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 122.734 -0.274 . . . . 0.0 110.411 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.494 ' HB3' ' OE2' ' A' ' 3' ' ' GLU . 90.9 m -128.28 133.68 48.8 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -65.99 -50.8 63.01 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -176.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.5 m -69.05 114.85 26.22 Favored Pre-proline 0 C--N 1.317 -0.844 0 CA-C-O 121.153 0.502 . . . . 0.0 111.208 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -60.18 125.1 16.64 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.269 1.979 . . . . 0.0 110.965 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.69 -19.68 28.13 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.707 -0.759 . . . . 0.0 111.477 -178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 64.5 m -89.23 115.34 26.66 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.254 0.55 . . . . 0.0 110.517 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.5 p -83.63 134.04 34.81 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.933 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 7.1 t -63.33 123.12 17.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.902 0.382 . . . . 0.0 110.252 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.425 ' O ' ' N ' ' A' ' 20' ' ' ASN . 13.7 m -120.96 -168.8 1.72 Allowed 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.5 ptpt -47.59 83.46 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.556 ' O ' HG22 ' A' ' 4' ' ' THR . 28.9 t-20 61.04 15.14 5.92 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.314 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 7.1 mmtp -148.36 138.78 22.72 Favored 'General case' 0 C--O 1.218 -0.571 0 O-C-N 121.91 -0.494 . . . . 0.0 111.539 -179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.745 ' HB2' ' HG3' ' A' ' 3' ' ' GLU . 38.5 m -88.37 125.44 34.71 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.4 p -116.8 142.36 47.02 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.814 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.421 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 28.7 ttt85 -91.51 100.43 13.19 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.9 t30 59.36 40.87 20.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.717 0.77 . . . . 0.0 109.484 -177.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 88.57 -12.39 65.38 Favored Glycine 0 CA--C 1.522 0.494 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.613 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.632 ' HG ' HG13 ' A' ' 29' ' ' VAL . 16.2 tp -91.38 113.48 58.63 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 117.442 0.621 . . . . 0.0 110.778 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -73.97 56.94 3.76 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.429 2.752 . . . . 0.0 113.001 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.632 HG13 ' HG ' ' A' ' 27' ' ' LEU . 13.5 m . . . . . 0 C--N 1.315 -0.9 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.8 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 48.6 m . . . . . 0 N--CA 1.45 -0.445 0 CA-C-O 121.026 0.441 . . . . 0.0 111.564 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.87 -36.56 2.32 Favored Glycine 0 CA--C 1.521 0.447 0 CA-C-N 116.005 -0.543 . . . . 0.0 113.689 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 21' ' ' LYS . 23.1 mt-10 -57.88 173.88 0.29 Allowed 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.994 0.739 . . . . 0.0 112.994 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.611 HG22 ' H ' ' A' ' 5' ' ' CYS . 0.6 OUTLIER -122.92 -178.44 3.95 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 114.759 -1.109 . . . . 0.0 108.881 178.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.611 ' H ' HG22 ' A' ' 4' ' ' THR . 0.8 OUTLIER -129.18 134.81 48.18 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.191 0.519 . . . . 0.0 111.25 179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -79.85 53.77 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.996 0.903 . . . . 0.0 109.58 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.27 -44.28 1.54 Allowed Glycine 0 N--CA 1.445 -0.753 0 CA-C-N 114.745 -1.116 . . . . 0.0 110.735 -178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.3 35.78 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.2 179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.557 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 10.7 p -136.03 139.83 43.4 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.646 -0.326 . . . . 0.0 110.748 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 53.4 m -131.15 136.83 48.67 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -70.72 -50.79 32.49 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.411 ' HA ' ' HD2' ' A' ' 13' ' ' PRO . 28.4 m -59.79 117.82 26.47 Favored Pre-proline 0 C--N 1.321 -0.666 0 CA-C-O 121.286 0.565 . . . . 0.0 111.818 -178.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 13.7 Cg_endo -56.97 131.85 48.05 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.023 2.482 . . . . 0.0 112.3 -179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.96 -16.5 60.75 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.38 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 85.6 m -89.24 117.21 28.04 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.383 0.611 . . . . 0.0 111.273 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.66 142.91 27.27 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.218 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 11.6 t -63.37 134.23 55.4 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.84 0.352 . . . . 0.0 110.722 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.426 ' O ' ' N ' ' A' ' 20' ' ' ASN . 36.6 m -142.18 -171.3 3.35 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.2 ptpt -46.57 83.71 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.509 ' O ' HG23 ' A' ' 4' ' ' THR . 4.2 m120 56.9 19.69 4.72 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.72 -179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 25.9 mmtm -150.94 145.59 25.7 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 44.7 m -89.16 133.09 34.54 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.497 HG22 ' HA ' ' A' ' 28' ' ' PRO . 80.5 p -125.45 143.49 50.97 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.983 0.42 . . . . 0.0 111.807 -178.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.4 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 59.5 mtt85 -88.7 93.35 9.54 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 56.46 36.92 28.32 Favored 'General case' 0 C--N 1.33 -0.282 0 O-C-N 123.889 0.743 . . . . 0.0 109.714 -178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 108.69 -26.94 14.39 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.529 -0.843 . . . . 0.0 113.313 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.7 tp -76.74 110.58 12.15 Favored Pre-proline 0 CA--C 1.532 0.283 0 CA-C-N 117.39 0.595 . . . . 0.0 111.505 -179.079 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.497 ' HA ' HG22 ' A' ' 23' ' ' THR . 5.6 Cg_exo -78.74 57.43 6.37 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 123.578 2.852 . . . . 0.0 112.681 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 C--N 1.315 -0.933 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.889 -179.414 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 121.29 0.567 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.82 -36.16 2.31 Favored Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.677 -0.692 . . . . 0.0 113.527 179.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 -56.58 160.4 3.27 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.447 0.641 . . . . 0.0 112.239 -179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 20' ' ' ASN . 13.4 p -113.03 151.39 30.73 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.551 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.609 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.2 p -97.68 114.42 26.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.496 0.665 . . . . 0.0 110.825 178.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 t -84.3 55.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.109 -179.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.66 43.23 0.9 Allowed Glycine 0 C--N 1.314 -0.676 0 CA-C-N 114.803 -1.089 . . . . 0.0 111.418 -179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.556 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.57 30.4 68.8 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.66 -179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.609 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 17.0 p -129.04 138.79 52.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.799 0.333 . . . . 0.0 110.21 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 80.9 m -135.38 140.37 44.94 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.087 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -72.72 -56.52 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -177.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 23.9 m -58.98 117.64 22.93 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 121.206 0.527 . . . . 0.0 111.79 -178.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 38.9 Cg_exo -59.49 129.85 32.98 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.811 2.34 . . . . 0.0 111.458 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.63 -17.3 57.75 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.859 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 86.0 m -88.47 100.02 12.73 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 121.372 0.606 . . . . 0.0 110.86 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 p -74.71 138.11 42.55 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.666 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.556 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.6 t -63.02 127.45 31.29 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.895 0.379 . . . . 0.0 110.597 -179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 20' ' ' ASN . 14.4 m -127.15 -167.08 1.68 Allowed 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -49.1 81.87 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.619 ' O ' HG22 ' A' ' 4' ' ' THR . 31.3 t30 58.56 21.28 8.46 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.004 0.921 . . . . 0.0 111.092 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 62.1 mmtt -150.42 143.08 24.57 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.598 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 29.4 m -88.98 130.69 35.42 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 178.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 53.4 p -119.64 137.55 53.81 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.804 0.335 . . . . 0.0 110.522 -179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -88.0 97.24 10.85 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.5 m120 59.1 38.49 23.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.839 -178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.12 -15.87 62.15 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.876 -0.678 . . . . 0.0 113.268 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.599 ' HG ' HG13 ' A' ' 29' ' ' VAL . 17.5 tp -86.73 111.52 40.5 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 117.322 0.561 . . . . 0.0 110.755 -179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.435 ' HA ' HG22 ' A' ' 23' ' ' THR . 68.3 Cg_endo -75.58 56.87 4.73 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 123.154 2.57 . . . . 0.0 113.469 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.599 HG13 ' HG ' ' A' ' 27' ' ' LEU . 14.8 m . . . . . 0 C--N 1.314 -0.944 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.515 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 28.1 m . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 121.299 0.571 . . . . 0.0 110.826 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.79 -34.84 2.52 Favored Glycine 0 C--O 1.238 0.391 0 CA-C-N 115.719 -0.673 . . . . 0.0 113.836 178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -59.82 172.46 0.73 Allowed 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.448 0.642 . . . . 0.0 112.211 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.555 HG23 ' O ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -121.23 179.45 4.4 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.637 179.062 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.574 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -124.64 118.82 27.37 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.35 0.595 . . . . 0.0 111.208 179.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 t -89.48 54.53 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.883 0.849 . . . . 0.0 109.859 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.97 42.4 0.61 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.389 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.412 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.42 31.0 71.06 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 121.11 -0.566 . . . . 0.0 112.756 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 13.5 p -131.95 139.4 48.68 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 58.0 m -128.6 141.53 51.33 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.747 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -66.73 -56.71 9.31 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.4 m -62.98 118.62 44.26 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 121.168 0.509 . . . . 0.0 111.599 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.61 129.77 32.4 Favored 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.644 2.229 . . . . 0.0 111.307 179.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.71 -18.9 54.34 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.621 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 73.6 m -89.15 105.45 17.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.127 0.489 . . . . 0.0 110.843 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.54 140.62 38.51 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.424 178.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.412 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 7.0 t -63.52 132.1 50.23 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 123.159 0.287 . . . . 0.0 110.472 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.432 ' O ' ' N ' ' A' ' 20' ' ' ASN . 10.1 t -138.35 -167.83 2.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -46.77 81.92 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 -178.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.555 ' O ' HG23 ' A' ' 4' ' ' THR . 44.6 t30 58.13 18.07 5.0 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.695 0.798 . . . . 0.0 111.079 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.9 mmtt -150.71 144.31 25.08 Favored 'General case' 0 C--O 1.221 -0.43 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.917 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.622 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 36.2 m -88.53 130.61 35.19 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.443 HG22 ' CA ' ' A' ' 28' ' ' PRO . 64.3 p -115.21 133.57 55.92 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.828 0.347 . . . . 0.0 110.553 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.414 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 57.3 ttp180 -94.29 105.05 17.03 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 59.78 40.08 19.98 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -177.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 85.91 -10.96 63.64 Favored Glycine 0 CA--C 1.522 0.483 0 CA-C-N 115.334 -0.848 . . . . 0.0 113.704 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.601 ' HG ' HG13 ' A' ' 29' ' ' VAL . 16.4 tp -91.26 113.46 58.45 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 117.52 0.66 . . . . 0.0 110.827 -179.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.443 ' CA ' HG22 ' A' ' 23' ' ' THR . 68.3 Cg_endo -75.93 56.21 4.7 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 123.203 2.602 . . . . 0.0 113.359 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.601 HG13 ' HG ' ' A' ' 27' ' ' LEU . 14.9 m . . . . . 0 C--N 1.313 -0.985 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.647 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 38.7 m . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 121.115 0.484 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.79 -38.38 2.34 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.789 -0.641 . . . . 0.0 113.857 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -58.71 155.85 12.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.25 0.547 . . . . 0.0 111.798 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 20' ' ' ASN . 25.1 p -105.55 152.19 23.37 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.028 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.639 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.5 p -100.42 133.02 45.46 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 121.244 0.545 . . . . 0.0 110.883 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.66 54.44 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.952 0.882 . . . . 0.0 109.695 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.42 -41.6 2.11 Favored Glycine 0 C--N 1.315 -0.612 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.994 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.4 36.21 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.865 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.203 179.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.561 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.2 p -136.09 138.86 42.52 Favored 'General case' 0 CA--C 1.513 -0.465 0 O-C-N 122.671 -0.311 . . . . 0.0 110.531 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.639 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 69.1 m -135.79 134.31 38.81 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.077 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -67.54 -54.78 17.11 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -62.19 116.16 20.54 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-O 121.255 0.55 . . . . 0.0 111.503 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.79 129.83 35.46 Favored 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.746 2.297 . . . . 0.0 111.775 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.74 -17.16 56.87 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.113 -179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 82.6 m -89.14 109.6 20.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.16 0.505 . . . . 0.0 110.83 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.1 p -80.36 139.46 36.55 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.631 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.0 t -63.71 135.94 57.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.046 0.451 . . . . 0.0 110.536 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.539 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 21.8 m -136.64 177.56 7.75 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.7 ttpp -49.79 95.03 0.01 OUTLIER 'General case' 0 C--O 1.236 0.365 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.552 ' O ' HG22 ' A' ' 4' ' ' THR . 9.1 m120 66.71 7.06 4.91 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.498 1.119 . . . . 0.0 113.674 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.539 ' HD2' ' HB2' ' A' ' 18' ' ' SER . 0.0 OUTLIER -154.79 151.52 28.75 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 118.685 0.675 . . . . 0.0 112.732 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.537 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.2 m -88.94 136.95 32.74 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 179.086 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 28' ' ' PRO . 56.1 p -125.94 141.75 51.83 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.017 0.437 . . . . 0.0 111.5 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.8 ttm-85 -93.85 97.31 10.31 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 178.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 58.89 42.45 19.61 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 92.34 -20.95 40.56 Favored Glycine 0 N--CA 1.448 -0.531 0 CA-C-N 115.526 -0.761 . . . . 0.0 113.53 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.461 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 26.1 tp -79.11 113.37 35.45 Favored Pre-proline 0 CA--C 1.53 0.206 0 CA-C-N 117.614 0.707 . . . . 0.0 111.276 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 6.1 Cg_exo -77.75 57.68 6.13 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 123.237 2.624 . . . . 0.0 112.329 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 C--N 1.314 -0.964 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.981 -179.168 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.588 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 60.1 m . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.988 0.423 . . . . 0.0 111.282 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.02 -33.85 2.17 Favored Glycine 0 N--CA 1.452 -0.267 0 CA-C-N 115.901 -0.59 . . . . 0.0 113.124 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.429 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 9.6 mt-10 -54.59 155.01 4.35 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 122.943 0.497 . . . . 0.0 111.691 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 20' ' ' ASN . 15.9 p -111.35 149.41 31.19 Favored 'General case' 0 N--CA 1.432 -1.336 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.827 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.605 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.2 p -97.97 116.25 29.82 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.421 0.629 . . . . 0.0 110.823 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 t -86.42 55.82 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.093 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.95 43.14 0.88 Allowed Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 114.843 -1.072 . . . . 0.0 111.508 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.5 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.73 30.71 68.12 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.539 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.605 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 16.1 p -129.23 138.48 51.71 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 90.1 m -135.67 140.34 44.4 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.124 -179.183 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -66.26 -62.43 1.48 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.659 0.985 . . . . 0.0 113.659 -177.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.5 HG21 ' NH2' ' A' ' 24' ' ' ARG . 55.7 m -66.03 122.01 78.98 Favored Pre-proline 0 C--N 1.318 -0.769 0 CA-C-O 121.366 0.603 . . . . 0.0 112.506 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -59.7 130.74 36.5 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.688 2.258 . . . . 0.0 110.767 178.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 104.33 -20.61 39.6 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.437 -0.887 . . . . 0.0 111.068 -178.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 79.9 m -88.64 83.51 6.75 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.056 0.455 . . . . 0.0 110.287 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -66.09 135.4 54.55 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.692 179.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.5 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 8.8 t -59.84 136.55 58.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 0.0 110.708 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.45 ' O ' ' N ' ' A' ' 20' ' ' ASN . 14.6 t -140.72 -163.96 1.64 Allowed 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 45.9 tptt -46.73 84.9 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.754 0 O-C-N 123.828 0.705 . . . . 0.0 112.04 -179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.532 ' O ' HG22 ' A' ' 4' ' ' THR . 19.2 p30 49.59 23.26 0.9 Allowed 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.978 1.311 . . . . 0.0 111.939 -178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 12.9 mmtp -150.16 145.11 26.1 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.427 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.635 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 32.8 m -88.41 130.4 35.18 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.469 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 45.2 p -114.47 134.42 55.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.007 0.432 . . . . 0.0 110.959 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.588 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.0 ttm180 -89.71 101.12 13.81 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 59.89 35.12 21.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.589 -177.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.72 -14.62 64.54 Favored Glycine 0 N--CA 1.448 -0.566 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.397 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.0 tp -89.22 116.37 66.13 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.478 0.639 . . . . 0.0 111.148 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.402 ' CA ' HG22 ' A' ' 23' ' ' THR . 63.0 Cg_endo -75.08 56.4 4.29 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 123.028 2.485 . . . . 0.0 112.435 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.5 p . . . . . 0 C--N 1.314 -0.955 0 CA-C-N 115.295 -0.866 . . . . 0.0 110.962 -179.254 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 21.4 m . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.069 0.462 . . . . 0.0 110.748 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.05 -38.87 2.01 Favored Glycine 0 C--O 1.238 0.367 0 CA-C-N 115.692 -0.685 . . . . 0.0 113.873 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.484 ' HG3' ' OG1' ' A' ' 12' ' ' THR . 18.8 mm-40 -54.43 161.74 1.32 Allowed 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 123.215 0.606 . . . . 0.0 112.222 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -110.59 155.03 22.92 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.895 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.602 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -99.01 134.63 41.57 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.806 178.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.5 t -79.11 55.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 121.894 0.854 . . . . 0.0 109.478 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.48 -43.93 1.58 Allowed Glycine 0 C--N 1.314 -0.683 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.876 -178.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.03 32.79 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.203 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.602 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.7 p -136.6 138.8 41.6 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 50.3 m -125.12 128.47 48.48 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.205 0.526 . . . . 0.0 110.804 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -70.41 -30.09 66.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.015 -0.993 . . . . 0.0 112.088 -178.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.519 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 1.3 m -73.62 119.46 76.12 Favored Pre-proline 0 C--N 1.32 -0.678 0 CA-C-O 120.764 0.316 . . . . 0.0 110.623 -179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.3 Cg_endo -56.64 131.72 47.35 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.693 2.262 . . . . 0.0 112.524 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.52 -7.22 69.61 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.613 -0.721 . . . . 0.0 113.371 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.2 m -94.15 123.0 37.25 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.268 0.556 . . . . 0.0 111.432 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -92.43 145.49 24.42 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.059 178.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 18.8 t -65.41 135.07 54.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.941 0.4 . . . . 0.0 111.117 -179.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 37.2 m -141.31 -174.5 4.04 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -47.5 86.0 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -178.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.532 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 59.0 t30 56.62 21.02 5.4 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 123.665 0.786 . . . . 0.0 111.322 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.532 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 7.9 mmtm -150.8 141.54 22.75 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -178.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 69.2 m -89.59 129.99 35.96 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.502 HG22 ' CA ' ' A' ' 28' ' ' PRO . 42.7 p -115.01 137.18 52.3 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.068 0.461 . . . . 0.0 111.489 -178.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.419 ' HG2' ' OD1' ' A' ' 25' ' ' ASN . 41.6 ttm180 -96.15 113.42 25.02 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 107.664 -1.235 . . . . 0.0 107.664 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.419 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 5.5 p-10 47.59 37.2 6.25 Favored 'General case' 0 N--CA 1.468 0.461 0 O-C-N 124.088 0.868 . . . . 0.0 111.218 -177.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.16 -16.1 60.54 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.816 -0.629 . . . . 0.0 114.012 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.1 tp -90.86 116.49 66.53 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 117.592 0.696 . . . . 0.0 111.498 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.502 ' CA ' HG22 ' A' ' 23' ' ' THR . 72.7 Cg_endo -76.85 58.67 6.13 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 123.079 2.519 . . . . 0.0 112.372 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.315 -0.914 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.097 -179.004 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 121.137 0.494 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 79.73 -37.92 2.11 Favored Glycine 0 N--CA 1.451 -0.317 0 CA-C-N 115.595 -0.73 . . . . 0.0 113.378 179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -55.86 154.7 6.89 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.347 0.594 . . . . 0.0 111.681 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.622 HG22 ' O ' ' A' ' 20' ' ' ASN . 2.9 p -104.8 153.75 20.91 Favored 'General case' 0 N--CA 1.432 -1.374 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.302 179.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.621 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.8 p -102.07 133.1 47.44 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.14 0.495 . . . . 0.0 110.705 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.4 t -78.55 54.24 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 121.979 0.895 . . . . 0.0 109.615 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.85 -42.71 1.83 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.748 -1.114 . . . . 0.0 110.98 -178.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.72 36.45 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.321 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.54 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 9.9 p -136.17 139.73 43.07 Favored 'General case' 0 CA--C 1.513 -0.478 0 O-C-N 122.623 -0.339 . . . . 0.0 110.244 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.621 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 99.7 m -135.33 137.65 42.62 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.67 -179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -67.56 -57.28 6.75 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 35.1 m -62.38 119.89 53.97 Favored Pre-proline 0 C--N 1.32 -0.688 0 CA-C-O 121.237 0.541 . . . . 0.0 111.898 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 28.1 Cg_exo -59.82 129.64 31.51 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.671 2.247 . . . . 0.0 111.082 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 101.15 -20.04 49.08 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.405 -0.902 . . . . 0.0 111.569 -178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 68.3 m -88.71 105.58 17.79 Favored 'General case' 0 N--CA 1.451 -0.405 0 CA-C-O 121.068 0.461 . . . . 0.0 110.363 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 t -81.93 145.08 30.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 t -64.09 137.13 57.83 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 20' ' ' ASN . 17.4 t -140.85 -166.76 2.22 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -45.8 80.58 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.622 ' O ' HG22 ' A' ' 4' ' ' THR . 28.8 t-20 60.41 13.98 4.45 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.385 0.674 . . . . 0.0 111.175 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 10.1 mmtp -149.45 147.3 28.08 Favored 'General case' 0 C--O 1.223 -0.295 0 O-C-N 121.962 -0.461 . . . . 0.0 111.969 -178.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 50.6 m -88.51 134.4 33.87 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.482 HG22 ' HA ' ' A' ' 28' ' ' PRO . 65.8 p -122.48 136.77 54.96 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.795 0.331 . . . . 0.0 110.802 -179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -89.04 99.42 12.41 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.009 -0.738 . . . . 0.0 109.009 179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 58.44 38.28 25.65 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 123.879 0.737 . . . . 0.0 109.911 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 94.61 -13.99 66.16 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.641 -0.708 . . . . 0.0 113.192 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.64 ' HG ' HG13 ' A' ' 29' ' ' VAL . 17.5 tp -87.99 112.58 50.12 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 117.533 0.666 . . . . 0.0 110.986 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.482 ' HA ' HG22 ' A' ' 23' ' ' THR . 3.0 Cg_exo -75.93 57.36 5.1 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.587 2.858 . . . . 0.0 113.053 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.64 HG13 ' HG ' ' A' ' 27' ' ' LEU . 16.1 m . . . . . 0 C--N 1.315 -0.921 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.772 -179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.484 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 32.6 m . . . . . 0 N--CA 1.449 -0.497 0 CA-C-O 121.103 0.477 . . . . 0.0 111.092 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 80.52 -41.17 2.48 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.531 -0.759 . . . . 0.0 112.888 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 54.8 mm-40 -56.28 160.1 3.19 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.637 0.732 . . . . 0.0 112.399 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.538 HG22 ' O ' ' A' ' 20' ' ' ASN . 20.9 p -116.82 152.77 33.73 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.841 -1.072 . . . . 0.0 111.205 -179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.586 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -95.31 132.49 40.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.09 0.471 . . . . 0.0 110.732 178.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 t -79.46 54.26 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.95 0.881 . . . . 0.0 109.625 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.84 -43.87 1.63 Allowed Glycine 0 N--CA 1.445 -0.744 0 CA-C-N 114.748 -1.114 . . . . 0.0 111.103 -178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.41 33.91 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.411 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.7 p -136.3 138.06 41.33 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.629 -0.336 . . . . 0.0 110.374 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.474 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 62.6 m -130.24 128.79 42.34 Favored 'General case' 0 C--N 1.312 -1.056 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.198 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 23.2 p30 -71.03 -34.15 71.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.465 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.526 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 2.5 m -73.14 117.22 58.24 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-O 120.96 0.409 . . . . 0.0 110.979 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -57.14 131.62 46.31 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 122.794 2.329 . . . . 0.0 112.298 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.32 -11.58 69.3 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.65 -0.704 . . . . 0.0 112.929 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 64.2 m -89.57 106.93 18.78 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 117.438 0.619 . . . . 0.0 111.455 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.95 137.89 40.62 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 178.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 10.4 t -67.49 124.49 23.36 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.334 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.563 ' HB3' ' HD3' ' A' ' 19' ' ' LYS . 62.8 m -125.89 -166.73 1.6 Allowed 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.718 ' H ' ' HD3' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -45.49 82.21 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -179.129 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.538 ' O ' HG22 ' A' ' 4' ' ' THR . 14.6 t-20 57.22 20.65 5.88 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.177 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 33.1 mmtm -150.68 144.28 25.09 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 122.008 -0.432 . . . . 0.0 111.643 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 38.4 m -87.8 127.35 35.33 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.566 HG22 ' HA ' ' A' ' 28' ' ' PRO . 61.9 p -128.38 140.93 51.59 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.393 -178.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.484 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 91.6 mtt180 -92.88 103.69 16.0 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 178.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 59.39 35.69 23.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.669 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.71 -14.84 64.4 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.534 -0.757 . . . . 0.0 113.31 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 28.1 tp -82.06 114.99 54.85 Favored Pre-proline 0 C--O 1.235 0.341 0 CA-C-N 117.311 0.556 . . . . 0.0 111.079 -179.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.566 ' HA ' HG22 ' A' ' 23' ' ' THR . 72.5 Cg_endo -79.75 60.74 7.95 Favored 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 123.038 2.492 . . . . 0.0 112.411 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.61 -179.34 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.551 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 25.5 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.282 0.563 . . . . 0.0 110.426 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.66 -38.74 3.17 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.829 -0.7 . . . . 0.0 113.435 178.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -56.35 161.9 2.34 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.552 0.691 . . . . 0.0 112.04 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.62 HG22 ' O ' ' A' ' 20' ' ' ASN . 16.5 p -114.23 151.07 33.37 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.606 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.57 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -95.08 117.99 31.13 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.353 0.597 . . . . 0.0 110.612 178.471 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -88.32 54.56 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.959 0.885 . . . . 0.0 110.099 -179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.68 42.7 0.61 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.388 -179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.556 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 68.83 32.13 73.57 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.001 -0.619 . . . . 0.0 112.726 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.2 p -135.09 140.18 45.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 120.742 0.306 . . . . 0.0 110.263 179.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.425 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 72.5 m -132.53 133.64 44.01 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.366 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -69.29 -42.56 75.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.754 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 13' ' ' PRO . 8.5 m -68.87 118.26 59.3 Favored Pre-proline 0 C--N 1.317 -0.806 0 CA-C-O 121.033 0.444 . . . . 0.0 111.572 -178.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 12' ' ' THR . 31.6 Cg_exo -58.41 131.44 42.83 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.803 2.335 . . . . 0.0 111.873 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.98 -19.17 55.41 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.932 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.4 m -89.62 104.79 17.32 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.217 0.532 . . . . 0.0 111.066 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.2 p -81.24 143.56 32.2 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.634 178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.556 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 13.5 t -62.59 135.02 57.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.813 0.339 . . . . 0.0 110.677 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.401 ' O ' ' N ' ' A' ' 20' ' ' ASN . 40.1 m -141.82 -171.55 3.37 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.0 tppt? -46.83 89.36 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 O-C-N 123.608 0.567 . . . . 0.0 111.931 -179.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.62 ' O ' HG22 ' A' ' 4' ' ' THR . 17.8 p30 48.5 24.22 0.72 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.816 1.246 . . . . 0.0 112.268 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.6 mmtm -150.58 144.13 25.09 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 122.342 0.257 . . . . 0.0 111.449 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.612 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 60.2 m -89.35 128.02 35.86 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.55 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 41.0 p -110.57 133.01 53.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.244 0.545 . . . . 0.0 111.428 -178.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.551 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 50.7 ttp180 -90.28 102.66 15.38 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 59.26 37.49 23.65 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 123.812 0.695 . . . . 0.0 109.703 -177.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.47 -14.24 65.73 Favored Glycine 0 CA--C 1.522 0.516 0 CA-C-N 115.674 -0.693 . . . . 0.0 113.568 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.3 tp -91.4 114.08 60.59 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 117.601 0.7 . . . . 0.0 111.128 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.512 ' CA ' HG22 ' A' ' 23' ' ' THR . 61.3 Cg_endo -74.26 56.2 3.74 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 123.18 2.587 . . . . 0.0 112.656 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 C--N 1.314 -0.973 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.353 -179.035 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.405 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 46.0 m . . . . . 0 N--CA 1.455 -0.22 0 CA-C-O 121.037 0.446 . . . . 0.0 111.185 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.0 -36.58 2.34 Favored Glycine 0 N--CA 1.451 -0.315 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.738 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -56.44 158.22 4.5 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.294 0.568 . . . . 0.0 112.148 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 20' ' ' ASN . 1.6 p -107.63 156.18 19.33 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.855 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.58 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 4.5 p -108.82 132.4 54.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.367 0.603 . . . . 0.0 111.106 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.2 t -78.65 54.66 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.671 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 103.15 -41.4 2.14 Favored Glycine 0 C--N 1.315 -0.633 0 CA-C-N 114.85 -1.068 . . . . 0.0 111.219 -178.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.75 36.34 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.223 179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 9.2 p -136.41 139.64 42.6 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.58 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 66.9 m -134.35 137.61 44.28 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.126 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 22.5 t30 -65.81 -57.77 7.18 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -177.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.8 m -64.59 115.6 21.6 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-O 121.282 0.563 . . . . 0.0 111.641 -178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -58.75 128.07 26.76 Favored 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.66 2.24 . . . . 0.0 111.074 179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 108.38 -22.96 25.83 Favored Glycine 0 N--CA 1.442 -0.93 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.301 -178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 68.2 m -89.58 118.46 29.22 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 120.937 0.399 . . . . 0.0 110.254 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.2 t -89.68 147.84 23.64 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 6.2 t -66.47 134.57 52.73 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.682 0.277 . . . . 0.0 110.437 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.459 ' HB3' ' HD2' ' A' ' 21' ' ' LYS . 10.0 t -137.77 -177.51 4.84 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.474 ' H ' ' HD3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -48.87 91.91 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.963 0.727 . . . . 0.0 112.963 -178.715 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.542 ' O ' HG22 ' A' ' 4' ' ' THR . 39.9 t30 62.14 11.07 4.11 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 124.459 1.104 . . . . 0.0 113.008 179.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -155.19 151.37 28.09 Favored 'General case' 0 C--N 1.327 -0.379 0 O-C-N 121.558 -0.714 . . . . 0.0 112.419 179.23 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.488 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 47.1 m -88.89 133.19 34.37 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.137 -0.483 . . . . 0.0 109.9 179.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.46 HG22 ' CA ' ' A' ' 28' ' ' PRO . 37.4 p -117.75 138.48 52.01 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.053 0.454 . . . . 0.0 110.754 -179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 29.4 ttt85 -91.65 98.87 11.9 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.296 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 40.3 t30 58.57 37.48 25.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.663 0.744 . . . . 0.0 109.137 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.04 -20.66 49.93 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.446 -0.797 . . . . 0.0 113.521 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.598 ' HG ' HG13 ' A' ' 29' ' ' VAL . 16.2 tp -81.95 114.09 47.96 Favored Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 117.46 0.63 . . . . 0.0 111.028 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.46 ' CA ' HG22 ' A' ' 23' ' ' THR . 72.2 Cg_endo -77.16 56.45 5.45 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.918 2.412 . . . . 0.0 113.45 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.598 HG13 ' HG ' ' A' ' 27' ' ' LEU . 15.5 m . . . . . 0 C--N 1.313 -1.009 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.751 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.558 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 1.6 m . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.596 0.236 . . . . 0.0 110.976 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.74 -37.24 0.73 Allowed Glycine 0 CA--C 1.524 0.608 0 C-N-CA 121.456 -0.402 . . . . 0.0 113.824 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 1' ' ' CYS . 47.2 mm-40 -57.25 164.01 1.95 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.298 0.57 . . . . 0.0 112.449 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.2 p -104.95 153.95 20.74 Favored 'General case' 0 N--CA 1.437 -1.08 0 CA-C-N 115.276 -0.875 . . . . 0.0 111.698 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.565 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -96.45 137.13 35.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.72 178.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.9 t -78.83 55.45 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.93 0.872 . . . . 0.0 109.413 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 104.68 -42.77 1.81 Allowed Glycine 0 C--N 1.314 -0.641 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.722 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.61 34.22 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.01 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.565 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 9.1 p -136.75 140.12 42.35 Favored 'General case' 0 CA--C 1.511 -0.525 0 N-CA-C 110.166 -0.309 . . . . 0.0 110.166 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 65.3 m -127.17 133.98 50.23 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-O 120.908 0.385 . . . . 0.0 110.553 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 15.4 p-10 -60.42 -45.42 93.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.118 -177.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.558 ' HB ' ' SG ' ' A' ' 1' ' ' CYS . 8.7 m -77.52 112.45 24.15 Favored Pre-proline 0 C--N 1.318 -0.764 0 CA-C-O 120.951 0.405 . . . . 0.0 111.438 -179.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.454 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.9 Cg_endo -57.56 127.5 25.61 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.526 2.151 . . . . 0.0 111.379 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 111.68 -24.65 14.74 Favored Glycine 0 N--CA 1.439 -1.16 0 CA-C-N 115.421 -0.809 . . . . 0.0 111.429 -178.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 74.3 m -92.42 118.52 31.03 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.356 0.598 . . . . 0.0 111.498 179.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 p -84.08 143.24 29.85 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.434 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.9 t -63.17 133.43 54.33 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.717 0.294 . . . . 0.0 110.812 -179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 27.8 m -138.69 -176.1 4.36 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 41.3 tptt -48.31 88.71 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.534 ' O ' ' HG2' ' A' ' 21' ' ' LYS . 8.0 m120 54.17 23.12 3.98 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.783 -179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.534 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 10.4 mmtm -150.98 138.4 19.49 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 69.1 m -89.8 121.35 31.86 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 28' ' ' PRO . 57.0 p -109.61 137.47 47.39 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.111 0.481 . . . . 0.0 111.295 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.5 ttt85 -88.79 92.79 9.35 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 57.57 44.04 21.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.26 -177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 96.18 -21.79 43.33 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.441 -0.799 . . . . 0.0 113.603 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.659 ' HG ' HG13 ' A' ' 29' ' ' VAL . 18.4 tp -83.19 110.94 26.9 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 117.558 0.679 . . . . 0.0 111.151 -179.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 27' ' ' LEU . 7.1 Cg_exo -73.32 63.27 4.39 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 123.341 2.694 . . . . 0.0 113.076 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.659 HG13 ' HG ' ' A' ' 27' ' ' LEU . 8.3 m . . . . . 0 C--N 1.319 -0.732 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 60.2 m . . . . . 0 N--CA 1.449 -0.521 0 CA-C-O 120.996 0.427 . . . . 0.0 111.605 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.54 -38.76 2.64 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.929 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -58.93 156.85 10.8 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.377 0.608 . . . . 0.0 112.031 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.473 HG22 ' O ' ' A' ' 20' ' ' ASN . 20.4 p -113.19 151.22 31.23 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.742 177.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.597 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 2.2 p -98.11 131.35 44.57 Favored 'General case' 0 C--N 1.316 -0.888 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.172 179.187 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 t -78.38 55.07 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.627 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.92 -42.03 2.02 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 114.758 -1.11 . . . . 0.0 110.869 -178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.426 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . -179.79 36.08 0.07 OUTLIER Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.058 179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 10.6 p -136.32 139.04 42.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.88 0.371 . . . . 0.0 110.997 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.597 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 89.6 m -135.38 140.73 45.22 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.33 -52.07 8.59 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 m -61.84 118.08 34.99 Favored Pre-proline 0 C--N 1.318 -0.761 0 CA-C-O 121.48 0.657 . . . . 0.0 111.834 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -56.89 130.84 41.98 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.11 2.54 . . . . 0.0 112.015 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 100.49 -20.09 49.87 Favored Glycine 0 N--CA 1.442 -0.928 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.03 -179.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 62.5 m -89.47 110.97 21.75 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-O 121.195 0.521 . . . . 0.0 110.802 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 10.3 t -85.85 145.72 27.06 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.426 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 8.5 t -64.32 131.74 48.18 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.006 0.432 . . . . 0.0 109.97 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.427 ' HB2' ' HD2' ' A' ' 21' ' ' LYS . 11.0 m -132.65 179.43 6.15 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 19' ' ' LYS . 17.7 mtpp -47.9 94.0 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.263 0.838 . . . . 0.0 113.263 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.473 ' O ' HG22 ' A' ' 4' ' ' THR . 7.1 m120 63.83 7.82 3.46 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.676 178.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.427 ' HD2' ' HB2' ' A' ' 18' ' ' SER . 0.0 OUTLIER -154.84 152.44 29.81 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 179.551 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 33.5 m -88.87 136.74 32.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.095 179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.407 HG22 ' HA ' ' A' ' 28' ' ' PRO . 82.5 p -128.36 145.03 51.2 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.07 0.462 . . . . 0.0 110.629 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 52.7 ttm-85 -89.12 90.95 8.6 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 57.25 43.08 24.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.301 -0.863 . . . . 0.0 109.386 -177.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 99.68 -24.16 33.3 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.714 -0.755 . . . . 0.0 113.421 -179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.566 ' HG ' HG13 ' A' ' 29' ' ' VAL . 16.2 tp -78.41 111.26 17.59 Favored Pre-proline 0 CA--C 1.531 0.231 0 CA-C-N 117.401 0.6 . . . . 0.0 110.968 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 71.8 Cg_endo -79.0 57.79 6.63 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.986 2.457 . . . . 0.0 113.344 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.566 HG13 ' HG ' ' A' ' 27' ' ' LEU . 19.1 m . . . . . 0 C--N 1.315 -0.901 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.407 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.486 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 39.3 m . . . . . 0 N--CA 1.451 -0.393 0 CA-C-O 120.91 0.386 . . . . 0.0 111.307 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.33 -33.7 2.48 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.877 -0.601 . . . . 0.0 113.268 179.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.9 172.51 0.4 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-O 121.915 0.864 . . . . 0.0 112.561 -179.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 20' ' ' ASN . 2.0 p -126.65 156.07 41.59 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.284 -1.326 . . . . 0.0 111.74 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.641 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -102.88 115.01 29.77 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.192 0.52 . . . . 0.0 110.578 178.527 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.0 t -89.97 54.54 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.855 0.835 . . . . 0.0 110.049 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.97 42.84 0.5 Allowed Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 114.969 -1.014 . . . . 0.0 111.365 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.36 29.6 73.17 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.734 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 11.9 p -135.17 140.28 45.23 Favored 'General case' 0 CA--C 1.511 -0.537 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 57.3 m -127.05 129.7 48.53 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.769 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -69.51 -34.05 73.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.983 -178.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.453 ' HA ' ' HD2' ' A' ' 13' ' ' PRO . 4.4 m -70.34 117.68 57.06 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-O 120.903 0.382 . . . . 0.0 111.116 -179.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.453 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 13.2 Cg_endo -57.34 130.52 39.69 Favored 'Trans proline' 0 C--O 1.237 0.462 0 C-N-CA 122.971 2.447 . . . . 0.0 112.697 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.3 -15.01 60.9 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-N 115.478 -0.783 . . . . 0.0 112.684 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 42.2 m -92.73 123.4 35.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.158 0.504 . . . . 0.0 111.397 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.6 t -95.13 154.44 17.18 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 29.6 t -67.89 139.5 56.49 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.067 0.46 . . . . 0.0 110.716 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 20' ' ' ASN . 41.7 m -144.25 -172.52 3.8 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -48.16 86.13 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.526 ' O ' HG22 ' A' ' 4' ' ' THR . 8.7 m120 54.36 22.11 3.58 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.729 -179.404 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 26.6 mmtp -151.41 149.98 29.92 Favored 'General case' 0 C--O 1.223 -0.332 0 CA-C-O 120.466 0.174 . . . . 0.0 111.318 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.451 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 60.8 m -93.56 130.06 39.57 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 178.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.447 HG22 ' CA ' ' A' ' 28' ' ' PRO . 76.0 p -118.46 138.61 52.36 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.892 0.377 . . . . 0.0 110.535 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.486 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.3 ttp180 -103.87 112.43 25.39 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 61.11 32.08 19.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.584 0.707 . . . . 0.0 109.115 -177.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 89.05 -10.4 73.05 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.292 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.2 tp -90.53 116.57 66.7 Favored Pre-proline 0 C--O 1.236 0.349 0 CA-C-N 117.147 0.473 . . . . 0.0 111.12 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.447 ' CA ' HG22 ' A' ' 23' ' ' THR . 74.5 Cg_endo -77.15 56.93 5.64 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.205 2.603 . . . . 0.0 112.286 179.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 C--N 1.314 -0.957 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.859 -179.148 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 10.5 m . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 121.344 0.593 . . . . 0.0 110.807 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.47 -41.11 2.78 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.389 -0.823 . . . . 0.0 113.488 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -60.14 161.78 6.56 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.4 0.619 . . . . 0.0 112.041 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.627 HG22 ' O ' ' A' ' 20' ' ' ASN . 22.4 p -111.69 151.79 28.48 Favored 'General case' 0 N--CA 1.435 -1.218 0 CA-C-N 115.228 -0.897 . . . . 0.0 111.031 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.632 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -93.26 115.49 28.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.228 0.537 . . . . 0.0 110.66 178.363 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.5 t -87.28 54.74 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.9 0.857 . . . . 0.0 110.05 -179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.5 42.64 0.68 Allowed Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 114.882 -1.054 . . . . 0.0 111.467 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.86 29.95 70.63 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.464 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 14.9 p -130.34 140.73 50.61 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 179.313 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.432 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 50.6 m -135.17 131.55 36.9 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-O 120.787 0.327 . . . . 0.0 111.166 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -74.54 -32.34 62.41 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.771 -178.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.69 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.2 OUTLIER -63.06 121.83 71.45 Favored Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-O 120.89 0.376 . . . . 0.0 110.516 -179.475 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.0 Cg_endo -57.5 122.74 12.29 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 122.711 2.274 . . . . 0.0 113.53 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.46 12.1 84.15 Favored Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.019 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.69 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 96.0 m -100.3 115.26 29.51 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.059 -0.656 . . . . 0.0 111.546 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.1 p -84.09 139.33 32.54 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.521 178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.433 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 9.0 t -62.76 135.87 57.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.733 0.301 . . . . 0.0 110.763 -179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.456 ' O ' ' N ' ' A' ' 20' ' ' ASN . 15.7 t -140.49 -168.74 2.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 179.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -46.4 80.38 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.627 ' O ' HG22 ' A' ' 4' ' ' THR . 4.7 m120 57.56 22.07 7.78 Favored 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.365 -0.834 . . . . 0.0 111.338 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 32.2 mmtm -150.95 145.55 25.66 Favored 'General case' 0 C--O 1.223 -0.313 0 CA-C-N 116.662 -0.245 . . . . 0.0 111.499 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 40.6 m -88.47 138.81 31.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.496 HG22 ' CA ' ' A' ' 28' ' ' PRO . 32.7 p -128.92 140.29 51.74 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -177.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.623 ' HG2' ' SG ' ' A' ' 15' ' ' CYS . 3.6 mtp-105 -89.09 95.36 10.28 Favored 'General case' 0 CA--C 1.511 -0.523 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 178.163 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.5 m120 57.85 33.53 23.32 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 123.724 0.64 . . . . 0.0 109.868 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 107.83 -24.47 23.43 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.187 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HG ' HG13 ' A' ' 29' ' ' VAL . 18.7 tp -78.89 111.98 23.92 Favored Pre-proline 0 CA--C 1.533 0.297 0 CA-C-N 117.317 0.558 . . . . 0.0 111.219 -179.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.496 ' CA ' HG22 ' A' ' 23' ' ' THR . 73.0 Cg_endo -78.0 57.82 6.28 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.111 2.541 . . . . 0.0 113.843 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.591 HG13 ' HG ' ' A' ' 27' ' ' LEU . 15.8 m . . . . . 0 C--N 1.314 -0.97 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.691 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 120.989 0.423 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 81.01 -37.89 2.37 Favored Glycine 0 CA--C 1.52 0.401 0 CA-C-N 115.814 -0.63 . . . . 0.0 113.537 179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.7 mm-40 -58.96 165.13 2.55 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-O 121.535 0.683 . . . . 0.0 112.45 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 20' ' ' ASN . 7.3 p -115.68 153.41 31.38 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.067 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.588 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . 1.5 p -101.92 133.56 46.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.184 0.516 . . . . 0.0 110.842 178.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.6 t -79.53 54.02 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.914 0.864 . . . . 0.0 109.681 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 106.63 -43.23 1.73 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 114.895 -1.048 . . . . 0.0 111.03 -178.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.74 35.61 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.355 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.57 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 10.2 p -136.2 139.78 43.05 Favored 'General case' 0 CA--C 1.511 -0.528 0 N-CA-C 110.124 -0.324 . . . . 0.0 110.124 179.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.588 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 56.8 m -133.6 129.77 37.42 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-O 121.109 0.481 . . . . 0.0 111.229 -179.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 17.0 p-10 -75.69 -26.83 57.94 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.767 -179.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.582 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 0.8 OUTLIER -72.14 121.49 84.8 Favored Pre-proline 0 N--CA 1.444 -0.733 0 CA-C-O 120.93 0.395 . . . . 0.0 110.569 -179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.4 Cg_endo -56.99 129.41 34.35 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.598 2.199 . . . . 0.0 112.768 -179.232 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.24 10.07 85.51 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.118 -0.946 . . . . 0.0 113.555 179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.582 ' SG ' ' HB ' ' A' ' 12' ' ' THR . 86.1 m -103.82 117.53 34.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.672 0.736 . . . . 0.0 111.596 179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -85.84 140.44 30.42 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 115.412 -0.813 . . . . 0.0 108.926 178.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 9.7 t -64.25 135.96 56.74 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.74 0.305 . . . . 0.0 110.421 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.412 ' O ' ' N ' ' A' ' 20' ' ' ASN . 13.4 t -137.58 -167.11 2.06 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.5 tppp? -47.48 86.31 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.818 0.673 . . . . 0.0 112.818 -179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.617 ' O ' HG22 ' A' ' 4' ' ' THR . 6.6 m120 56.78 15.78 2.38 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.125 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.405 ' HG2' ' O ' ' A' ' 20' ' ' ASN . 62.2 mmtt -150.27 150.26 31.27 Favored 'General case' 0 C--O 1.222 -0.374 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 46.1 m -88.45 131.48 34.86 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.228 -0.442 . . . . 0.0 109.827 178.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 28' ' ' PRO . 42.7 p -122.92 137.55 54.91 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.864 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.427 ' HG2' ' OD1' ' A' ' 25' ' ' ASN . 43.3 ttm180 -93.88 113.48 25.51 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.427 ' OD1' ' HG2' ' A' ' 24' ' ' ARG . 5.6 p-10 47.39 36.97 5.42 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 124.163 0.914 . . . . 0.0 111.274 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.23 -13.65 64.42 Favored Glycine 0 C--N 1.336 0.53 0 CA-C-N 115.744 -0.662 . . . . 0.0 114.072 178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.43 HD12 ' HD2' ' A' ' 28' ' ' PRO . 26.9 tp -91.42 118.12 68.23 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 117.506 0.653 . . . . 0.0 111.529 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.511 ' HA ' HG22 ' A' ' 23' ' ' THR . 74.3 Cg_endo -77.63 58.34 6.35 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 123.073 2.515 . . . . 0.0 112.24 179.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 C--N 1.316 -0.856 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.865 -179.048 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.583 ' SG ' ' HB2' ' A' ' 24' ' ' ARG . 23.1 m . . . . . 0 C--O 1.223 -0.327 0 CA-C-O 121.317 0.58 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.05 -39.36 3.03 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.406 178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.6 mp0 -57.28 165.67 1.37 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 121.239 0.543 . . . . 0.0 112.071 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.437 HG23 ' O ' ' A' ' 20' ' ' ASN . 0.2 OUTLIER -113.81 178.4 4.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.461 -0.791 . . . . 0.0 109.97 178.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -120.08 119.91 34.72 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.322 0.582 . . . . 0.0 110.774 179.089 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.0 t -87.35 54.84 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.935 0.874 . . . . 0.0 109.979 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 117.14 42.59 0.64 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.347 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.576 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.0 32.46 73.26 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.781 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.521 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 14.1 p -135.03 139.51 44.86 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-O 120.868 0.366 . . . . 0.0 110.439 179.472 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 69.2 m -128.07 132.86 49.01 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.056 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -71.81 -45.16 62.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.953 -178.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.402 ' HA ' ' HD2' ' A' ' 13' ' ' PRO . 5.0 m -59.89 116.61 17.77 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.561 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 12.5 Cg_endo -57.43 128.5 29.69 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 123.064 2.509 . . . . 0.0 112.643 -179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.61 -20.04 52.18 Favored Glycine 0 N--CA 1.444 -0.821 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.945 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 57.3 m -89.66 118.5 29.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.325 0.583 . . . . 0.0 111.112 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -95.88 145.24 25.54 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.576 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 15.2 t -62.26 133.3 54.96 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.949 0.404 . . . . 0.0 111.012 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.429 ' O ' ' N ' ' A' ' 20' ' ' ASN . 35.1 m -141.58 -170.73 3.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.276 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -47.39 83.29 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.437 ' O ' HG23 ' A' ' 4' ' ' THR . 18.1 t30 55.83 22.9 5.96 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 123.999 0.92 . . . . 0.0 111.026 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -151.48 144.04 24.26 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.678 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.669 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 66.7 m -89.43 127.62 35.85 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 177.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.56 HG22 ' CA ' ' A' ' 28' ' ' PRO . 43.9 p -108.51 133.79 52.17 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.972 0.415 . . . . 0.0 111.015 -178.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.583 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 44.6 ttt-85 -97.21 110.94 23.38 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.8 m120 60.15 30.78 20.18 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.79 0.681 . . . . 0.0 109.543 -177.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.37 -14.01 65.78 Favored Glycine 0 CA--C 1.522 0.505 0 CA-C-N 115.793 -0.639 . . . . 0.0 113.42 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 tp -91.8 116.55 66.66 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 117.546 0.673 . . . . 0.0 111.296 -179.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.56 ' CA ' HG22 ' A' ' 23' ' ' THR . 62.2 Cg_endo -75.11 56.52 4.34 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.071 2.514 . . . . 0.0 112.627 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 C--N 1.314 -0.959 0 CA-C-N 115.301 -0.863 . . . . 0.0 111.445 -178.832 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 22' ' ' CYS . 1.7 m . . . . . 0 C--O 1.225 -0.187 0 CA-C-O 120.898 0.38 . . . . 0.0 111.035 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.53 -27.75 1.28 Allowed Glycine 0 CA--C 1.523 0.558 0 C-N-CA 120.91 -0.662 . . . . 0.0 113.256 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 1' ' ' CYS . 6.5 mt-10 -58.64 172.02 0.56 Allowed 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.67 0.788 . . . . 0.0 112.011 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.435 HG22 ' H ' ' A' ' 5' ' ' CYS . 0.2 OUTLIER -118.34 -179.91 3.92 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.09 178.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 9' ' ' THR . 0.8 OUTLIER -128.74 134.59 48.49 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.218 0.532 . . . . 0.0 111.538 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.1 t -80.82 53.98 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.911 0.862 . . . . 0.0 109.372 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 110.02 -43.97 1.6 Allowed Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.011 -178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.83 35.65 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.282 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.535 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 8.9 p -136.13 140.88 44.01 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 122.794 -0.239 . . . . 0.0 110.507 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 66.1 m -129.83 143.38 50.78 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.313 -0.403 . . . . 0.0 109.973 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.404 ' HB2' ' OE1' ' A' ' 3' ' ' GLU . 5.9 m120 -61.32 -56.85 15.74 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.553 HG21 ' NH2' ' A' ' 24' ' ' ARG . 76.3 m -70.74 116.09 42.38 Favored Pre-proline 0 C--N 1.319 -0.746 0 CA-C-O 121.374 0.606 . . . . 0.0 111.945 -178.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.76 129.92 34.47 Favored 'Trans proline' 0 N--CA 1.457 -0.662 0 C-N-CA 122.631 2.221 . . . . 0.0 110.766 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 110.87 -28.0 10.4 Favored Glycine 0 N--CA 1.438 -1.209 0 C-N-CA 120.37 -0.919 . . . . 0.0 111.063 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 34.6 m -88.81 112.22 22.97 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.583 0.706 . . . . 0.0 110.9 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.43 142.52 34.24 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 114.953 -1.022 . . . . 0.0 108.979 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.5 t -62.18 124.24 20.33 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.804 0.335 . . . . 0.0 110.474 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.448 ' HB2' ' O ' ' A' ' 21' ' ' LYS . 13.0 m -126.76 -175.78 3.51 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.6 mmmt -48.49 85.51 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -178.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.412 ' N ' ' O ' ' A' ' 18' ' ' SER . 79.5 m-20 60.69 14.89 5.35 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.037 0.935 . . . . 0.0 111.974 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 18' ' ' SER . 50.7 mmtt -147.82 141.27 25.35 Favored 'General case' 0 C--O 1.22 -0.451 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.68 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 50.0 m -89.41 127.47 35.83 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 178.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.594 HG22 ' HA ' ' A' ' 28' ' ' PRO . 62.1 p -119.84 136.69 54.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.855 0.359 . . . . 0.0 110.954 -179.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.553 ' NH2' HG21 ' A' ' 12' ' ' THR . 13.9 ptp180 -99.68 109.99 22.42 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.36 34.09 22.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.141 -177.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 93.28 -14.94 64.1 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.596 -0.729 . . . . 0.0 113.577 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.438 ' HA ' ' HD3' ' A' ' 28' ' ' PRO . 28.5 tp -82.88 112.12 35.31 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-N 117.288 0.544 . . . . 0.0 111.343 -179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.594 ' HA ' HG22 ' A' ' 23' ' ' THR . 6.2 Cg_exo -78.65 59.4 7.21 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 123.578 2.852 . . . . 0.0 112.204 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 C--N 1.315 -0.901 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.589 -178.896 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.637 ' SG ' ' HG3' ' A' ' 24' ' ' ARG . 25.9 m . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 121.2 0.524 . . . . 0.0 111.418 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 83.6 -40.14 2.85 Favored Glycine 0 N--CA 1.448 -0.521 0 CA-C-N 115.618 -0.719 . . . . 0.0 112.539 -179.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -58.0 162.18 3.52 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 121.89 0.852 . . . . 0.0 112.489 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 20' ' ' ASN . 28.5 p -119.84 150.61 40.17 Favored 'General case' 0 N--CA 1.43 -1.452 0 CA-C-N 114.203 -1.362 . . . . 0.0 109.444 179.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.61 ' HA ' ' O ' ' A' ' 9' ' ' THR . 1.7 p -92.79 114.93 27.62 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.454 0.645 . . . . 0.0 110.91 178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 t -86.94 54.92 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.058 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.02 42.91 0.69 Allowed Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 114.953 -1.021 . . . . 0.0 111.409 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.577 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.92 31.26 69.83 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.664 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.61 ' O ' ' HA ' ' A' ' 5' ' ' CYS . 12.7 p -132.96 139.23 47.2 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 120.909 0.385 . . . . 0.0 110.588 179.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.51 ' SG ' ' HB3' ' A' ' 5' ' ' CYS . 67.3 m -135.65 136.92 41.35 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.804 -179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 37.3 m-20 -75.03 -48.91 21.7 Favored 'General case' 0 CA--C 1.518 -0.282 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -177.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.446 ' HB ' ' SG ' ' A' ' 15' ' ' CYS . 16.2 m -60.0 118.34 31.75 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.768 -178.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 12' ' ' THR . 15.3 Cg_endo -57.94 131.29 42.77 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.948 2.432 . . . . 0.0 112.258 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.13 -16.05 61.82 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.233 -179.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 22' ' ' CYS . 61.9 m -88.7 108.39 19.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.238 0.542 . . . . 0.0 110.944 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 9.7 t -83.99 146.11 28.16 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.577 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 9.8 t -65.89 121.79 15.88 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.833 0.349 . . . . 0.0 110.188 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 20' ' ' ASN . 6.8 m -122.53 -170.61 2.11 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.126 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -49.47 85.28 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.555 ' O ' HG22 ' A' ' 4' ' ' THR . 7.0 m120 56.11 23.01 6.46 Favored 'General case' 0 C--N 1.334 -0.076 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.525 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.413 ' HG2' ' C ' ' A' ' 20' ' ' ASN . 26.1 mmtp -151.07 143.95 24.52 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -178.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 35.4 m -89.76 132.87 34.99 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 177.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 79.8 p -128.75 141.71 51.23 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.847 0.356 . . . . 0.0 111.297 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.637 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 71.4 mtp180 -88.68 96.94 10.86 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 6.7 m120 58.63 34.35 23.77 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.81 0.694 . . . . 0.0 110.01 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.409 ' O ' ' HD3' ' A' ' 28' ' ' PRO . . . 103.88 -20.15 42.0 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.781 -0.723 . . . . 0.0 113.059 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.602 ' HG ' HG13 ' A' ' 29' ' ' VAL . 17.5 tp -81.83 111.06 23.32 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 117.358 0.579 . . . . 0.0 110.947 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.476 ' HA ' HG22 ' A' ' 23' ' ' THR . 72.8 Cg_endo -78.46 57.37 6.25 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 123.187 2.591 . . . . 0.0 113.454 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.602 HG13 ' HG ' ' A' ' 27' ' ' LEU . 15.8 m . . . . . 0 C--N 1.313 -1.012 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.313 179.916 . . . . . . . . 1 1 . 1 stop_ save_